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Abstract
Tuberculosis causes the deaths of 1.8 million people per year and imposes a significant health 
burden on infected people. Tuberculosis presents many challenges in terms of both treatment 
and infection prevention. The chemotherapy course lasts for 6 months and there are 
increasing numbers of drug-resistant infections. The current BCG vaccination fails to control 
adult pulmonary disease and can cau% infections in susceptible individuals. To address the 
deficiencies in protection induced by BCG vaccination research has been directed towards 
enhancement or replacement vaccine strategies.
Mycobacterial Hsp70 has been shown to ch^jerone peptides in vivo and in vitro and has 
immunostimulatory activity, promoting maturation of antigen-presenting cells and the release 
o f proinflanunatory cytokines. This project has sought to harness the immunostimulatory 
activity and the peptide binding capacity of Hsp70 to deliver a range of mycobacterial 
peptides to the host immune system as a novel vaccine to mycobacteria.
This study showed that mycobacterial Hsp70 can be purified fi’om BCG in complex with a 
range of different peptides and vaccination with the Hsp70-peptide complexes induced 
activation and IFNy production by CD4+ T-cells in addition to the secretion of DL-2, IFNy 
and TNFa. Conversely, vaccination with Hsp70 alone did not induce significant T-cell 
activation or cytokine production. Overexpression of Hsp70 in BCG did not enhance 
mycobacterial antigen-specific T-cell activation or cytokine production compared to 
vaccination with the BCG parent strain. Ovcrcxprcssion of both Hsp70 and GroEL in BCG 
did not induce a mycobacterial antigen-specific T-cell response.
Recombinant Mycobacterium vaccae were engineered to express M. tuberculosis alpha- 
crystallin 2 (Acr2) and the fusion protein construct Hsp70-Acr2. Vaccination with M. vaccae 
that overexpressed Acr2 resulted in Acr2-specific IFNy production by CD4+ T-cells. M.
___________________________    P a g e  I 12
vaccae that expressed Hsp70-Acr2 fusion protein had raised numbers of T-cells that 
expressed IFNy and EL4 for all culture conditions but lacked an Acr2-specific T-cell 
response.
The research presented here suggests that the effect of mycobacterial Hsp70 on splenic T-cell 
function appears to be dependent upon the context of the Hsp70 and antigen-presenting-cell 
interaction, that over-expression of Hsp70 by mycobacterial species results in a mixed Type 
1/Type 2 T-cell response, and that Acr2 and Hsp70-peptide complexes represent good heat 
shock protein candidates for further vaccine development.
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1.1 Tuberculosis
I f  the importance o f  a disease fo r  mankind is measured by the number offatalities 
it causes, then tuberculosis must be considered much more important than those 
most feared infectious diseases, plague, cholera and the like.
~ Robert Koch, 24^ March 1882
One third of the world’s population is infected with mycobacteria and at risk of developing 
active disease. Tuberculosis infection is the leading cause of death from a single infectious 
agent resulting in 1.45 million deaths per year worldwide (World Health Organisation, 2011). 
In addition, infection causes significant morbidity with symptoms including a persistent 
cough with bloody sputum, weight-loss, fever and night-sweats.
Mycobacterium tuberculosis was identified as the infectious agent responsible for causing the 
disease tuberculosis by Robert Koch in 1882, but other mycobacterial species including 
Mycobacterium bovis (Wilkins et al., 1986), Mycobacterium qfricanum (Baril et al., 1995), 
Mycobacterium microti (Niemann et al., 2000), Mycobacterium pinipedii, Mycobacterium 
caprae (Cvetnic et al., 2007) and Mycobacterium canetti . are capable o f producing 
tuberculosis-like illness. Infection with M. tuberculosis most commonly occurs through 
inhalation of aerosolised M. tuberculosis in 1-5 pm droplets exhaled from an infected human 
with active disease (Ratcliffe and Palladino, 1953; Riley, 1961). Zoonotic transmission of M  
bovis from infected cattle occurs in a number of countries in Europe and New Zealand and in 
agricultural conununities in developing countries (Cosivi et al., 1998; Shrikrishna et al.,
2009). However^ the majority of cases of mycobacterial disease are due to human to human 
transmission of disease. Individual risk of infection is dependent on a number of factors 
including closeness and frequency of contact with infected individuals, the health of the host
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and the strain of mycobacteria. For example, tuberculosis infection rates are particularly high 
in regions with endemic HIV/AIDS infections in conjunction with poor quality and cramped 
housing.
The small droplet size allows the mycobacteria within to penetrate into the alveolar space in 
the lung where the inhaled bacteria are then engulfed by alveolar macrophages in the lung. In 
general, engulfinent of non-pathogenic bacteria is followed by the formation of a 
phagolysosome where the ingested bacteria are exposed to lytic enzymes that kill and 
degrade the bacteria. M. tuberculosis actively inhibits this fusion and the bacilli that survive 
harsh intracellular environment replicate within the phagosome (Armstrong and Hart, 1971; 
Sangari et al., 2000). Although the pathways involved have not been fully characterised, 
mannose capped lipoarabinomannan (Fratti et al., 2003) and secreted protein-kinase G 
(Walburger et al., 2004) have been identified as part of this evasion mechanism.
Eventually the replication of mycobacteria can result in cell lysis, releasing large numbers of 
bacilli that can infect nearby cells including alveolar epithelial and endothelial cells 
(Bermudez and Goodman, 1996; McDonough and Kress, 1995) as well as monocyte-derived 
macrophage and dendritic cells (Henderson et al., 1997; Lurie, 1964; Thumher et al., 1997) 
that are attracted to the site of infection.
In some infections mycobacteria escape from the primary infection site in the lungs by 
translocating across the epithelial layer or within infected phagocytes, entering the blood 
system and resulting in disseminated mycobacterial disease (Bermudez et al., 2002). 
Mycobacterial dissemination occurs before the host develops adaptive immunity to the 
mycobacteria (Chackerian et al., 2002).
The macrophage and dendritic cells that migrate to the infection site interact with 
mycobacteria via a number of surface receptors. The recognition of mycobacteria is mediated
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by a number of host pathogen recognition receptors including toll-like receptors (TLRs). 
TLR2 and TLR4 respond to mycobacterial cell wall components; lipoarabinomannan (LAM) 
(Bermudez et al., 2002; Quesniaux et al., 2004) and 19 and 27kDa lipoproteins (Pattani et al.,
2010). Stimulation via TLR induces the release of proinflammatory cytokines, including IL12 
and TNFa, by dendritic cells and macrophages (Underhill et al., 1999). The importance of the 
induction of this innate immune response to mycobacteria is demonstrated in a mouse TLR2 
and TLR4 deletion strains where the mice rapidly succumb to mycobacterial infection (Abel 
et al., 2002; Drennan et al., 2004). There is nuance in the innate response, as nucleotide- 
binding oligomerisation domain protein functions in conjunction with TLR2 to produce 
proinflammatory cytokine production in vitro, . but NOD deletion did not increase 
susceptibility to M. tuberculosis infection in vivo (Gandotra et al., 2007).
Pathogenic mycobacteria are further able to modulate this initial proinflammatory response 
through the binding of mannose capped LAM (ManLAM) to c-type lectins including 
dendritic cell specific intercellular adhesion molecule non-grabbing integrin (DC-SIGN) 
(Geijtenbeek et al., 2003; Tailleux et al., 2003) or the mannose receptor (Astarie-Dequeker et 
al., 1999), resulting in uptake of mycobacteria without proinflammatory cytokine release.
Overall, the innate immune response to mycobacteria infection is strongly proinflammatory 
and results in the activation of macrophages and dendritic cells (Henderson et al., 1997). 
Activated dendritic cells upregulate surface expression of major histocompatibility complex 
molecules and costimulatory molecules CD80 and CD86 (Banchereau et al., 2000; Thery and 
Amigorena, 2001). The activated dendritic cells also express chemokine receptor 7, migrate 
to the secondary lymphoid organs where the dendritic cells present mycobacterial antigen to 
T-Cells (Bhatt et al., 2004). Cell mediated immunity develops approximately 2-8 weeks after 
infection (Bloom, 1994).
______________________________   _^ P a g e  I 17
The CD4+ T-cell and the CD8+ T-cell subsets are both involved in mycobacterial immunity 
(Mogues et al., 2001; Muller et al., 1987; Orme and Collins, 1984). The CD4+ and CD8+ T- 
cells activate macrophages by secretion of IFNy and TNFa, although TNFa is also produced 
by macrophages and dendritic cells. Activation of macrophages by IFNy and TNFa results in 
the macrophage killing internalised mycobacteria (Bodnar et al., 2001). This is achieved by 
overcome the mycobacterial block on phagosome lysosome fusion in the macrophage (Herbst 
et al., 2011). IFNy acting in conjunction with TNFa also increases macrophage antigen- 
presentation making the cells more efficient at priming further T-cells. IFNy stimulation 
induces the expression of a range of anti-microbicidal compounds including nitric oxide 
(Denis, 1991; Saito and Nakano, 1996), and other reactive nitrogen intermediates that kill the 
intracellular mycobacteria (Chan et al., 1992). In addition to reactive nitrogen intermediates, 
IFNy stimulation also induces interleukin 12 (EL 12) expression by activated macrophages, 
dendritic cells and B-cells, which in turn enhances the expression of IFNy and TNFa 
production by the T=cells in a positive feedback mechanism. Mice that are deficient in TNFa 
or TNFa receptor expression have defects in granuloma formation and mycobacterial control 
(Bean et al., 1999; Roach et al., 2002). Mice with defects in IFNy , or EL12p40 subunit 
production (Cooper et al., 2002; Cooper et al., 1997) are more susceptible to mycobacterial 
infections and reactivation of latent infections (Botha and Ryffel, 2003). Humans with 
familial susceptibility to mycobacterial infections have also been shown to have deficiencies 
in TNFa production and responses to IFNy (Levin et al., 1995). Genomic studies found 
mutations in families susceptible to weakly pathogenic mycobacteria; and these are located in 
five genes including the EFNy receptor 1 (Jouanguy et al., 1997; Newport et al., 1996), BFNy 
receptor 2 (Dorman and Holland, 1998), lL12p40 subunit (Elloumi-Zghal et al., 2002), IL 12 
receptor B1 (de Jong et al., 1998) and in the transcription factor Signal Transducers and
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Activators of Transcription 1 (STATl), part of the IFNy signalling pathway (Dupuis et al., 
2001).
CD4+ T-cells are important in resistance to mycobacterial infection as demonstrated by 
increased infections rates in HIV positive people (De Cock et al., 1992) and in mice with 
depleted CD4+ T-cell populations (Flory et al., 1992; Muller et al., 1987). It was previously 
thought that only CD4+ T-cells were required for protection from mycobacterial infection but 
CD8+ T-cells were shown to be involved in protection from mycobacterial infection (Flynn 
et al., 1992; Sousa et al., 2000) through both the release o f Thl cytokines ^ d  also through 
the induction of Fas-mediated mechanisms (Brookes et al., 2003) and by induction of 
apoptosis of infected cells by granulysin (Stenger et al., 1998). Apoptosis releases the 
mycobacteria from the protected environment within the cell and the mycobacteria are then 
engulfed by activated macrophages that can kill the bacilli. Of course, the T-cell response 
includes interactions between CD4+ and CD8+ T-cells, with CD4-H T-cells supporting the 
development of CD8+ T-cell responses in mycobacterial infections (Serbina et al., 2001).
Chemokines including CCL2, CCL5 and 1L8 are also secreted by macrophages in response to 
TNFa stimulation (McMurray et al., 2005). These compounds recruit further T-cells and 
activated macrophages to the infection site. This influx of immune cells results in formation 
of granulomas in the lung and TNFa is essential for this process (Bean et al., 1999; Roach et 
al., 2002). The granuloma consists of a centre containing infected macrophage and epithelial 
cells and free bacilli, the centre also has low oxygen levels and may display signs of necrosis. 
Surrounding the centre is a dense population of both CD4+ and CD8+ T-cells, which activate 
macrophages and lyse infected cells respectively. A fibrous wall contains the granuloma, this 
is formed as a result of lymphotoxin A and and TNFa secretion by CD4+ T-cells (Ulrichs and 
Kauffinann, 2006). The granuloma is semi-structured and provides a micro-environment for 
the control of infection, allowing interaction between the immune cells for an efficient
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response and also by limiting the ability of the mycobacteria to spread to other regions of the 
host (Bean et al., 1999; Roach et al., 2002).
The majority o f  mycobacteria are killed within tlie grailuloma and disease progression is 
halted. The surviving mycobacteria enter a non-replicative state within the infected cells in 
the granuloma. At this point the mycobacteria may enter an apparent dormancy, producing 
what is referred to as a latent infection. This dormancy period can last a substantial period of 
time (Lillebaek et al., 2002) and during latent infection the infected individual does not 
display active symptoms of disease, nor are they contagious.
Ninety to 95% of mycobacterial infections lead to this latent stage of infection, with a total 
risk of developing active disease of 5-10% (World Health Organisation, 2010) (Selwyn et al,,
1989). Latently infected individuals are non-infectious and non-symptomatic but these 
individuals remain at risk of reactivation of the infection and progressing to active disease. 
Reactivation can occur as a result of a disturbance in the host immune system leading to poor 
control of infection. Risk factors involved in reactivation disease include malnutrition, 
diabetes, immunosuppressant drugs therapy and IÜV co-infection. An estimate of 
reactivation rates can range from 2% up to 23% over an individual’s lifetime (Parrish et al., 
1998), but may be as high as 5-10% per year in people co-infected with HIV and not 
receiving effective anti-retroviral therapy (Selwyn et al., 1989).
Active tuberculosis occurs when the host immune system is no longer able to control the 
mycobacterial infection, and the bacilli proliferate. The high antigen load induces the T-cells 
in the granuloma to secrete high levels of lytic enzymes, which results in the disruption of the 
granuloma structure, referred to as caseating necrosis. In contrast to latent infection, active 
disease is highly infectious and causes a wide range symptoms; pulmonary tuberculosis 
disease results in coughing and bloody sputum and chest pain, night sweats, fever and chills.
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fatigue and unintentional weight-loss. Additional symptoms can occur in extrapulmonary 
tuberculosis such as swelling of affected regions and disruption of organ functions.
1.2 Current therapy
The current WHO recommended treatment for tuberculosis disease involves a multi-drug 
chemotherapy that lasts for 6 months (World Health Organisation, 2009). For newly 
presenting cases of tuberculosis with presumed drug sensitivity, treatment consists of a daily 
dosage of isoniazid, rifempicin, pyrazinamide and ethambutol for two months followed by 
four to six months on continuation therapy of rifampicin and isoniazid (World Health 
Organisation, 2009). If isoniazid resistance is prevalent in the population ethambutol is 
recommended as part of the continuation phase of treatment. The long time-course for 
treatment is required due to non-genetic drug resistance o f the dormant mycobacteria as the 
drugs are not effective on mycobacteria that are not undergoing active growth.
Compliance with the treatment regime is complicated by severe side-effects of the anti- 
mycobacterial drugs and potential instability of supply due to logistical factors such as 
distance from medical centres and the cost of treatment in developing countries. As a result of 
non-compliance patients may be at risk of developing drug resistant mycobacterial infections. 
To combat this, the World Health Organisation has asked countries to implement the TB- 
DOTS program, this involves directly observed therapy where patients are monitored taking 
their medication to ensure compliance with treatment protocols. This program has been 
expanded into the STOP TB Partnership,
1.3 Current vaccine
Given the difficulties in treating a mycobacterial infection research has focussed on vaccine 
development. Currently the only available vaccine licensed for use in humans is an attenuated
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form of M. bovis. Bacille Calmette Guerin (BCG), which has been in use for 100 years and is 
the most widely used vaccine in human history. The BCG was created from repeated passage 
of a strain of M  bovis on a potato starch medium for 14 years until it no longer caused 
disease in animals. The bacteria accumulated deleterious mutations and deletions (Othieno et 
al., 1999) that led to attenuation of M. bovis whereby it was no longer pathogenic to humans 
with healthy immune systems and induced a protective response to further infection with 
mycobacteria such as M  tuberculosis.
BCG vaccination has been successful in reducing the incidence of disseminated disease and 
meningitis in children, but it has proven less effective at preventing pulmonary tuberculosis 
in adults, as indicated by 9.4 million new cases of tuberculosis in 2009 (World Health 
(Organisation, 2010). BCG vaccination is most effective when administered to newborn 
infants, vaccination in adolescence does not induce significant protection to M  tuberculosis 
challenge. The efficacy of BCG vaccination as measured by protection from infection 
showed variation from 80% to 0% ôVéf different geographical regions (Fine, 1995). Cytokine 
analysis showed that BCG vaccination induced different cytokine profiles according to 
geographical region (Lalor et al., 2009). The differences in BCG-induced immune responses 
and protection could be due to differences in the age of vaccination (Tripathy, 1983), 
variation in the strain of BCG used for vaccination (Lagranderie et al., 1996). Confounding 
factors such as malnourishment (McMurray and Yetley, 1982), co-infection with HIV 
(Mansoor et al., 2009) or pre-vaccination exposure to environmental mycobacteria (Brandt et 
al., 2002; Fine, 1995) could also be responsible for the disparity between the protective effect 
of BCG vaccination. These factors can affect the immune response leading to inefficient 
priming of memory responses.
BCGitis and BCGosis are two clinical complications of BCG vaccination where the BCG 
causes local or systemic infections in immunocompromised individuals such as cancer
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patients (Steg et al., 1989), people with inherited immune defects of the lL12-lFNy axis 
(Mansouri et al., 2005) or people co-infected with HIV (Grohmann et al., 2003a).
1.4 New vaccines
The deficiencies of BCG vaccination have lead to considerable research into alternative 
vaccine candidates. There are various new vaccines in development that aim to either replace 
the BCG or to enhance the protective effect of BCG by using protein subunit vaccines, viral 
vaccines, recombinant BCG vaccines. Many of these novel vaccines use BCG prime boost 
vaccination strategies as BCG protection can diminish over time (Weir et al., 2008) and a 
boost may maintain the magnitude of thé mycobacterial-specific immune response induced 
by BCG vaccination.
Replacement of BCG with a protein subunit vaccine aims to remove the issue of 
immunocompromised individuals who cannot tolerate the live BCG vaccination and therefore 
miss out on protection from infection. Protein subunit vaccines may also avoid the induction 
of inhibitory responses that BCG and other mycobacteria can induce to evade the host 
immune response. Current protein vaccines in clinical trials include a combination of Ag85B 
and ESAT-6 with an adjuvant (Langermans et al., 2005), a fusion construct of Rv 1196 and 
Rv0125 with an adjuvant (Reed et al., 2009) and a fusion of Ag85B and TB10.4 with an 
adjuvant (Dietrich et al., 2005). Adjuvants of often required for protein subunit vaccines as 
the proteins themselves usually have low immunostimulatory potential. The adjuvant 
increases local responses, recruiting antigen-presenting cells and lymphocytes to the site of 
vaccination and so increases the uptake and presentation of the protein vaccine.
Viral vector vaccines efficiently deliver DNÀ into the host cells, where the host protein 
synthesis machinery expresses the encoded genes. The foreign proteins are presented on the 
surface of the cell via MHCn and generate antigen-specific CD4+ T-cell activity. The viral
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vaccines are based on a modified Vaccinia ankara virus that encodes M. tuberculosis Ag85A 
(Scriba et al., 2010; Verreck et al., 2009) or modified non-replicative adenovirus vectors that 
express Ag85A (Wang et al., 2004) or a combination of Ag85A, Ag85B and TB10.4 as a 
boost to BCG priming (Santosuosso et al., 2006). Non-replicative vectors are used to prevent 
viral infection of the host; only cells that originally take up the viral vector vaccine present 
the encoded antigen, the vector cannot follow the viral life-cycle of replication within the 
host cell, lysis and reinfection. Of these viral vector vaccines, the MVA85 A vaccine used as a 
booster with BCG has progressed furthest in clinical trials, demonstrating in safety in infants 
(Scriba et al., 2010), healthy adults (Hawkridge et al., 2008) and latently infected individuals 
(Sander et al., 2009) and the induction of antigen-specific IFNy and IL2 and polyfunctional 
T-cells (Hawkridge et al., 2008; Scriba et al., 2010).
One approach using reconibinant BCG strains is to express antigens of M. tuberculosis. This 
should induce M. tuberculoisis-sptci^c T-cell activity in addition to the other BCG induced 
protective T-cell responses. This approach has been investigated using rBCG30, which 
expresses the M. tuberculosis 30kDa antigen, Ag85B (Horwitz et al., 2006) and resulted in 
greater protection that BCG alone to M  bovis challenge. Another approach is to alter BCG to 
make it inherently more immunogenic. Superior protection to m. tuberculosis aerosol 
challenge was found in mice that were vaccinated with rBCG Prague that is urease deficient 
and also expresses listeriolysin compared to those that received BCG only (Grode et al., 
2005). Urease is secreted by BCG and inhibits MHCn surface expression by macrophages 
(Sendide et al., 2004) therefore deletion should increase MHCII-peptide expression. 
Listeriolysin is secreted by Listeria monocytogenes and lyses the phagosome, allowing the 
bacteria entry to the cytosol. It is hypothesised that expression of listeriolysin by BCG will 
increase BCG en t^  to the cytosol and thus further enhance BCG antigen-presentation to 
CD8+ T-cells.
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Alternative vaccines include non-tuberculosis mycobacteria such as Mycobacterium vaccae, 
which arc less pathogenic in humans than BCG. Additionally, M  vaccae^ as a mycobacterial 
species, shares many antigens with M  tuberculosis so can induce cross-species immune 
reactivity when used as a vaccine (Skinner et al., 1997). Using M. vaccae as a separate 
adjuvant or as an expression vector should result in T-cell responses to a variety of 
mycobacterial antigens, not just the expressed target antigen. This has been found by several 
groups that use M  vaccae to express foreign antigens such as superoxide dismutase where 
the T-cells are capable of responding against mycobacterial lysate in addition to responding 
to stimulation with target antigen (Hetzel et al., 1998).
M  vaccae has already received licensing for use in humans and been used in clinical trials. 
Safety data from early trials showed M. vaccae appears to be less pathogenic than BCG and 
safe for use in HIV positive and other immunocompromised individuals (Stanford et al.,
1990). Trials in humans have shown that subjects vaccinated with M  vaccae while 
continuing standard M  tuberculosis chemotherapy produce IFNy in response to PPD 
stimulation.
Overall, the aim of these new vaccines is to promote a stronger and longer lasting immune 
response than BCG. Much research has focussed on the induction of strong Thl-like T-cell 
response as it has been well documented that T-cell responses are required to clear 
mycobacterial infections. The T-cell response in a successful immune response to 
mycobacteria involves both the CD4+ and CD8+ T-cell populations (Mogues et al., 2001; 
Muller et al., 1987; Orme and Collins, 1984; Scanga et al., 2000). The expression of IFNy is 
an essential part of the successful immune response to mycobacteria, demonstrated most 
clearly in mice with IFNy deletions (Cooper et al., 1993) and in humans with inherited 
defects in the EL12-lFNy axis who are more susceptible to mycobacterial infection (Aleman 
et al., 2005; Mansouri et al., 2005; Newport et al., 1996). Prior to challenge experiments.
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IFNy production is used as a correlate of protection, an indication that the vaccine has 
induced appropriate protective T-cell responses and that the vaccine should move forward to 
protection assays. As mentioned earlier, IFNy activates macrophages, stimulating 
phagocytosis and the expression of iNO, superoxide, lysosomal proteins and cytokine TNFa 
and IFNy.
Many of the antigens mentioned above as part of novel mycobacterial vaccines were 
identified from antigen-specific T-cell clones and antibody production in M. tuberculosis 
patients and BCG vaccinated individuals. In terms of novel antigens for incorporation into 
mycobacterial vaccines, candidate proteins should be known antigenic targets in 
mycobacterial infections or in BCG vaccinated persons and that are well recognised by a 
wide range of individuals. Additionally, proteins essential for survival are attractive targets as 
M. tuberculosis would then not be able to disable expression of the antigen to avoid detection 
by the host immune system. Another desirable trait is the ability of the antigen to 
independently stimulate immune responses in host, particularly the induction of IFNy 
expression.
As discussed more fully later on, IFNy, although required for protection, is not sufficient 
itself for protection. Correlates of protection are biomolecular markers that allow the 
differentiation of protected individuals versus susceptible individuals. These markers may not 
necessarily be involved in the successful immune response. The correlates of protection in 
mycobacterial disease have not been well defined; IFNy is required but as people with 
mycobacterial disease still produce IFNy there are other factors that influence a successful 
response and much research is being directed at identifying reliable correlates of protection in 
mycobacterial disease.
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1.5 Heat shock proteins .
The immunogenic targets of M tuberculosis have been characterised by many different 
groups and some of these targets have been used in some of the novel vaccines currently in 
development. One class of proteins that appear to be strongly immunogenic are 
mycobacterial heat shock proteins (Baird et al., 1988; Mehlert and Young, 1989; Munk et al., 
1988; Mustafa et al., 1993; Ofhmg et al., 1988; OttenhofiF et al., 1988). Heat shock proteins 
are a group of proteins that are upregulated in response to heat (Patel et al., 1991; Young and 
Garbe, 1991) and other stressors such as hypoxia (Manganelli et al., 2001; Sherman et al., 
2001), nitric oxide (Garbe et al., 1999), superoxide and nutrient deprivation. Heat shock 
protein expression is also constitutive as these proteins often play essential roles within the 
cell aiding the correct folding of nascent peptides (Fayet et al., 1989; Houry et al., 1999).
Heat shock protein families are usually classified by molecular size into families, HsplOO, 
Hsp90, Hsp70, Hsp60, Hsp33 and small Hsp’s and each family has separate functions within 
the cell. Heat shock protein families are primarily intracellular proteins although in certain 
conditions the heat shock proteins can relocate to the membrane or are secreted by the cell 
(Johnson and Fleshner, 2006). Heat shock proteins o f M  tuberculosis are of particular interest 
as their expression is increased within the host macrophage (Monahan et al., 2001) and they 
are required for mycobacterial persistence in vivo.
1.5.1 Heat shock protein 70
Heat shock protein 70 (Hsp70) is a 70kDa protein that has an N-terminal ATP-binding site 
(Flaherty et al., 1990) and a C-terminal peptide-binding cleft (Zhu et al., 1996) joined by a 
linker region. Hsp70 functions as a molecular chaperone by binding to hydrophobic peptide 
regions (Rudiger et al., 1997) on both nascent and damaged peptides (Gething and Sambrook, 
1992). A correctly folded protein is unlikely to have hydrophobic regions exposed therefore
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when hydrophobic regions are exposed it indicates that the protein is incorrectly folded. The 
binding of Hsp70 covers the hydrophobic region and prevents the aggregation of misfolded 
peptides in the cell that form as a result of the hydrophobic intermolecular interactions 
between these peptides. Additionally, Hsp70 binding can induce localised unfolding of 
peptides allowing the peptide to refold correctly when released.
Hsp70 is expressed as part of the hsp70 operon which includes Hsp70, GrpE, DnaJ and 
HspR. GrpE is a nucleotide exchange factor that functions as a homodimer, binding to the 
ATP binding site of Hsp70 and facilitating the release of AD? from the Hsp70 ATP binding 
site (Packschies et al., 1997). Hsp70 binds proteins in a 1:1 ratio but the binding is a slow 
reaction (Palleros et al., 1991); The cochaperone DnaJ enhances peptide delivery and binding 
by the Hsp70 (Silver and Way, 1993). DnaJ binds to the ATP binding domain of Hsp70 
(Gassier et al., 1998) and stimulates the hydrolysis of ATP to ADP by Hsp70 (Pierpaoli et al., 
1997), which has a low innate ATPase activity (Schmid et al., 1994).
In M. tuberculosis the expression of the Hsp70 operon is regulated by both transcriptional 
repression by HspR (Stewart 2001) and also by the alternative sigma factor H (Raman et al., 
2001). HspR binds as a dimer with Hsp70 (Bucca et al., 2000; Stewart et al., 2001) to HspR 
associated inverted repeats (HAIR) sequences CTTGAGT-N7-ACTCAAG (Grandvalet et al., 
1999) that are found upstream of several HspR regulated genes. Binding of HspR prevent the 
binding of the transcription machinery inhibiting expression of the downstream gene. 
Uprcgulation of Hsp70 expression occurs when hcat-dcgradcd proteins titrates Hsp70 from 
the Hsp70-HspR dimer. Without Hsp70 the HspR is unable to bind the HAIR sequence 
controlling the expression of the Hsp70 operon and the binding of transcription machinery is 
unimpeded.
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Both human and mycobacterial Hsp70 has been of interest to immunologists due to its ability 
to bind to antigen-presenting cells and enter the cell through receptor mediated endocytosis 
(Amold-Schild et al., 1999; Castellino et al., 2000). Several receptors have been implicated in 
this Hsp70 uptake including LOX-1 (Delneste et al., 2002), CD40 (Becker et al., 2002; Wang 
et al., 2001), CD14 (Asea et al., 2000b), CD91 (Basu et al., 2001) and TLR2 and TLR4 
(Vabulas et al., 2002) as well as scavenger receptor 1 (Gong et al., 2009). Mycobacterial 
Hsp70 has also been shown to interact with human Hsp70 receptors CCR5 (Floto et al., 
2006). It has been suggested that mycobacteria Hsp70 can bind receptors for human Hsp70 
due to the high conservation in Hsp70 sequences between mycobacteria and mammals 
Binding of Hsp70 to Hsp70 receptors induces a proinflammatory response by the antigen 
presenting cells (Retzlaff et al., 1994).
The specific uptake of Hsp70 by receptor mediated endocytosis can be exploited as a delivery 
system for other molecules to antigen-presenting cells. As mentioned above Hsp70 can bind 
peptides, when Hsp70 is taken up by antigen-presenting cells through receptor mediated 
endocytosis the peptide bound by Hsp70 is also engulfed as part of the Hsp70-peptide 
complex. This concept led to the initial interest in Hsp70-peptide complexes in tumour 
vaccines.
Hsp70 can be purified fi’om cells using ATP affinity chromatography (Garsia et al., 1989) and 
Hsp70 can also be purified in complex with peptides naturally chaperoned within the cell 
using ADP affinity chromatography (Peng et al., 1997). Purification of Hsp70-peptide 
complexes fi’om tumour samples induced tumour-specific T-cell activity in vivo (Udono and 
Srivastava, 1993). Purified human Hsp70 resulted in enhanced presentation of tumour antigen 
by antigen-presenting cell (Bendz et al., 2007).
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Peptides shuttled into host cells via Hsp70-mediated uptake are processed as endogenous 
peptides, demonstrated by enhanced presentation by MHCI (Suto and Srivastava, 1995). 
Some research has demonstrated that the tumour-specific responses elicited by vaccination 
with Hsp70-peptide complexes are dependent on CD8+ T-cells only (Harmala et al., 2002; 
Huang et al., 2000) but in vitro models have demonstrated the ability of Hsp70 to deliver 
OVA peptides for processing and presentation by both MHCI (Tobian et al., 2004a) and 
MHCn (Tobian et al., 2004b).
It is possible to load Hsp70 with peptides in vitro and vaccination with the complexes 
induced peptide-specific CD8+ T-cell responses (Blachere et al., 1997). An alternative to 
loading Hsp70 with peptides is to express fusion genes of Hsp70 and other peptides, which 
also results in enhanced peptide-specific responses (Suzue et al., 1997). A further ^proach 
used a DNA vaccine that encoded mycobacterial Hsp70 fused to the human p^illom a type 
16 virus protein E7 that induced greater E7-specific CD8+ T-cell IFNy production than a 
DNA vaccine encoding E7 alone (Chen et al., 2000).
Both mycobacterial and human Hsp70 has been shown to induce proinflammatory responses 
in macrophages and dendritic cells (MacAry et al., 2004; Vabulas et al., 2002). This Hsp70 
stimulatory activity is independent of peptide binding (Asea et al., 2000a; MacAry et al.,
2004).
Mycobacterial Hsp70 shows high sequence similarity between different mycobacterial 
species and also to the eukaryotic Hsc70 (Garsia et al., 1989). It has been proposed that this 
sequence similarity between nfiycobacterial and eukaryotic Hsp70 is the reason that 
mycobacterial Hsp70 can bind to eukaryotic Hsp70-receptors and deliver peptides for 
processing and presentation. Although raised levels of Hsp70 antibodies have been identified 
in some autoimmune disorders (Zlacka et al., 2006) and chronic inflammatory conditions
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(Elsaghier et al., 1992), vaccination with Hsp70 does not necessarily induce Hsp70-specific 
T-cell responses (Peng et al., 1997). In fact, mycobacterial Hsp70 has been shown in inhibit 
the development of inflammatory conditions (Wendling et al., 2000; Wieten et al., 2009). 
This disparity highlights the complexity of the interaction between host cells and 
mycobacterial Hsp70.
1.5.2 GroEL
Another heat shock protein that has been investigated for its immunological properties is 
GroEL. It is a 65kDa protein that is constitutively expressed within cells but also shows 
increased expression when the cells are exposed to a variety of stressors including heat.
From studies in Escherichia coli, GroEL was found to form cylinder-like structures of 
fourteen GroEL molecules structured in two heptameric rings with open cavities at either end 
of the GroEL construct (Ranson et al., 1998). Non-native peptides have exposed hydrophobic 
regions that interact with the exposed hydrophobic region in the cavity of the GroEL 
multimer (Braig et al., 1993; Fenton et al., 1994). The cavity is the enclosed by the binding of 
GroES, a lOkDa cochaperone of GroEL. The GroES molecules form a c ^  that seals the 
cavity in the GroEL (Langer et al., 1992) and this GroEL-GroES interaction alters the internal 
structure o f the cavity, enlarging the space and replacing hydrophobic residues with 
hydrophilic residues (Xu et al., 1997). This structural change dislodges the peptide from the 
hydrophobic residues on GroEL and encourages protein remodelling within the cavity 
(Weissman et al., 1995). The GroEL molecules contain an ATP binding site in the central 
domain on the external surface of the GroEL multimer. Binding of ATP allows the binding of 
GroES and refolding of the eontained peptide, hydrolysis of ATP to ADP releases the GroES 
cap and discharges the peptide (Rye et al., 1997). Some proteins require repeated rounds of 
interaction with GroEL/GroES to reach their native form (Weissman et al., 1994).
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Both GroEL and GroES are essential for cell survival (Fayet et al., 1989) and this is because 
the GroEL-GroES complex is required for the assisting the folding of several essential 
proteins (Horwich et al., 1993; Houry et al., 1999). 10-15% of peptides associate with GroEL 
under normal conditions in E. coli but up to 30% of proteins require GroEL support under 
cellular stress (Ewalt et al., 1997).
Mycobacteria have a duplication of the groEL, groELJ is part of an operon with groES and 
hrcA, but groEL2 is located separately on the genome (Kong et al., 1993). In E. coli GroEL is 
an essential gene (Fayet et al., 1989) but in mycobacteria only groEL2 is essential, an M. 
tuberculosis mutant with groELl deleted is viable but induces less granuloma formation in a 
mouse infection model (Hu et al., 2008).
In terms of structure and function, mycobacterial GroEL does not appear to form the 
tetradecameric structure that E. coli GroEL does. Rather, mycobacterial GroEL consistently 
purifies as a dimer (Qamra et al., 2004) so if it does ch^erone peptides it may not act as a 
cage environment. The dimer structure may be due to alanine to serine and glutamate to 
serine mutations at two sites in mycobacterial GroELl. Mutant E. coli with serine in these 
positions also had GroEL that formed lower order oligomers (Qamra et al., 2004). The 
mycobacterial GroEL dimer structure does have a hydrophobic region exposed and may act 
as a chaperone in a similar mode to Hsp70 by binding to hydrophobic regions in non-native 
peptides (Qamra et al., 2004).
Similarly to Hsp70, GroEL was initially identified as an antigen of interest in vaccine design 
because mycobacterial infections induced humoral and cell-mediated responses to GroEL in 
tuberculosis patients and BCG vaccinated people . From an immunological perspective, 
mycobacterial GroEL is enable Of activating human peripheral mononuclear cells.
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stimulating them to release proinflammatory cytokines (Retzlaff et al., 1994), although 
GroELl is a stronger inducer of cytokine release than GroEL2 (Lewthwaite et al., 2001).
Mycobacterial GroEL has been used in a viral vector D N A  vaccine encoding both GroEL and 
the human cytokine IL12 as part of a modifled haemaglutinating virus of Japan, encased in a 
liposome (Okada et al., 2007). This vaccine resulted in greater protection than BCG only in 
cynomolgus challenge model and protected 100% of challenged monkeys as part of a BCG 
prime-boost strategy.
1.5.3 Alpha crystallin 2
The flnal heat shock protein that was investigated in this thesis is alpha crystallin 2 (Acr2). 
The alpha crystallins are a diverse chaperone family with more sequence variation between 
bacterial species than other ch^erone families. Alpha crystallin chaperones consist of a 
conserved alpha crystallin domain (Caspers et al., 1995) with a more variable N-terminal 
domain (Narberhaus, 2002) and a short C-terminal domain. Mycobacterial alpha crystallin 
exists in vivo as a multimer (Chang et al.; 1996). The multimeric structure of alpha crystallins 
dissociates with heat stress revealing hidden hydrophobic regions that can then bind to 
hydrophobic region on misfolded proteins in a “holdase” activity similar to the of Hsp70. 
This chaperone activity appears to be ATP independent, unlike Hsp70 and GroEL (Jakob et 
al., 1993). Expression of alpha crystallins is generally low in un-stressed cells but is 
signiflcantly increased when the cells are exposed to raised temperatures. Alpha crystallins 
have the ability to prevent protein aggregation due to raised temperatures (Yuan et al., 1996).
There are three classes of alpha crystallin proteins in mycobacteria. The alpha crystallins 
show relatively high sequence conservation between different mycobacterial species, acr2 has 
75% sequence homology between M. tuberculosis^ M. marinum and M. avium. This is high
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compared to the sequence homology of alpha crystallins in other bacteria, which show much 
lower levels of inter-species sequence conservation of around 15-25% (Stewart 2004).
M  tuberculosis has two alpha crystallins. Rv0251c, also designated as alpha-crystallin 2 
(acr2) is a mycobacterial heat-shock-protein. Elevated Acr2 expression is observed when M. 
tuberculosis bacilli are engulfed by both activated and quiescent macrophages in a mouse 
model (Schnappinger, 2003) and this has also been demonstrated when M  tuberculosis is 
taken up by human macrophages (Stewart et al., 2005). The expression of Acr2 is regulated 
by HspR with a HAIR sequence 71 bp upstream of the gene (Stewart et al., 2002) and is the 
most highly upregulated protein in M. tuberculosis one hour post-infection. Increased Acr2 
expression can be seen as early as 1 hour of M. tuberculosis entering a macrophage and 
increases, peaking at 24 hours post infection and this induction of Acr2 expression appears to 
be dependent on reactive oxygen intermediates produced by the infected cell (Wilkinson
2005). The expression of Acr2 is maintained during both acute and chronic phases of murine 
tuberculosis infection, and also during non-replicating persistence (Stewart et al., 2005). The 
consistency and high level of Acr2 expression throughout the lifecycle of M  tuberculosis 
make it an attractive target for vaccine design.
Although heat shock proteins are required for survival in macrophages (Manganelli et al., 
2001; Monahan et al., 2001), they are also readily recognised by immune cells and potent 
stimulators o f an immune response (Lewthwaite et al., 2001; Retzlaff et al., 1994). Cattle 
infected with M. bovis are capable of responding to Acr2 within three weeks of infection 
(Wilkinson et al., 2005). Humans respond to exposure to pathogenic mycobacteria with a 
rapid expansion of Acr2 responding T-cell population. This response was more rapid than the 
response observed against other strong M  tuberculosis antigens such as ESAT6 and CFPIO.
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However, the Acr2 response is smaller in people with active tuberculosis compared to people 
with no clinical signs of disease but a positive PPD skin test (Wilkinson, 2005). This su^ests 
that the ability to mount a strong T-cell response against Acr2 could enable a human to clear 
the infection as subjects with active disease had a lesser T-cell response against Acr2. If the 
host immune system was primed by vaccination to recognise an antigen from early phase of 
M. tuberculosis infection, such as Acr2, it would be possible for the host to eliminate the 
bacteria before the infection was well established and overwhelmed the immune system of 
the host.
Although the similarity between mycobacterial Hsp70 and eukaryotic Hsp70 may mean 
mycobacterial Hsp70 can hijack the eukaryotic Hsp70 receptors to deliver antigens for 
processing more efficiently, there may be a danger that Hsp70 vaccination could induce an 
autoimmune disease. If the immune response is targeted to the mycobacterial heat shock 
protein, T-cells may cross-react with eukaryotic heat shock proteins and target effector 
functions at host cells. GroEL reactive T-cells have been implicated in the development of 
arthritis in a rat model (van Eden et al., 1988) and both Hsp70 and GroEL-specific T-cells 
have been detected in human arthritis patients (Young et al., 1988). GroEL-specific PBMC’s 
have been detected in patients with chronic inflammatory conditions including rheumatoid 
arthritis (Res et al., 1988). Bacterial heat shock proteins have been identified in a number of 
autoimmune disorders (Young, 1988; Zugel and Kaufinann, 1999).
Protein subunit vaccines generally require an ^juvant in order to provoke an immune 
response. This is because most proteins are not strong immune stimulators on their own. The 
strategy used in this thesis exploits the peptide-binding edacity of mycobacterial Hsp70, the 
Hsp70-specific receptors on the host antigen-presenting cells and the peptide-independent 
immunostimulatory activity of mycobacterial Hsp70 to use the mycobacterial Hsp70 as an 
adjuvant for associated peptides. The Hsp70 in the Hsp70-peptide complexes purified from
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BCG will deliver the naturally chaperoned peptides for presentation and the induction of 
peptide-specific T-cell responses. This strategy will deliver a wide-range of mycobacterial 
peptides to the immune system for presentation. An advantage of this system over a static 
protein subunit vaccine is that a wide-range of peptides will allow the host immune system to 
select which peptides T-cells respond to. Some protein subunits provoke variable responses 
in different people depending on their HLA genotype. Introducing a range of peptides to the 
host immune system may induce protective T-cell responses in a greater number of people.
An alternative to adding alum or other chemically licensed adjuvants is to express the fusion 
protein within a bacterial strain. In general, whole bacterial cell vaccines are more 
immunogenic than protein subunit vaccines. Bacteria are often potent immune activators 
through the interaction of pathogen associated molecular patterns (PAMPs) and the host 
immime cells receptors such as LPS stimulation via TLR4. These PAMPs can activate local 
immune cells, which in turn signal and attract other immune cells to the region, via positive 
feedback signalling and provoke stronger immune response than protein only vaccines.
Mycobacteria can be used to promote an immune response either as a mixer with the target 
antigen (Skinner et al., 2001) or the mycobacteria can be used to express the target antigen 
(Abou-Zeid et al., 1997). This avoids the need to express and purify the target antigen fi*om 
other sources. BCG strains that overexpress heat shock proteins will deliver heat shock 
protein-peptide complexes to the immune system, inducing an enhanced response compared 
to BCG parent strain. An M  vaccae strain that expresses Acr2 will induce Thl-biased Acr2- 
specific T-cell responses. In order to enhance the Acr2-specific T-cell response a fusion of 
Hsp70 and Acr2 was engineered to exploit the delivery edacity of Hsp70, and was expressed 
in M. vaccae as further whole cell vaccine.
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A further advantage of using M. vaccae as the vector for Acr2 and Hsp70-Acr2 is that this 
strain is capable of stably expressing foreign antigens. As mentioned above, M. vaccae can be 
transformed and .can express foreign antigens from various promoters, with antigen 
expression being particularly strong fr-om the hsp60 promoter (Dellagostin et al., 1995; 
Medeiros et al., 2002). Consideration was given to expressing the fusion construct in BCG 
Pasteur. However, it is known that BCG does not always tolerate well the expression of genes 
from an hsp60 promoter on a plasmid (Al-Zarouni and Dale, 2002; Carroll et al., 2010).
1.6 Aims and objectives
Mycobacterial Hsp70 has been shown to have proinflammatory immunostimulatory 
properties in mammalian cell culture, to form complexes with other mycobacterial peptides, 
and to promote enhanced specific T-cell responses to the associated peptides. Mycobacterial 
heat shock proteins GroELl and GroEL2 are also immunostimulatory in mammalian cell 
culture, and Acr2 is the target of rq)id and sustained specific T-cell responses.
The aim of this thesis was to measure the immunogenicity of (i) purified mycobacterial heat 
shock proteins and (ii) mycobacteria that over-express heat shock proteins in a mouse 
vaccination model.
The spécifie objectives of this research were to
- Purify Hsp70 arid Hsp70-peptide complexes from BCG parent strain and BCGA/wpR
- Identify peptides that are purified as part of the Hsp70-peptide complexes
- Delete hrcA from BCG parent strain to engineer a BCG strain, BCGA/*rc/4, that 
overexpresses GroEL
- Engineer M. vaccae strains that over-express M. tuberculosis Acr2 or the fusion 
protein Hsp70-Acr2
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Assess the T-cell responses 21 days post-vaccination generated by vaccination with 
mycobacterial Hsp70, mycobacterial Hsp70-peptide complexes, BCG Pasteur (BCG 
parent strain), BCGÀhspR, BCGAhspRAhrcA, M. vaccae NMIB 9937, M. vaccae 
Acr2 and M. vaccae Hsp70-Acr2.
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Chapter 2: Materials and Methods
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2.1 Bacterial strains and growth conditions
The Mycobacterium bovis strain, Bacille-Calmette-Guerin Pasteur wildtype (BCG parent 
strain), was kindly obtained from Dr Stewart (Culture Collection, University of Surrey). The 
BCG parent strain were grown on agar plates of Middlebrook 7H11 medium (Gibco, UK) 
supplemented with 0.5% glycerol and 10% oleic acid/albumin/dextrose/catalase (OADC) at 
37°C for three weeks, or the bacteria were cultured in liquid 4.7% w/v Middlebrook 7H9 
(Difco, UK) supplemented with 0.5% v/v glycerol, 0.2% Tween 80 v/v and 10% v/v OADC.
BCGAhspR and BGGAhspRAhrcA were provided by Dr Stewart (Culture Collection, 
University of Surrey) and were propagated on solid media of 7H11 (Gibco, UK) 
supplemented with 10% OADC with 50pg/ml of hygromycin for BCGAhspR or both 
50pg/ml of hygromycin and 15pg/ml of kanamycin for BCGlshspRAhrcA. The plates were 
incubated at 37°C for three weeks. Liquid cultures were grown in 7H9 media (Sigma, UK) 
with 0.5% v/v glycerol, 0.2% Tween 80 v/v, 10% OADC and the appropriate antibiotics and 
incubated 37°C for seven days, rotating at 60rpm;
Esherichia coli {E. coli) DH5a were provided by S Wall (Culture Collection, University of 
Surrey). For subcloning. One Shot® Top 10 Chemically Competent E. coli (frivitrogen, UK) 
(Top 10 E. coli) were used. The E. coli strains were grown using Luria Bertani (LB) broth 
(0.5% w/v yeast extract (Sigma, UK), 1% w/v tryptone (Sigma, UK), 10% w/v sodium 
chloride (Fischer, UK) pH7.0) for liquid cultures or LB broth with 3% w/v bacteriological 
agar (Fischer, UK) for solid media plates. Both the liquid and solid media were supplemented 
with 150 pg/ml hygromycin or 50pg/ml kanamycin when the antibiotics were required for 
bacterial selection.
Mycobacterium vaccae wildtype NCIMB 9937 (M vaccae Wt) was kindly provided by Dr 
Mendum (Culture Collection, University o f Surrey), M, vaccae Wt was grown on agar plates
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(Nutrient Broth 2 (Gibco, UK), 3% bacteriological agar, distilled water) or in liquid media 
(Nutrient Broth 2, glycerol, distilled water) for five days at 37°C static for plates or rotating 
at 60rpm for liquid cultures. M  vaccae carrying plasmids for the overexpression of Acr2 or 
Hsp70-Acr2 see section 2.10.
2.2 Plasmids
The plasmid pSMT3-Acr2 was kindly provided by Dr Stewart (Culture collection. University 
of Surrey). pSMT3-Acr2 is a mycobacterial shuttle plasmid that contains the acr2 sequence 
fi-om M. tuberculosis H37Rv under the control of the mycobacterial Hsp60 promoter (Figure 
1). The plasmid also contains a mycobacterial origin of replication and a hygromycin 
resistance gene.
Acr2 Eco RV (27)
AzmHI(5712) 
H SP60 
A&ûI(53H) 
%/n(5279)
Hind m(31)
y
pSMT3-Acr2
6195 bp
%/n(1284:
Mori
Figure 1: The plasmid map of pSMT3-Acr2. The plasmid map of pSMT3-Acr2 shows the mycobacterial 
origin of replication (mori), the hygromycin resistance gene (hyg), the Hs60 promoter (HSP60) and the acr2 
gene (Acr2). Also shown are the restriction digest sites for Eco RV, Bg II, Xba I  and BamHL
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TOPO® TA Cloning® vector . (Invitrogen, UK) was used for E. coli subcloning of 
M.tüberçulosis H37Rv hsp70 and contains ampicillin and kanamycin resistance genes for 
antibiotic selection (Figure 2).
mg#
kh tr ,  "h-r l- L- ^r.
Figure 2: The plasmid map of the TOPO® TA® Cloning vector from Invitrogen used for E. coli 
subcloning of the M. tuberculosis H37Rv hsp70 PCR product
The plasmid pSMT163 is a mycobacterial suicide plasmid that contains a gene for kanamycin 
resistance flanked by homologous regions of hrcA. HrcA is the repressor of GroEL
transcription and acts by binding CIRCE sequences upstream of the regulated gene.
' .
Homologous recombination should occur between the plasmid and the genome of BCG at the 
hrcA locus,* replacing the genomic /y c f  with the kanamycin resistance gene. sacB is a gene 
from Bacillus subUlis that encodes levansucrase. Expression of levansucrase from sacB in
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mycobacteria is toxic when the bacteria are cultured in the presence of sucrose (Pelicic et al., 
1996). Non-homologous incorporation of the plasmid into the BCG genome would enable the 
expression of levansucrase resulting in death for those BCG clones. Only clones with 
insertion of KN(R) by homologous recombination will survive on 7H11 with 10% OADC 
containing 2% sucrose and 15pg/ml of kanamycin.
hrca 3/5
£coR V (112)
//md m (217) 
sacB
KN(R)
pSIVrT163
8266 bp
a n d  m  (2016;
hrca 1/2 £coR V (3865)
Figure 3: The plasmid map for pSMT163. The plasmid map shows the kanamycin resistance gene [KN(R)], 
which is flanked by homologous regions of hrcA, hrcA 1/2 and hrcA 3/5, and the sacB gene for selection against 
non-homologous incorporation of the plasmid into the BCG genome. Also shown are the restriction enzyme 
sites for Hindlll and EcoR V.
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2.3 DNA amplification
The gene hsp70 was amplified from DNA of Mycobœterium tuberculosis H37Rv using 
polymerase chain reaction (PCR). The reagents for a 20pl reaction are shown in Table 1.
Table 1: The reagents and volumes for the PCR reaction to amplify hsp70 from genomic 
DNA from Af. tuberculosis H37Rv.
ü J îm m ilA . \ï§ m
W e il
GoTaq® Hot Start PCR kit reagents include the GoTaq® Hot Start DNA polymerase, 5x 
Colourless Flexi Buffer and Magnesium Chloride Solution (Promega^ UK).
The PCR protocol followed is detailed below, steps 2,3 and 4 were repeated for 30 cycles:
Step 1-95°C for 5 mins 
Step 2- 95°C for 30 seconds 
Step 3- 72°C for 30 seconds 
Step 4-56°C for 60 seconds 
Step 5- 72*C for 5 minutes 
Step 6- 4°C on hold
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2.4 DNA restriction enzyme digestion
Digestion o f  plasm ids pSM T3-Acr2 and Hsp70-TOPO
20pl of the plasmid pSMT3-Acr2 and of Hsp70-TOPO clone 4 were digested with 1.5pl of 
enzyme, BamHI (Promega, UK) equivalent to 15 units of enzyme, with 5 pi of lOx Buffer E 
(NEB, UK), 0.5pl of lOOpg/ml bovine serum albumin (BSA) and 23pl of DNase-free water. 
The reactions were incubated at 37°C for 3 hours. Calf Intestinal Alkaline Phosphatase was 
added to the digest of pSMT3-Acr2 and the reaction incubated for a further 40 minutes at 
37°C.
Digestion o f  pSM T3-Hsp70-Acr2 to confirm orientation o f  Hsp70 insertion
2pl of pSMT3-Hsp70-Acr2 (52ng of DNA) was digested with 0.25pl of Kpnl (Promega, 
UK) equivalent to 2.5 units of enzyme, with Ipl of lOx Buffer J (Promega, UK) and 6.75pi 
of DNase-free water. The reactions were incubated at 37°C for three hours.
2.5 Ligation of 7/? to pSMT3-Acr2
1.5pl o f BamHI digested linearized pSMT3-Acr2 (45ng of DNA) was incubated with 7pl of 
BamHI digested hsp70 DNA (35ng of DNA), Ipl of lOx Ligation Buffer and 0.5pl of T4 
DNA ligase equivalent to 200 units of enzyme. A no insert ligation control was also made. 
The reactions were incubated at room temperature overnight.
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2.6 Transformation of E. co/;
50pl of & coli DH5a or Top 10 E. coli were thawed on ice. The cells were mixed with 5pl of 
plasmid DNA and incubated on ice for 30 minutes. The cells were heat shocked for 1 minute 
for E. coli DH5a or for 30 seconds for Top 10 E. coli at 42 °C and then were incubated on ice 
for 2 minutes. 250pl of super optimal broth with catabolite repression (SOC; 2% w/v 
tryptone, 0.5% w/v yeast extract, lOmM sodium chloride, 2.5mM potassium chloride, lOmM 
magnesium chloride, 20mM glucose in distilled water) (Invitrogen, UK) warmed to 37°C was 
added to the cells and the cells were incubated for I hour at 37°C rotating at 200rpm. The 
cells were plated onto LB plates containing the appropriate antibiotic for selection and were 
incubated overnight static at 37°C.
2.7 E. coli subcloning
4pl of fresh hsp70 PCR product was incubated with Ipl Salt Solution (Invitrogen, UK) and 
Ipl of TOPO TA® vector (Invitrogen, UK) for 30 minutes at room temperature as per 
manufacturer’s protocol.
The product was used to transform 50pl of One Shot Top 10 Chemically Competent E. coli 
(Invitrogen, UK) that were then plated on LB plates containing 50pg/ml kanamycin and 
incubated overnight at 37°C. Colonies were picked and grown in 5ml of LB with 50pg/ml 
kanamycin at 37°C overnight. The plasmids were extracted using the Qiaquick mini-prep kit 
(Qiagen, UK) and digested with BamHI at 37°C for three hours to confirm the presence of 
hsp70 sequence. The hsp70 DNA was Separated from TOPO TA plasmid digestion products 
by running the digested product on a 1% TAB agarose gel. The hsp70 band, approximately 
2000bp, was excised and the hsp70 DNA was recovered using the Qiaquick Gel Extraction 
kit (Qiagen, UK).
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2,S E, coli cloning
The plasmid pSMT3-Acr2 was digested with BamHI. The hsp70 DNA obtained by digestion 
from the TOPO vector was incubated with pSMT3-Acr2, T4 DNA ligase and salt at room 
temperature overnight. The ligated product was transformed into E. coli DH5a usual 
protocol. After overnight incubation at 37°C, colonies were picked into 5ml of LB with 
hygromycin at 150pg/ml and grown overnight at 37°C. The plasmids were isolated from the 
5ml cultures using the Qiaquick mini-prep kit (Qiagen, UK). The plasmids were digested 
with 50 units of Kpnl (New England Biolabs, UK) as described above and the digestion 
products were run on an agarose gel to identify the plasmids that have the correctly orientated 
insertion of the hsp70 sequence.
2.9 Transformation of BCG wildtype and selection for gene replacement of hrcA
A 50ml culture of BCG parent strain was grown as described in 2.1. The bacteria were 
harvested by centrifugation at 4000g for ten minutes, and the pellet was washed in 50ml 10% 
glycerol at 37°Cand centrifuged for a further 10 miniites. The cells were washed with 20ml of 
10% glycerol and the wash was repeated twice more with 10ml and then 5ml of 10% glycerol 
all at 37°C. The pellet was resuspended in 200pl 10% glycerol. 5pi of pSMT163 DNA was 
irradiated with 1000 units of UV and was mixed into the 200pl of bacteria. The bacteria were 
then transferred to an electroporation cuvette 0.2ml and were electroporated at 2.5v, 25pF, 
lOOOfl. The bacteria were immediately recovered in 1ml 7H9 with 10% OADC prewarmed 
to 37°C. The bacteria were cultured at 37®C overnight shaking and were plated onto 7H11 
plates containing 10%OADC, 2% sucrose and kanamycin (15pg/ml).
2.10 Transformation of Af. vaccae wildtype
50ml cultures of Af. vaccae Wt were incubated at 37°C for five days. The cultures were then 
placed on ice for one hour prior to tr^sformation, as described in Parrish. The bacteria were
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harvested by centrifugation at 1500g for 10 minutes. The cells were washed with 20ml of 
10% glycerol, the wash was repeated twice more with 10ml and then 5ml of 10% glycerol. 
The cells were finally resuspended in 300pl of 10% glycerol with 5pl of the plasmid pSMT3- 
Hsp70-Acr2 and placed into an electroporation cuvette 0.2ml (RnD, UK). The cells were 
electroporated 2.5v, 25mF, lOOOD and were immediately recovered in 1ml of Nutrient Broth 
2 at 37°C. The cells were incubated at 30°C for 1 hour. The cells were then plated onto NB2 
plate with Hygromycin (50pg/ml) and were incubated at 30°C for five days. The M. vaccae 
Acr2 and M. vaccae Hsp70-Acr2 strains were cultured in Nutrient Broth 2 supplemented with 
50pg/ml of hygromycin.
2.11 Purification of cell-free mycobacterial antigen (MycAg)
BCG parent strain cultures of 100ml were harvest by centrifuging the cells at 1500g for 10 
minutes. The cells were resuspended in 0.5ml Dulbecco’s phosphate buffered saline (PBS) 
(Oxoid, UK) and transferred to Lysing Matrix B tubes (QBiogene, USA). The tubes were 
shaken using a FastPrep 120 set to speed 5 for twenty seconds. The tubes were cooled on ice 
for 10 minutes before the tubes were shaken again. The cooling and shaking were repeated 
for a total of 6 cycles. The lysed cells were centrifuged at 1500g for 10 minutes at 4°C. The 
supernatant was collected and passed through a 0.2pm filter (Millipore, UK) to remove any 
whole bacteria. The supernatant, referred to as MycAg, was stored at -80°C until required.
2.12 Treatment to obtain whole cell protein preparations
BCG parent strain and BCGA/w/?/? cultures of 100ml were harvested as described above and 
the cells were lysed by shaking with the FastPrep 120 as above. The lysed cells were 
centrifuged at 10,000g for twenty minutes at 4°C to sediment whole bacteria and cellular. 
debris. The supernatant, referred to as whole cell protein preparation (WCPP), was decanted 
and stored at -80°C until required for Hsp70 or Hsp70-peptide complexes purification.
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12ml of the M. vaccae Wt, M. vaccae Acr2 or M  vaccae Hsp70-Acr2 cultures was 
centrifuged for ten minutes at 1500g and the supernatant was removed. The cell pellets were 
resuspended in 0.5ml PBS with Complete protege inhibitor (Roche, UK). The cells were 
disrupted by mechanical shaking for 120 seconds with 0.1mm silica beads using a bead 
beater set to high speed. The resulting product was centrifuged at 10,000g for twenty minutes 
and the WCPP, was decanted and stored at -80°C until analysis.
2.13 Bradford assay for protein concentration
The protein content of the MycAg and the lysates described above was analysed using 
Bradford reagent (Sigma Aldrich, UK). The Bradford reagent was left in the dark to 
equilibrate to room temperature for 30 minutes: lOpl of Bradford reagent was mixed with 
lOpl of the samples. The absorbance of 2pl of each reaction was measured at 595nm using a 
nanodrop. Bovine serum albumin w ^  used to establish a standard curve for the B r^ford 
reaction over the range 0 to lOOOpg/ml.
2.14 Purification of Hsp70 from BCG Pasteur and BCG AhspR
Mycobacterial Hsp70 has a strong ATP binding affinity and binds readily to the ATP bonded 
to agarose beads. The Hsp70 can be eluted from the ATP-agarose beads by incubating the 
column with an ATP containing buffer. The Hsp70 also binds to ADP and binds to the ADP 
bonded to the agarose beads in the ADP-agarose. The Hsp70 can be eluted by incubating the 
column with an ADP containing buffer.
Five 100ml cultures of BCG Pasteur or BCG AhspR were grown in 7H9 medium. The cells 
were harvested by centrifugation and the cells were treated as described to obtain the whole 
cell protein preparations (WCPP).
_____________________________________ -_______________[_______ P a g e  I 49
320pg of agarose beads bonded to adenosine triphosphate (ATP) (Sigma-Aldrich, UK) were 
washed with 10ml of equilibration buffer (20mmol Trls-acetate, 20mM NaCl, 15mM 2- 
mercaptoethanol, 3mM MgCl], pH7.5) and then incubated with 4ml of WCPP and 4ml of 
equilibration buffer for 30 minutes at 4°C rotating in chromatography columns (BioRad, 
UK). Unbound material was collected from the columns. The column was rinsed with 20ml 
of wash buffer (equilibration buffer with 0.5M NaCl, pH7.5) and then incubated with 10ml of 
elution buffer (equilibration buffer with 3mM ATP, pH7.5) for 1 hour at 4°C rotating. 
Fractions of 0.5ml were eluted from the column and stored at -80°C until required. Columns 
were washed with wash buffer and the agarose beads stored in the column at 4°C as a 50% 
slush with 2ml storage buffer (equilibration buffer with IM sodium chloride, 4 0 ^  lactose, 
ImM ATP, 0.02% sodium azide).
2.15 Purification of E[sp70-peptide complexes from BCG Pasteur and BCQAhspR
320pg of agarose beads bonded to adenosine diphosphate (ADP) (Sigma-Aldrich, UK) were 
incubated with 4ml of WCPP and 4 ml of equilibration buffer for 30 minutes at 4°C rotating 
in columns (Biorad, UK). Unbound material was eluted from the columns and the column 
was rinsed with 20ml of wash buffer to remove non-specifrcally bound proteins. The column 
was then incubated with 10ml of ADP elution buffer (equilibration buffer with 3mM ADP) 
for 1 hour at 4°C rotating. Fractions of 0.5ml were eluted from the column and stored at - 
80°C until required. Columns were washed wish wash buffer and the agarose beads stored in 
the column at 4°C as a 50% slush with 2ml storage buffer (equilibration buffer with IM 
NaCl, 40g/l lactose, ImM ADP, 0.02% sodium azide).
2.16 Peptide separation from Hsp70
Preparations of Hsp70 and Hsp70-peptide complexes were centrifuged at 200g for 5 minutes 
in CentriconlO columns to separate loosely attached material.
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The Hsp70 and Hsp70-peptide complexes were incubated with 500pl of lOmM ATP and 
3mM MgCl: for 30 minutes at room temperature to allow the Hsp70 to bind to ATP resulting 
in the release of bound peptides. The Hsp70 and Hsp70-peptide complexes were then 
centrifuged in CentriconlO columns as before to collect the released peptides. This incubation 
and centrifugation was repeated twice more. The peptide fractions were concentrated by 
SpeedVac and the resulting samples were pooled and redissolved in 0.1% trifluoroacetic acid 
(TFA), producing an Hsp70 and an Hsp70-peptide complex sample. The TFÀ solutions were 
sent for mass-spec analysis by Dr Newcombe (University of Surrey, UK).
2.17 SDS-PAGE gels for protein analysis
12% SDS-PAGE gels were poured for protein analysis. The resolving gel (2ml 30% bis- 
acrylamide, 1.25ml of resolving buffer (1.5M Tris HCl, 0.4% SDS, pH8.8), 1.65ml distilled 
water, lOOpl of 10% ammonium persulphate (APS), lOpl Of tetramethylethylenediamine 
(TEMED)) was poured and butan-l-ol was applied to the top of the gel to allow the resolving 
gel to set. When the resolving gel was set a stacking gel was poured (1ml 30% bis- 
acrylamide, 0.75ml of stacking buffer (0.5M Tris HCl, 0.4% SDS, pH6.8), 4ml distilled 
water, 60pl 10% APS, 6pl TEMED) and a well comb inserted. Running buffer stock (0.55M 
glycine, 1% SDS, 1 litre distilled water) was diluted 1/10 in distilled water to make running 
buffer for use in the mini-protean HI tank (Biorad, UK). When set, the SDS-PAGE gel was 
placed in the mini-protean m  tank and submerged with running buffer.
The concentration of protein samples was assessed as described in Materials and Methods
2.13 and concentrations were adjusted accordingly. 20pl of protein solution was boiled for 5 
minutes in 20pl of 2xSDS-loading buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 
0.004% w/v bromophenol blue, 0.125M Tris HCl) and 15 pi of boiled sample plus buffer was 
loaded per well and the gel was run at 150v for one hour. The gel was stained with
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Coomassie Blue stain (50% distilled water, 40% methanol, 10% acetic acid, 0.025% Fluka 
Brilliant Blue R250 (Sigma Aldrich, UK) and rotated with destain (50% distilled water, 40% 
ethanol, 10% acetic acid) for visualisation of protein bands.
2.18 Western blots of SDS-PAGE gels
Protein gels were produced as described in Materials and Methods 2.17. The protein gel was 
soaked in transfer buffer (25mM Tris, 192mM glycine, 20% v/v methanol) for 15 minutes. 
The protein gel was placed onto a piece of PVDF membrane (Thermo Scientific Pierce, UK) 
that had been pre-soaked in methanol for 5 minutes, rinsed in distilled water and soaked in 
transfer buffer for 15 minutes. The protein gel and PVDF membrane were sandwiched 
between two pieces of 3MM blotting paper (Thermo Scientific Pierce, UK) that had been 
soaked in transfer buffer for 15 minutes. These were placed in a semi-dry blotter and the gel 
was blotted for 20 minutes at 200 millivolts. The membrane was removed and soaked in a 
blocking solution (PBS, 5% w/v non-fat milk powder (Tesco, UK), 0.05% v/v Tween 20 
(Sigma Aldrich, UK)), rotating at room temperature for 1 hour. The membrane was then 
soaked in blocking solution with a 1:5000 dilution of mouse anti-Hsp70 (Professor D. Young, 
Imperial College London) or 1:5000 rabbit anti-Acr2 (Dr Stewart, University of Surrey) and 
rotated at room temperature for 1 hour. The membrane was washed for ten minutes at room 
temperature in wash buffer (PBS, 0.05% Tween 20). The wash was repeated twice more 
before the membrane was soaked in blocking solution with a 1:5000 dilution of rabbit anti- 
mouse-alkaline phosphatase (Abeam, UK) or a 1:5000 dilution of goat anti-rabbit-alkaline 
phosphatase (Abeam, UK). After 60 minutes the membrane was washed three times for ten 
minutes at room temperature in wash buffer. The membrane was washed for a final ten 
minutes at room temperature in PBS. The membrane was covered with 2ml of CSPD Ready- 
to-use solution (Roche, UK) and left for 5 minutes at room temperature. Excess liquid was
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removed and the membrane was incubated for 15 minutes at 37°C. X-ray film was exposed to 
the membrane for 30 minutes and was developed with developer and fixative.
2.19 Vaccine preparation
PBS which was endotoxin-free was used to dilute protein and bacterial samples for 
vaccination. Bacterial strains were grown as described previously.
Viable cell counts of each vaccine were determined by thawing the cell stocks and plating out 
the cells onto suitable media; 7H11 with 10% OADC for BCG parent strain with 50pg/ml of 
hygromycin added for BCG AhspR and BCG AhspR AhrcA strains. Nutrient Broth ,2 was 
used for M. vaccae or Nutrient Broth 2 with 50pg/ml Hygromycin for M  vaccae Acr2 
and M  vaccae Hsp70-Acr2. BCG plates were incubated for 16 days and M. vaccae plates 
were incubated for 6 days and cell counts calculated for the frozen vaccine stocks.
An appropriate volume of bacteria was thawed and suspended in saline just prior to use. The 
aliquots of M  vaccae bacteria were heated at 90°C for 20 minutes to heat-kill the 
mycobacteria.
2.20 Animals
Female C57/B6 mice aged six weeks were obtained from B&K Universal Ltd (UK). The 
animals were maintained in a Specific Pathogen Free environment in groups of five. The 
animals were fed standard mouse chow and water ad libitum. All mice were allowed a 
settling period of one week prior to vaccination.
2.21 Vaccinations
Each vaccine was administered to a group of five mice. A group size of five was chosen for 
logistical reasons as the mouse accommodation units were suitable for up to five C57B/6
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female mice. Housing a single vaccine group per unit enabled all mice in each vaccine group
to be exposed to the same food, water and air supply, minimising any potential environmental
.
variation within each vaccine group:
In Chapter 3 groups of five mice were vaccinated with saline (200pl), BCG parent strain (2 x 
10^  c.fu. in 200pl of saline), Hsp70 (lOpg in 200pl of saline) and Hsp70-peptide complexes 
(lOpg in 200pl o f saline). The Hsp70 and Hsp70-peptide complexes vaccinations were 
repeated at 7 days post-initial vaccination.
In Chapter 4 groups of five mice were vaccinated with Saline (200pl), BCG parent strain (2 x 
10^  c.f.u. in 200pl of saline), BCGA/w/?R (2 x 10  ^c.f.u. in 200pl of saline), BCGAhspRAhrcA 
(2x10^ c.f.u. in 200pl of saline).
In Chapter 5 groups of five mice were vaccinated with Saline (200pl), BCG parent strain (2 x 
10^  c.f.u. in 200pl of saline), M  vaccae Wt (7.5 x 10  ^ c-f-u. in 200pl of saline), M. vaccae 
Acr2 (7.5 xlO* c.f.u. in 200pl of saline), or M  vaccae Hsp70-Acr2 (7.5 xlO* c.f.u. in 200pl 
of saline). All vaccinations were subcutaneous on the flank and were carried out under 
temporary anaesthesia with isofluorane.
2.22 Splénocytes harvest and isolation
Animals were culled under schedule 1 and spleens extracted. The spleens were teased apart to 
produce a single cell suspension of splenocytes. The splenocytes were washed with 25ml of 
KFM11640 (Sigma Aldrich, UK) with 10% foetal calf serum (FCS) with 1% penicillin and 
streptomycin solution (Complete Medium) and centrifuged at 400g for 5 minutes. The red 
cells were lysed using M-Lyse Cell Lysis kit (RnD, UK) and the remaining cells were washed 
in Complete Medium and spun at 400g for 5 minutes. The splenocytes were resuspended in 2 
or 3ml of Complete Medium and counted.
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2.23 Flow cytometry
In Chapter 3 the splenocytes were plated out in 24-well plates in 1ml volume at 5 x 10  ^cells 
per well. The splenocytes were cultured with Complete Medium or with PMA and ionomycin 
(50ng and Ipg respectively) for 7 hours at 37°C, 5% CO2 . Ipl of Brefeldin A Ready-made 
solution lOmg/ml (Sigma Aldrich, UK) was added to the wells to a final concentration of 
lOpg/ml 3 hours into the incubation.
In Chapter 4 the splenocytes were plated out in 24-well plates in 1ml volume at 5 x 10  ^cells 
per well. The splenocytes were cultured with Complete Medium, with PMA and ionomycin 
(50ng/ml and Ipg/ml respectively), or with MycAg (lOpg/ml). In Chapter 5 the splenocytes 
were plated out in 24-well plates in 1ml volume at 5 x 10  ^cells per well. The splenocytes 
were cultured with Complete Medium, with PMA and ionomycin (50ng/ml and Ipg/ml 
respectively), with MycAg (lOpg/ml) or with Acr2 (lOpg/ml). Brefeldin A was added 9 
hours into the incubation and the splenocytes were incubated for a further 12 hours.
The splenocytes were aliquoted into Facs tubes (BD Biosciences, UK) and were incubated at 
4°C for 20 minutes with PBS with 2% FCS. The cells were washed in 1ml of PBS with 0.5% 
FCS and 0.05% sodium azide (Facs buffer) and spun at 400g for five minutes.
The cells were incubated with antibodies to stain for surface markers for 30 minutes at 4°C in 
the dark. The antibodies used were anti-CD3e PerCp-Cy5.5 (aCD3), anti-CD4 APC (aCD4), 
anti-CD8 FITC (aCD8), anti-CD25 Pe (aCD25) or anti-CD69 Pe-Cy7 (qCD69). Cells were 
also stained with the appropriate isotype control antibodies. The full details of the amount of 
antibody used for staining are shown in Table 2.
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Splenocytes were stained in the following combinations:
(i) aCD3, aCD4, aCD8
(ii) aCD3, aCD4, aCD8, aCD69, aCD25
(iii) aCD3, aCD4, aCD8, aCD69 isotype, aCD25 isotype
(iv) isotype aCD3, isotype aCD4, isotype aCD8
After 30 minutes the splenocytes were washed with 1ml facs buffer, spun at 400g. The wash 
was repeated and staining groups (ii), (iii) and (iv), were resuspended in 400pl of facs buffer 
and stored at 4°C in the dark until acquisition using a BD Facs Canto.
Splenocytes that were stained with aCD3, aCD4, aCD8 (group i) were resuspended in 250pl 
of CytoFix/CytoPerm solution (BD Biosciences, UK) for 20 minutes at 4°C in the dark to fix 
and permeabilise the splenocytes. The splenocytes were washed in 2ml of Perm/Wash 
solution (BD Biosciences, UK) and spun at 400g for five minutes. The splenocytes were 
incubated for 45 minutes at room temperature in the dark with anti-IFNy Pe (oIFNy) or anti- 
IL4 Pe-Cy7 (aIL4) suspended in 50 pi of Perm/Wash. After 45 minutes the splenocytes were 
washed with 2ml of Facs buffer and spun at 400g for five minutes. The wash was repeated 
and the splenocytes were resuspended in 400pl of Facs buffer and stored at 4°C in the dark 
until acquisition with the BD Facs Canto.
Examples of the flow cytometric analysis of T-cell activation and T-cell expression of IFNy 
and IL4 for a saline and a BCG parent strain vaccinated mouse shown in Appendices 1.1, 1.2, 
1.3 and 1.4.
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Table 2: The antibody-fluorophore conjugates used for mouse splenocyte cell staining. The table shows the 
antibody target molecule,, fluorophore bound to the antibody, the host animal and isotype of the antibody and 
amount used for staining. Included also are the isotype control antibodies. All antibodies were purchased from 
Ebioscience, UK. Armenian hamster (A. Hamster), a tandem dye of peridinin-chlorophyll-protein complex and 
Cy5.5 (PerCp-Cy5.5), allophycocyanin (APC), fluorescein isothiocyanate (FITC), phycoerythrin (Pe) and a 
tandem dye of Pe and Cy7 (Pe-Cy7).
Antibody Fluorophore Host & Isotype jug/10  ^ceils
<Anti-mouseCD3e ; PerCp-Cy 5.5 A. Hamster IgG : 0.125 L
Anti-mouse CD4 APC Rat IgG2bK 0.06
Antirmouse GD8b FITC : RatIgCI2bK ; 0:125
Anti-mouse CD69 Pe-Cy7 A. Hamster IgG 0.5
t Anti-mouse GD25 y::=y''0;06i:'y..'-
Anti-mouse IFNy Pe Rat IgG I k 0.125
RatlgGTK -  r
A. Hamster IgG PerCp-Cy5.5 N/A 0.125
/Pe-CyT 1%  y . ' ' ' [ H E i .
Rat XgG2bK APC N/A 0.06
^at IgÔ2bic 1 FITC/^ 'N/A§'
Rat IgG I k Pe N/A 0.125
RatlgGIX ^ Pe N/A -y t 0.06 -
Rat IgG I k Pe-Cy7 N/A 0.5
2.24 Cytometric bead array analysis
The splenocytes were from vaccinated mice were cultured at 1 x 10  ^cells per ml for 72 hours 
at 37*C with 5% CO2 . 50pl of the splenocyte culture supernatants were collected and stored 
at -80°C until analysis. The supernatant were thawed and analysed with the cytokine bead
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array (CBA) mouse Thl/Th2 kit (BD Biosciences, UK) to detect the concentration of 
secreted IL2  ^IL4, DL5, IFNy and TNFa.
2.25 Statistical analysis
The data were analysed using one-way analysis of variance (ANOVA) to detect variance 
between vaccine groups in response to an ex vivo stimulation condition with the Bonferroni 
post-hoc test to locate the source of the variance. Repeated measures ANOVA were used to 
compare the effect of ex vivo stimulation within a vaccine group. Where stated, Students’ T- 
test was used to compare two groups. Analysis was carried out using Microsoft Excel 2007 
and Graphpad Prism 5.0.
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Chapter 3: The Immunogenicitv of Mycobacterial 
Hsp70 and Hsp70-peptide complexes
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3.1 Introduction
Hsp70 is a 70kDa molecular chaperone that is ubiquitously present in all organisms. Under 
stress conditions proteins in the cell are denatured and hydrophobic residues are exposed. 
Hsp70 binds to hydrophobic peptide regions through the Hsp70 peptide-binding cleft (Flynn 
et al., 1991; Schmid et al., 1994), which prevents toxic protein aggregates forming in the cell 
and promoting the correct folding of the proteins. Hsp70 also aids the correct folding of 
nascent peptides.
Hsp70 has also been shown to interact with antigen-presenting cells through surface 
receptors, which leads to the internalisation of Hsp70 and any peptides bound by Hsp70. 
Putative receptors for Hsp70 uptake by antigen-presenting cells include CD91 (Basu et al., 
2001), CD40 (Becker et al., 2002), LOX-1 (Delneste et al., 2002) and CCR5 (Floto et al., 
2006). Various model studies have demonstrated the ability of Hsp70 that was bound to a 
control peptide to deliver the bound peptide for processing and presentation resulting 
ultimately in peptide-specific CD4+ (Tobian et al., 2004b) and CD8+ T-cell responses 
(Tobian et al., 2004a). In addition to delivering peptides for presentation, Hsp70 can also 
enhance the activation and maturation of antigen-presenting cells (Kuppner et al., 2001), a 
process that results in increased antigen-presentation, expression of costimulatory molecules 
CD80/86 and cytokines EL 12, and reduction in adhesion molecules to permit the migration of 
dendritic cells to secondary lymphoid organs.
Hsp70 contains both a peptide-binding cleft and a nucleotide binding site joined by a linker 
region. The nucleotide binding site binds ATP or ADP with high strength and specificity. By 
exploiting this ÀTP binding ability Hsp70 can be purified fi-om eukaryotic cells and bacterial 
cells using affinity chromatography with an ATP solid matrix. Later research showed that 
Hsp70 can be purified in complex with peptides naturally formed in the cell when the ATP is 
replaced with ADP in the affinity chromatography protocol.
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The aim of this chapter was to investigate the immunogenicity of mycobacterial Hsp70 and 
Hsp70-peptide complexes purified fi-om BCG Wild type and BCGAhspR, a strain of BCG 
that constitutively overexpresses Hsp70. The hypothesis of this chapter was that 
mycobacterial Hsp70 can be purified fiom BCG and used as a carrier molecule for the 
delivery of a diverse repertoire of mycobacterial peptides to antigen-presenting cells inducing 
efficient CD4+ and CD8+ T-cells responses characterised by IFNy expression in response to 
challenge with mycobacterial antigens. The specific objectives were to:
1) Purify Hsp70 and Hsp70-peptide complexes fix)m BCG parent strain and 
BCGAhspR
2) Identify the peptides that were bound by Hsp70 in the Hsp70-peptide 
complexes
3) Assess the T-cell responses generated by vaccination with Hsp70 or Hsp70- 
peptide complexes.
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3.2 Results
3.2.1 Purification of Hsp70 and Hsp70-peptide complexes
Hsp70 can be purified fi-om both prokaryotic and eukaryotic cells using ATP-affinity 
chromatography (Menoret, 2004). The Hsp70 has a strong ATP-binding site that can bind 
ATP with high affinity (Garsia et al., 1989). Incubating lysed cells with ATP bound to 
agarose beads allows Hsp70 to be retained in the column with other non-ATP specific 
molecules washed away. The bound Hsp70 can be eluted fiom the column by incubating the 
ATP-agarose beads with a buffer containing ATP.
This protocol, described fully in Materials and Methods 2.14, was followed to purify Hsp70 
fiom lysed BCG parent strain. BCG parent strain was grown and processed to produce whole 
cell protein preparations (WCPP) as described in Materials and Methods 2.1. The Hsp70 was 
collected as 0.5ml fi-actions which were analysed using SDS-PAGE and Coomassie stain. 
Dominant bands were visible at 70kDa (Figure 4), however other bands were visible which 
may be contaminating protein in the Hsp70 fi-actions. It is possible that other proteins with 
ATP-binding sites in BCG parent strain bound the ATP-agarose beads in this purification 
protocol.
Hsp70-peptide complexes can be purified fiom WCPP using ADP-agarose beads as the solid 
matrix in affinity purification. Binding of ADP to Hsp70 via the C-terminal ADP/ATP 
binding-site results in a conformational change in the Hsp70, closing the peptide-binding 
cleft and trapping any bound peptides in a complex with the Hsp70.
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SOkDa —— >
SOkDa ---- >
SOkDa ---->
40kDa ----^
Figure 4: SDS-PAGE separation of ATP-agarose affinity purified proteins from BCG wild type as the 
source material. BCG parent strain was cultured as described in Material and Methods. The cells were 
harvested and lysed mechanically with glass beads. The lysed product was centrifuged at 15,000g for 20 
minutes at 4°C. The supernatant was applied to ATP-agarose column and Hsp70 was purified using the protocol 
as described in Materials and Methods. The fractions were analysed on a 17% SDS PAGE gel and stained with 
Coomassie blue. The lanes a, b, d, e and f  are sequential fractions obtained from one ATP-agarose affinity 
purification procedure. The major band visible migrates at 70kDa but there are many other bands present, 
particularly evident in lane d.
In this study fast protein liquid chromatography (FPLC) was used to purify the Hsp70 from 
the contaminating proteins. The process did not purify the Hsp70 as the protein became too 
diluted by the FPLC process for the sensitivity of the UV detector and so no protein was 
detected in the fractions collected.
In order to increase the amount of Hsp70 in the WCPP used for purification a strain of BCG 
Pasteur that lacks the repressor of heat shock protein QispK) was obtained (Dr Stewart, 
University of Surrey). The BCGAhspR strain constitutively overexpresses Hsp70, which 
results in greatly increased concentrations of Hsp70 in the cytoplasm.
The WCPP produced from BCGAA^/?^ was subjected to ATP agarose affinity purification 
and the fractions obtained were analysed using SDS-PAGE and stained with Coomassie blue. 
Single bands o f approximately 70kDa protein, consistent with Hsp70 were visible on the gels 
e.g. Figure 5, without the extra bands seen in the BÇG parent strain ATP-agarose 
purifications (Figure 4). It is likely that excess Hsp70 in the BCGAhspR WCPP out-competed
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the other ATP-binding proteins leading to a pure fraction of Hsp70 from the ATP purification 
process described in Materials and Methods 2.14.
80kDa
60 kOa
50 kDa
40 kDa
Figure 5: SDS-PAGE separation of ATP-agarose affinity purified proteins from BCGAhspR as the source 
material. A single protein band at approximately 70kDa was observed. BCGAhspR was cultured as described in 
Material and Methods. The cells were harvests and lysed mechanically with glass beads. The lysed product 
was centrifuged at 15,000g for 20 minutes at 4®C. The supernatant was applied to ATP-agarose column and 
Hsp70 was purified using the protocol in Materials and Methods. The fractions were analysed on a 12% SDS 
PAGE gel and stained with Coomassie blue. Lanes 1 to 7 are the fractions I to 7 obtained from this purification.
BCGAhspR WCPP was then used in an ADP-agarose affinity chromatography and the 
fractions were analysed using SDS-PAGE and stained with Coomassie blue (Figure 6). A 
single band of approximately 70kDa was observed on the gel, no other protein bands were 
visible.
7 0  kDa
a b c d e f
Figure 6: SDS-PAGE separation of ADP-agarose affinity purified proteins from BCGAhspR as the source 
nmtcriaL A single protein band at approximately 70kDa was observed. BCGAhspR was cultured as described 
in Material and Methods. The cells were harvested and lysed mechanically with glass beads. The lysed product 
was centrifuged at 15,000g for 20 minutes at 4®C. The supernatant was applied to ADP-agarose column and 
Hsp70 was purified using the protocol in Materials and Methods. The fractions were analysed on a 12% SDS 
PAGE gel and stained with Coomassie blue. Lanes a to f  are sequential fractions obtained from the purification.
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Hsp70 fractions were batch purified using both ATP-agarose and ADP-agarose to purify 
Hsp70 and Hsp70-peptide complexes respectively. The fractions for each purification were 
pooled and extensively dialysed before protein content assessment using UV 293nm 
absorption. A Western blot with anti-Hsp70 antibody confirmed the presence of Hsp70 in the 
dialysed preparations of both ATP purified Hsp70 and ADP purified Hsp70-peptide 
complexes (Figure 7).
lOOkDa —----- >
70kDa  ------ >
SOkDa -------- >
40kDa ------ ^
Figure 7: 12% SDS-PAGE gel and Western blot of the ATP purified Hsp70 and the ÂDP purified Hsp70- 
peptide complexes. The pooled preparations of Hsp70 and Hsp70-peptide complexes were boiled for 5 minutes 
in 2x SDS-PAGE loading buffer. 40pg of protein was run on a 12% SDS-PAGE gel with Spectra Multicolour 
Broad Range Protein Ladder (Fermentas). The SDS-PAGE gel was blotted as described #nd was stained with 
Coomassie Blue to visualise the protein bands. The Western blot membrane was probed with anti-Hsp70 
antibody as described in Materials and Methods. A band migrating sA approximately 70kDa was observed in the 
ATP purified Hsp70 preparation on the Western blot (a) and the SDS-PAGE gel (b) and the 70kDa band was 
also observed fi’om the ADP purified Hsp70-peptide complexes preparation on the Western blot (c) and on the 
SDS-PAGE gel (d). - ‘
3.2.2 Separation and identification of Hsp70-bound peptides
It is possible to separate peptides from Hsp70-peptide complexes by incubating the Hsp70- 
peptide complex with ATP (Udono and Srivastava, 1993). The Hsp70 binds the ATP, which 
changes the conformation of the Hsp70, opening the peptide binding cleft and releasing the 
peptide. The Hsp70 can be separated Ifrom the peptides by spinning the incubation mixture 
through a size exclusion column, retaining the Hsp70 in the upper fim:tion and peptides 
below size SOkDa in the lower fraction.
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The ATP incubation and size exclusion centrifugation was used to septate the peptides from 
the Hsp70 in the Hsp70-peptide complexes that were purified fr-om BCGAhspR (Section 
3.2.1). In addition, the peptide-separation protocol was also repeated with the purified Hsp70 
preparation as a peptide-negative control, to identify any peptides that bind Hsp70 under ATP 
purification conditions. This separation was repeated and the results presented below are 
from two independent separations.
The peptide containing fi-actions were pooled and dried before being sent for analysis using 
mass spectrometry. The peptides were digested with trypsin into smaller peptide fragments 
and then the mass of the peptide fragments were determined by matrix-assisted laser 
desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry. The peptide 
fragments are suspended in a matrix solution of the matrix compound, an organic solvent and 
highly distilled water. This mixture is spotted onto a MALDI-plate, the solvent is vaporised 
and leave the peptide fragments and matrix crystallised on the MALDI-plate. The crystallised 
peptide/matrix spot is exposed to a laser, which causes desorption and ionisation of the 
matrix. The ionised matrix molecules then ionise the peptide fragments through proton 
transferral. The ionised peptide fragments then transfer to a time-of-flight mass-spectrometer 
where electrical fields give the ionised peptide fragments the same level of kinetic energy and 
the velocity of the ionised peptide fragment is equal to the mass to charge ratio. The 
experimentally derived peptide masses are then compared to a database to containing known 
peptide masses to identify the source of the peptide in the sample. In this study MASCOT 
was the database used
The peptide fractions from Hsp70-peptide complexes contained significantly higher numbers 
of identified peptides than found in the peptide fraction from the Hsp70 purified with ATP 
(Table 3).
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Table 3: The MASCOT search results to identify the peptides separated from Hsp70-peptide complexes 
and from Hsp70 preparations purified from BCGAhspR. Hsp70-peptide complexes and Hsp70 were 
incubated with ATP to separate peptides bound by Hsp70. The peptides were separated by size exclusion 
centrifugation and the fractions were air dried and diluted in TFA before trypsin digest and analysis by MALDI- 
TOF mass spectrometry. The peptide sequences were identified by MASCOT searches. The table shows the 
MASCOT reported peptide identity (Peptide column) and species origin (Species column), the MASCOT score 
(Score column) where scores over 5U indicate identity and scores over 29 indicate peptide homology, and the 
number of peptide matches (Matches column) with high quality matches in brackets.
1: Hsp70-peptide complexes
DnaK (molecular cliaperone Hsp70) M. tuberculosis H37Rv 127 13(5)
Acyl carrier protein M. tuberailosis H37Rv 38 2(1)
UDP-Galactopyranose mutase M. tuberculosis B31Rv 38 1(1)
GioEL (molecular chaperone Hsp65) M. iubei'culosis}i37Ry 35 4(1)
Probable LuxR/UHPA : M. tubeiculosis H37Rv 33 4(i);;-;;;; ■;
Putative ParA BCG Pastmir 31 1(1)
Possible MCE-family lipoprotein LPRN M. tuberculosis H37Rv 27 V I X I ) : ^
2: HspTO-peptide complexes
; DnaK (molecular chaperone Hsp70) M: titbercxilosis H37Rv 154 14(6)
Acyl carrier protein M. tuberculosis H37Rv 44 1(1)
Mannosyl tranferase PlMB M. tuberculosis H37Rv ■;43::;;r.:: 4 (1) : "
1: Hsp70
DnaK (molecular chaperone Hsp70) M: t^ibei'culosis U37R.Y :127:/::7 3(1)
GroEL (molecular chapa^one Hsp65) 
2: BLsp70
M. tuberculosis H37Rv 35 8(1)
DnaK (molecular chaperone Hsp70) M. tnbei'ailosisE31Rv 52 4(2)
GroEL (molecular chaperone Hsp65) M. tuberculosis H37Rv 49 9(2)
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The reliable identification of peptide identities requires two high quality MASCOT peptide 
matches where the peptide is unique to the identified protein, and this match must be 
statistically significant i.e. that the chance of a random peptide matching the protein sequence 
is less than 5%. Applying these criteria to the data in Table 3 the peptides separated fi-om the 
Hsp70-peptide complexes that were reliably identified were Hsp70 peptides in both 
purification 1 and 2. The Hsp70 preparations in purification 1 did not show any reliably 
identified peptides but in purification 2 both Hsp70 and GroEL peptides were found.
The finding of Hsp70 peptides in the peptide fi-actions of both the ATP purified Hsp70 and 
the ADP purified Hsp70-peptide complexes showed that fragments of Hsp70 may have 
crossed into the peptide fi-actions. Similarly, the identification of GroEL peptides in the 
peptide fi-actions of both the Hsp70 and Hsp70-peptide complexes suggest that GroEL may 
co-purify with Hsp70 and the purification procedure allows fi-agments of proteins to enter the 
peptide fraction. Alternatively, GroEL in mycobacteria adopts an unusual structure where 
rather than forming the tetradecameric barrel structure observed in E. colU the GroEL exists 
as monomers or dimers in the cell (Qamra and Mande, 2004) that leaves hydrophobic 
residues exposed. These hydrophobic residues may bind to the Hsp70 peptide binding cleft 
with high affinity and thus may not release fi-om Hsp70 in the ATP purification procedure.
One limitation of this method is that the peptide repertoire in the Hsp70-peptide complexes is 
likely to consist of a diverse range of different peptides, mass spec analysis looks at very 
small sample sizes. Therefore, due to the small sample sizes, peptides may be detected and 
identified only once in each peptide pool that was analysed with peptides fi-om abundant 
proteins such as Hsp70 and GroEL highly represented. Of course, the procedure can be 
repeated and here the two independently purified preparations of Hsp70 and Hsp70-peptide 
complexes were analysed. When the data are combined acyl carrier protein (AGP) appears as 
a peptide that was ch^eroned in the Hsp70-peptide complexes.
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3.23 Immunogenicity of HspTO-peptide complexes
In order to assess the T-cell responses generated by vaccination with HspTO and HspTO- 
peptide complexes, groups of mice were vaccinated with saline, BCG parent strain, HspTO 
and HspTO-peptide complexes as described in Materials and Methods 2.21. The splenocytes 
were harvested 21 days post-vaccination and cultured in vitro for Thrs at 37°C with 5% CO2 
with Brefeldin A added at 3 hours (Materials and Methods 2.22). Brefeldin A is an inhibitor 
of the cell secretory pathway, blocking the transport of proteins at the Golgi body, leading to 
the accumulation of cytokine within the cell to levels detectable using flow cytometry. The 
splenocytes were then stained for flow cytometric analysis as described in Materials and 
Methods 2.23 to detect production of IFNy and IL4. In addition, supernatants were collected 
from 72 hour splenocyte cultures and analysed for secreted IL2, IL4, IL5, IFNy and TNF to 
measure quantitatively the levels of cytokines produced by the splenocytes frt>m the 
vaccinated mice (Materials and Methods 2.25).
A sample of the flow cytometry analysis is shown (Figure 8). First the splenocytes were 
displayed according to forward scatter and side scatter to identify the lymphocyte population 
by the size and granularity of the cells (row a). The lymphocytes were gated and assessed for 
CD3-PerCp-Cy5.5 staining as T-cells express CD3 on the cell surface (row b). The CD3+ 
population was assessed for CD4-APC and CD8-FITC staining to identify the CD4+ and the 
CD8+ T-cells and the CD3+ CD4+ and the CD3+ CD8+ populations were gated (row c). The 
CD4+ and the CD8+ T-cells were assessed for surface expression of CD69 and CD25 (Figure
9) as indicators of activated T-cells, and for expression of the cytokines IFNy or IL4 (Figure
10). The splenocytes were also stained with the appropriate isotype antibodies to determine 
the background binding (not shown).
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Figure 8: The flow cytometry analysis of splenocyte T-cell subset identification from vaccinated mice. The
splenocytes are displayed according to the forward and side scatter (row a) for each vaccine group with 
lymphocytes gated. The lymphocytes were assessed for CD3 expression (row b) and the CD3+ lymphocytes 
were assessed for CD4 and CDS expression (row c) with the CD4+ and CD8+ T-cells gated.
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Figure 9: The activation of CD4+ and CD8+ T-cells according to the surface expression of CD69 and 
CD25. The CD4+ T-cells (row a) and the CD8+ T-cells (row b) were displayed according to CD69 and CD25 
surface expression for each vaccine group (displayed above). The cells that expressed CD69 or both CD69 and 
CD25 were backgated to the lymphocyte gate (row c).
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Figure 10: Flow cytometric analysis of the expression of EFNy or IL4 by CD4+ and CD8+ T-cells. The
CD4+ T-cells were displayed according to IFNy and IL4 expression (rows a and c respectively), CD8+ T-cells 
were also assessed for IFNy and IL4 expression (rows b and d respectively). All CD4+ and CD8+ T-cells that 
were positive for IFNy or IL4 were backgated to the lymphocyte gate (row e).
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The numbers of CD4+ and CD8+ T-cells per spleen
The numbers of CD4+ T-cells and CD8+ T-cells were measured to determine whether the 
vaccinations had induced a particular T-cell subset to proliferate in vivo. Compared to the 
saline vaccinated mice, no vaccine group showed a difference in the number of CD4+ T-cells 
isolated per spleen (Figure 11a). However, mice that were vaccinated with Hsp70-peptide 
complexes had significantly greater numbers of CD4+ T-cells compared to the HspTO 
vaccinated mice.
BCG parent strain and HspTO-peptide complex vaccinated mice showed comparable numbers 
of CD8+ T-cells to the saline vaccinated mice (Figure 11b) but HspTO vaccinated mice had 
substantially lower numbers of CD8+ T-cells compared to all other vaccine groups.
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Figure 11: The number of CD4+ and CD8+ T-cells that were isolated per spleen after ex vivo culture of the 
splenocytes in Complete medium. Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods 2.21. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
7 hours in Complete medium. Brefeldin A was added to the cell culture at 3 hours. The cells were harvested and 
stained as described in Materials and Methods 2.22 and 2.23. The graphs show the number of CD4+ T-cells (a) 
and of CD8+ Trcells (b) isolated per spleen. Each data point represents one mouse and the mean and S.E.M is 
shown for each vaccine group (x-axis). Statistical comparisons were made using one-way ANOVA and the 
Bonferroni correction. Significant differences are indicated by the horizontal bars, * equals a significance level 
of p<0.05, ** equals a significance level of p<0.01 and *** equals a significance level of p<0.001. Comparisons 
to saline (i), comparisons to BCG parent strain (ii) and comparisons to Hsp70 (iii) are indicated by the 
horizontal bars respectively.
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CD4+ and CD8+ T-cells expression of CD69 and CD25
Activated T-cells express CD69, the early activation antigen, and go on to express CD25, the 
IL2 receptor. The expression of th e^  two surface markers can be used to identify activated 
T-cells following ex vivo stimulation. T-cells need to be activated before they can proliferate 
or express cytokines.
Upon analysis of the CD4+ T-cells, mice vaccinated with BCG parents strain and Hsp70- 
peptide complexes have significantly greater numbers of CD4+ T-cells that expressed CD69 
or which co-èxpressed CD69 and CD25 compared to mice vaccinated with saline or Hsp70 
(Figure 12a).
PMA and ionomycin stimulation artificially stimulates T-cells to activate and subsequently 
express cytokines. This stimulation is non-specific but does indicate whether the T-cell have 
been primed for response as primed T-cells respond more rapidly to PMA and ionomycin 
stimulation than T-cells from naive animals. The saline group demonstrated the level of naive 
T-Cell activation. T-cells-that have previously encountered antigen and that have been 
exposed to appropriate costimulatory signals are more readily activated and so in PMA and 
ionomycin cultures these groups would have higher numbers of T-cells that expressed CD69 
or both CD69 and CD25.
Higher numbers of CD4+ T-cells expressed CD69 (the total height of the column) in the 
BCG parent strain compared to the saline vaccinated mice after ex vivo stimulation with PMA 
and ionomycin (Figure 12b). Of the CD4+ T-cells that expressed CD69 a greater number also 
expressed CD25 in BCG parent strain vaccinated mice compared to the saline vaccinated 
mice (Figure 12b). The Hsp70-peptide complex vaccinated mice had a higher number of 
CD4+ T-K^lls that expressed CD69 compared to the saline group (t-test p<0.05) but a wide 
data spread such that the Bonferroni correction did not detect a difference.
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In neither the unstimulated or the PMA and ionomyciri stimulated cultures did the Hsp70 
vaccinated mice have a higher level of activation than saline vaccinated mice (Figure 12).
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Figure 12: The number of CD4+ T-cells that expressed CD69 or co-expressed CD69 and CD25 after ex 
vivo culture of the splenocytes. Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods 2.21. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
7 hours in Complete medium (a) or with PMA and ionomycin (b). Brefeldin A was added to the cell culture at 3 
hours. The cells were harvested and stained as described in Materials and Methods 2.22 and 2.23. The gr^hs 
show the number of CD4+ T-cells that express CD69 only (lower section of the bar) and the number of CD4+ 
T-cells that coexpress CD(59 and CD25 after ex vivo culture (upper section of the bars) for the vaccine groups 
saline, BCG parent strain, Hsp70 and Hsp70-pepilde complexes (Hsp70-p). The gr^hs show the mean and 
S.E.M for each vaccine group. Statistical comparisons were made using one-way ANOVA and the Bonferroni 
correction. Significant differences are indicated by the horizontal bars, * equals a significance level of p<0.05, 
** equals a significance level of p<0.01 and *** equals a significance level of p<0.001. Comparisons to saline 
(i), comparisons to BCG parent strain (ii) and comparisons to Hsp70 (iii) are shown for the total number of 
CD69+ CD4+ T-cells (*, the height of the whole column) and for the number of CD4+ T-cells that are CD69 
and CD25 (•).
Analysis of the number of CD8+ T-cells that were activated following ex vivo culture showed 
that the unstimulated splenocyte cultures contained low numbers of CD8+ T-cells that 
expressed CD69 or co-expressed CD69 and CD25 for each vaccine group. The saline 
vaccinated mice have the highest number of unstimulated CD8+ T-cells that expressed CD69 
compared to the other vaccine groups (Figure 13a). .
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Following ex vivo stimulation with PMA and ionomycin, there was no variation , in the 
number of CD69 expressing CD8+ T-cells between the different vaccine groups (Figure 13b). 
BCG parent strain vaccinated mice had higher numbers of CD8+ T-cells that expressed CD69 
and CD25 after stimulation with PMA and ionomycin compared to the saline and Hsp70 
vaccinated mice (Figure I3b). This suggests that both BCG parent strain primed CD8+ T-cells 
but that Hsp70 and Hsp70-peptide complex vaccination did not.
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Figure 13: The number of CD8+ T-cells that expressed CD69 or co-expressed CD69 and CD25 after ex 
vivo culture of the splenocytes. Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods 2.21. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
overnight in medium (a) or with PMA and ionomycin (b). Brefeldin A was added to the cell culture at 3 hours. 
The cells were harvested and stained as described in Materials and Methods 2.22 and 2.23. The graphs show the 
number of CD8+ T-cells that express CD69 (lower section of the bar) and the number of CD8+ T-cells that 
coexpress CD69 and CD25 after ex vivo culture (upper section of the bars) for the vaccine groups saline, BCG 
parent strain, Hsp70 and Hsp70-peptide complexes (Hsp70-p). The graphs show the mean and S.E.M for each 
vaccine group. Statistical comparisons were made using one-way ANOVA and the Bonferroni correction. 
Significant differences are indicated by the horizontal bars, * equals a significance level of p<0.05, ** equals a 
significance level of p<0.01 and *** equals a significance level of p<0.001. Comparisons to saline (i), 
comparisons to BCG parent strain (ii) and comparisons to Hsp70 (iii) are shown for the total number of CD69+ 
CD8+ T-cells (*) and for the number of CD8+ T-cells that are CD69 and CD25 (•).
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CD4+ and CD8+ T-cell expression of IFNy or BL4
The T-cells were analysed for IFNy and EL4 expression to identify the type of immune 
response elicited by the vaccinations. Thl T-cell responses are required for the clearance of 
mycobacterial infection and for protection against mycobacterial infection (Cooper et al., 
1993; Cooper et al., 1995b; Flynn et al., 1993). IFNy is a typical cytokine produced as part of 
a Thl response and is important in anti-mycobacterial responses (Flynn et al., 1993). In 
contrast, 1L4 is a typical cytokine produced as part of a Type 2-like immune response, it is 
antagonistic of IFNy expression and is not associated with protection from mycobacterial 
infection. Therefore, a successful mycobacterial vaccine candidate should induce high 
expression levels of IFNy and low levels of 1L4.
Expression o f  IFNy and IL4 by CD4+ T-cells
Compared to the saline vaccinated mice, vaccination with BCG and Hsp70-peptide 
complexes resulted in an increased number of CD4+ T-cells that expressed IFNy in the 
splenocyte cultures (Figure 14a). Vaccination with Hsp70-peptide complexes resulted in a 
similar number of CD4+ T-cells that expressed IFNy as found in the spleens from BCG 
parent strain vaccinated mice but Hsp70 vaccination resulted in a significantly lower number 
of CD4+ T-cells that expressed IFNy (Figure 14a).
The number of CD4+ T-cells that expressed 1L4 was increased in BCG parent strain 
vaccinated mice compared to the saline vaccinated mice (Figure 14b). Vaccination with 
Hsp70 of Hsp70-peptide complexes resulted in significantly lower numbers of CD4+ T-cells 
that expressed 1L4 compared to the BCG vaccinated mice (Figure 14b).
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Figure 14: The number of CD4+ T-cells that express IFNy or IL4 after ex vivo culture of the splenocytes.
Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in Materials and Methods 2.21. At 
21 days post-initial vaccination the splenocytes were harvested and cultured for overnight in medium. Brefeldin 
A was added to the cell culture at 3 hours. The cells were harvested and stained as described in Materials and 
Methods 2.22 and 2.23. The graphs show the number of CD4+ T-cells that express IFNy (a) and the number of 
CD4+ T-cells that express IL4 after ex vivo culture for the vaccine groups saline, BCG parent strain, Hsp70 and 
Hsp70-peptide complexes (Hsp70-p). The individual data points for each mouse in each vaccine group are 
represented on the graphs in addition to the mean and S.E.M for each vaccine group. Statistical comparisons 
were made using one-way ANOVA and the Bonferroni correction. Significant differences are indicated by the 
horizontal bars, * equals a significance level of p<0.05, ** equals a significance level of p<0.01, *** equals a 
significance level of p<0.001 and **** equals a significance level of p<0.0001 for comparisons to saline (i), 
BCG parent strain (ii) or Hsp70 (iii).
The mean fluorescence intensity (MFI) refers to the average strength (brightness of 
fluorescence) of staining for a particular marker in a particular cell population. For example, 
in Figure 15 the MFI expresses, in arbitrary units, the level of IFNy per CD4+ T-cell that was 
positive for IFNy production. The MFI can be used to look at relative differences in marker 
production between different samples but does not give a quantitative measure of the marker 
production. The MFI data displayed here were generated by the measuring geometric mean of 
fluorescence intensity for Pe, the fluorophore conjugated to a mouse IFNy antibody, or the 
geometric mean for Pe-Cy7, the fluorophore conjugated to a mouse IL4-antibody.
The CD4+ T-cells that expressed IFNy in the BCG parent strain, Hsp70 or Hsp70-peptide 
complex vaccinated mice showed increased intracellular levels o f IFNy compared to the
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saline vaccinated mice (Figure 15a). There were no significant differences in the intracellular 
IFNy levels between the BCG parent strain, Hsp70 and Hsp70-peptide complex vaccinated 
mice.
In addition, of the CD4+ T-cells that expressed IL4 showed higher intracellular IL4 levels in 
the BCG parent strain, Hsp70 and Hsp70-petide complex vaccinated mice compared to the 
saline group (Figure 15b).
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Figure 15: The mean fluorescence intensity (MFI) of staining for IFNy (Pe) or EL4 (Pe-Cy7) for the CD4+ 
T-cells that expressed IFNy or IL4 after ex vivo culture of the splenocytes. Groups of 5 female C57B/6 mice 
aged 6 weeks were vaccinated as described in Materials and Methods 2.21. At 21 days post-initial vaccination 
the splenocytes were harvested and cultured for overnight in medium. Brefeldin A was added to the cell culture 
at 3 hours. The cells were harvested and stained as described in Materials and Methods 2.22 and 2.23. The 
giaplis show tlic IFNy MFI of CD4+ T-oclls that expressed IFNy (a) and the IL4 MFI of CD4+ T-cells that 
expressed IL4 after ex vivo culture for the vaccine groups saline, BCG parent strain, Hsp70 and Hsp70-peptide 
complexes (Hsp70-p). The individual data points for each mouse in each vaccine group are represented on the 
graphs in addition to the mean and S.E.M for each vaccine group. Statistical comparisons were made using one­
way ANOVA and the Bonferroni correction. . Statistical comparisons were made using one-way ANOVA and 
the Bonferroni correction. Significant differences are indicated by the horizontal bars, * equals a significance 
level o f p<0,05, ** equals a significance level of p<0.01, *** equals a significance level of p<O.Ofil and **** 
equals a significance level of p<0.0001 for comparisons to saline (i), BCG parent strain (ii) or Hsp70 (iii).
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To assess the magnitude of the T-cell immune response the total number of CD4+ T-cells per 
spleen that produced either IFNy or IL4 was higher in mice vaccinated with BCG parent 
strain and Hsp70-peptide complex when compared to the saline vaccinated mice (
Figure 16a). BCG parent strain vaccination also resulted in greater numbers of CD4+ T-cells 
that expressed IFNy or IL4 compared to the Hsp70 vaccination (
Figure 16a). Vaccination with Hsp70-peptide complexes resulted in similar numbers of CD4+ 
T-cells that expressed IFNy and EL4 compared to BCG parent strain vaccinated mice but 
significantly higher numbers compared to the Hsp70 vaccinated mice (
Figure 16a).
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Figure 16: The total number of CD4+ T-cells that express IFNy or IL4 after ex vivo culture of the 
splenocytes and the ratio of IFNy to TLA expression. Groups of 5 female C57B/6 mice aged 6 weeks were 
vaccinated as described in Materials and Methods 2.21. At 21 days post-initial vaccination the splenocytes were 
harvested and cultured for overnight in medium. Brefeldin A was added to the cell culture at 3 hours. The cells 
were harvested and stained as described in Materials and Methods 2.22 and 2.23. The graphs show the total 
number of CD4+ T-cells that express IFNy or IL4 after ex vivo culture (a) and the ratio of the number of CD4+ 
T-cells that expressed IFNy to IL4 (b) for the vaccine groups: saline, BCG parent strain, Hsp70 and Hsp70- 
peptide complexes (Hsp70-p). Tlic individual data points for each mouse in each vaccine group are represented 
on the graphs in addition to the mean ^ d  S.E.M for each vaccine group. Statistical comparisons were made 
using one-way ANOVA and the Bonferroni correction. Statistical comparisons were made using one-way 
ANOVA and the Bonferroni correction. Significant differences are indicated by the horizontal bars, * equals a 
significance level of p<0.05, ** equals a significance level of p<0.01, *** equals a significance level of p<0 001
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and **** equals a significance level of p<0.0001 for comparisons to saline (i), BCG parent strain (ii) or Hsp70 
(iii).
The ratio of the number of CD4+ T-cells that expressed IFNy to IL4 indicates the type of 
immune response generated by the vaccine. An IFNy dominated response shown by a high 
IFNy to EL4 ratio suggests a Type I-like response whereas an IL4 dominated response with a 
low IFNy to IL4 ratio demonstrates a Type 2-like response. As mentioned previously, Type 1 
immune responses with high IFNy expression are part of the protective response although 
IFNy expression is not a correlate of protection by itself.
Vaccination with BCG parent strain, Hsp70 and Hsp70-peptide complexes resulted in IFNy 
dominated CD4+ T-cell responses with Hsp70 and Hsp70-peptide complexes having 
significantly more Type I polarised responses than found in BCG parent strain vaccinated 
mice (
Figure I6b).
The data show that Hsp70-peptide complexes were as potent stimulators of CD4+ T-cells as 
BCG parent strain vaccination in terms of both the number of CD4+ T-cells that expressed 
IFNy and the intracellular levels of IFNy. However, BCG parent strain vaccination resulted in 
significantly greater numbers of CD4+ T-cells that expressed IL4 compared to both the 
Hsp70 and Hsp70-peptide complex vaccinated mice although the intracellular levels of IL4 
were similar between these three groups. The resulting CD4+ T-cell response in mice 
vaccinated with Hsp70-peptide complexes was more polarised to a Type 1 response than 
observed in the saline or BCG parent strain vaccinated mice.
Expression o f  IFNy and 1L4 by CD8+ T-cells
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To determine the type o f CD8+ T-cells immune response elicited by vaccination with Hsp70- 
peptide complexes the CD8+ T-cells were assessed for expression of IFNy or IL4 to identify 
Type 1 or Type 2-like responses.
The number of CD8+ T-cell per spleen that expressed IFNy was increased in mice that were 
vaccinated with BCG parent strain vaccinated mice compared to the saline vaccinated mice 
(Figiure 17a). However, vaccination with Hsp70 and Hsp70-peptide complexes showed no 
difference to the saline vaccinated mice in the number of CD8+ T-cells that expressed IFNy.
Compared to the saline vaccinated mice, the number of CD8+ T-cells that expressed IL4 was 
increased in BCG parent strain vaccinated mice but not in mice vaccinated with Hsp70 or 
Hsp70-peptide complexes (Figure 17b).
Figure 17: The number of CD8+ T-cells per spleen that expressed EFNy or IL4 after ex vivo culture of the 
splenocytes. Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in Materials 2.19. At 
21 days post-initial vaccination the splenocytes were harvested and cultured for overnight in medium. Brefeldin 
A was added to the cell culture at 3 hours. The cells were harvested and stained as described in Materials and 
Methods. The gr^hs show the number of CD4+ T-cells that express IFNy (a) and the number of CD8+ T-cells 
that express IL4 after sx vivo culture for the vaccine groups saline, BCG parent strain, Hsp70 and Hsp70 peptide 
complexes (Hsp70-p). The individual data points for each mouse in each vaccine group are represented on the 
graphs in addition to the mean and S.E.M for each vaccine group. Statistical comparisons were made using one­
way ANOVA and the Bonferroni correction. Statistical comparisons were made using one-way ANOVA and the 
Bonferroni correction. Significant differences are indicated by the horizontal bars, * equals a significance level
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of p<0.05, ** equals a significance level of p<0.01, *** equals a significance level of p<0.001 and **** equals 
a significance level of pO.OOOl for comparisons to saline (i), BCG parent strain (ii) or Hsp70 (iii).
As mentioned above, the MFI represents the average strength of staining for a marker in a 
given cell population. The MFI levels plotted in Figure 18 are the geometric mean of 
fluorescence staining with each data point showing the MFI for the CD8+ T-cells that 
expressed IFNy (Figure 18a) or IL4 (Figure 18b) for each mouse in each vaccine group.
The intracellular IFNy levels in the CD8+ T-cells were significantly higher in the saline 
vaccinated mice than in the BCG parent strain vaccinated mice. However, this appears to be 
an artefact from using the geometric mean measurement as when the median was used for the 
MFI saline had low IFNy levels; Switching to the median fluorescence intensity did not alter 
the results for the other vaccine groups.
More importantly, there were no differences between the BCG parent strain, Hsp70 or 
Hsp70-peptide complex vaccinated mice in terms of the intracellular levels of IFNy (Figure 
18a) and the intracellular EL4 levels of the CD8+ T-cells showed no variation between the 
vaccine groups (Figure 18b)
The total magnitude of the CD8+ T-cell response was investigated by analysis of the 
combined numbers of CD8+ T-cells that expressed IFNy and IL4. Compared to the saline 
vaccinated mice, only BCG parent strain vaccination resulted in increased numbers of CD8+ 
T-cells that expressed IFNy or IL4 (Figure 19a).
P a g e  I 83
a) IFNy MFI 
I—
b) IL4 MFI
(i)
(ii)
(0
2  1000-
P A
Vaccine group
S 2000-, (Hi)
I 1600-
Vaccine group
Figure 18: The mean fluorescence intensity (MFI) of staining for IFNy (Pe) or IL4 (Pe-CyT) for the CD8+ 
T-cells that expressed IFNy or IL4 after ex vivo culture of the splenocytes. Groups of 5 female C57B/6 mice 
aged 6 weeks were vaccinated as described in Materials and Methods 2.21. At 21 days post-initial vaccination 
the splenocytes were harvested and cultured for overnight in medium. Brefeldin A was added to the cell culture 
at 3 hours. The cells were harvested and stained as described in Materials and Methods 2.22 and 2.23. The 
graphs show the IFNy MFI of CD8+ T-cells that expressed IFNy (a) and the IL4 MFI of CD8+ T-cells that 
expressed IL4 after ex vivo culture for the vaccine groups saline, BCG parent strain, Hsp70 and Hsp70-peptide 
complexes (Hsp70-p). The individual data points for each mouse in each vaccine group are represented on the 
graphs in addition to the mean and S.E.M for each vaccine group. Statistical comparisons were made using one­
way ANOVA and the Bonferroni correction. Significant differences are indicated by the horizontal bars, * 
equals a significance level of p<0.05, ** equals a significance level of p<0.01, *** equals a significance level of 
p<0.001 and **** equals a significance level of p<0.0001 for comparisons to saline (i), BCG parent strain (ii) or 
Hsp70 (iii).
The ratio of the number of CD8+ T-cells that expressed IFNy compared to IL4 demonstrates 
the type of immune response with IFNy dominated responses indicate a Type 1-like immune 
response whereas IL4 dominated responses suggest a Type 2-like response. The ratios for the 
number of CD8+ T-cells that expressed IFNy to IL4 showed an IFNy dominated response in 
BCG parent strain vaccinated mice (Figure 19b). The CD8+ T-cells in mice vaccinated with 
Hsp70 and Hsp70-peptide complexes showed a more Type 1 polarised CD8+ T-cell response 
compared to BCG parent strain vaccination and compared to the response in saline 
vaccinated mice (Figure 19b).
P a g e  I 84
f )  Total Ratio
^  «
2:.S 2.6x10«-i
Ç: I  1:0x40»:
S 3  ÏOÔ-
ii -
Vaccine group^
Figure 19: The total number of CD8+ T-cells per spleen that expr^sed IFNy or IL4 after ex vivo culture 
of the splenocytes and the ratio of IFNy to IL4 expression. Groups of 5 female C57B/6 mice aged 6 weeks 
were vaccinated as described in Materials and Methods 2.21. At 21 days post-initial vaccination the splenocytes 
were harvested and cultured for overnight in medium. Brefeldin A was added to the cell culture at 3 hours. The 
cells were harvested and stained as described in Materials and Methods 2.22 and 2.23. The graphs show the total 
number of CD8+ T-cells that express IFNy or IL4 after ex vivo culture (a) and the ratio of the number of CD8+ 
T-cells that expressed IFNy to IL4 (b) for the vaccine groups: saline, BCG parent strain, Hsp70 and Hsp70- 
peptide complexes (Hsp70-p). The individual data points for each mouse in each vaccine group are represented 
on the graphs in addition to the mean and S.E.M for each vaccine group. Statistical comparisons were made 
using one-way ANOVA and the Bonferroni correction. Statistical comparisons were made using one-way 
ANOVA and the Bonferroni correction. Significant differences are indicated by the horizontal bars, * equals a 
significance level of p<0.05, ** equals a significance level of p<0.01, *** equals a significance level of p<0.001 
and **** equals a significance level of pO.OOOl for comparisons to saline (i), BCG parent strain (ii) or Hsp70
(iii).
In contrast to the findings from the CD4+ T-cell results, the CD8+ T-cells from mice 
vaccinated with Hsp70 or Hsp70-peptide complexes showed no increase in the number of 
CD8+ T-cells that expressed IFNy or IL4 compared to the saline vaccinated mice. However, 
the CD8+ T-cells that did produce IFNy or IL4 in the Hsp70 or Hsp70-peptide complexes 
vaccinated mice did show a more Type 1 polarised CD8+ T-cell response compared to the 
saline and BCG vaccinated mice.
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Splenocyte secreted cytokine levels
In order to assess quantitatively the levels of cytokine produced as part of the immune 
response generated by vaccination with Hsp70 or Hsp70-peptide complexes, splenocyte 
culture supernatants were analysed to determine the concentrations of secreted cytokines.
Supernatants from the 72 hour splenocyte cultures, where the splenocytes from mice were 
plated out at 1x10^ cells per well and cultured in Complete medium or with PMA and 
ionomycin, Hsp70 or MycAg, were analysed using a Mouse Type 17Th2 Cytometric Bead 
Array (CBA) kit (BD Biosciences, UK) to determine the concentrations of IL2, IL4, EL5, 
IFNy and TNFa secreted by the splenocytes. The lower limit of detection of the Mouse 
Thl/Th2 CBA kit is given in the manufacturer’s literature as 20pg/ml.
The unstimulated splenocytes showed no detectable levels of IL2, IL4, EL5, IFNy or TNF for 
any vaccine group and no vaccine group showed an increase in secreted cytokines when the 
splenocytes were stimulated with Hsp70.
The PMA and ionomycin stimulated splenocyte culture supernatants contained detectable 
levels of EL2, IFNy and TNF. Compared to the saline vaccinated mice, the splenocytes from 
mice vaccinated with BCG parent strain or Hsp70-peptide complexes secreted significantly 
more EL-2, IFNy and TNFa (Figure 20a(i),b(i) and c(i)). The splenocytes from BCG parent 
strain and Hsp70-peptide complex vaccinated mice secreted higher levels of IL-2 and TNFa 
than the splenocytes from mice vaccinated with Hsp70 (Figure 20a and c).
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Figure 20: The concentration of IL2, IFNy and TNFa in the 72 hour PMA and ionomycin splenocyte 
culture supernatants. Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods 2.21. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
72 hours in Complete Medium, or with PMA and ionomycin (50ng/ml and Ipg/ml respectively) at 37®C with 
5% CO2. At 72 hours supernatants were collected and analysed using a Thl/Th2 Cytometric Bead Array kit (BD 
Biosciences, UK) to determine the concentration of IL2 (a), IFNy (b) or TNFa (c) as described in Materials and 
Methods 2.25. The individual data points for each mouse in each vaccine group are represented on the graphs in 
addition to the mean and S.E.M for each vaccine group. Statistical comparisons were made using one-way 
ANOVA and the Bonferroni correction. Significant differences are indicated by the horizontal bars, * equals a 
significance level of p<0.05, ** equals a significance level of p<0.01, *** equals a significance level of p<0.001 
and **** equals a significance level of p<0.0001 for comparisons to saline (i), BCG parent strain (ii) or Hsp70 
(iii).
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3.3 Discussion
The purification of Hsp70 and Hsp70-peptide complexes from BCG parent strain did not lead 
to a pure preparation of Hsp70 or Hsp70-peptide complexes. This was probably due to many 
other proteins in mycobacteria containing an ATP/ADP binding site and binding to the ATP- 
or ADP-agarose. The use of lysed BCGAhspR as the source material enabled the purification 
of Hsp70 and Hsp70-peptide complexes without the extra protein bands on the SDS-PAGE 
Coomassie stained gels that were observed when BCG parent strain was used in the Hsp70 
purification protocol.
The peptides that were part of the Hsp70-peptide complexes purified from BCGAhspR were 
separated and identified by mass spectrometry. The Hsp70-peptide complexes chaperoned a 
range of peptides but the most frequently detected and identified were Hsp70 peptides. Given 
that Hsp70 is constitutively over expressed in the BCG AhspR strain it is likely to be highly 
represented in the Hsp70 peptide pool. In addition, other reliably identified peptides from 
Hsp70-peptide complexes included GroEL and Acyl carrier protein. The Hsp70 preparations 
contained two types of peptide that were identified, Hsp70 peptides and GroEL peptides. This 
suggests that Hsp70 may co-purify with GroEL and that the size exclusion centrifuge column 
allowed Augments of protein into the peptide pool. However, more peptides and more unique 
peptides were detected in the Hsp70-peptide complexes peptide pools than in the Hsp70 
peptide pools suggesting that these peptides were genuinely chaperoned by the Hsp70.
In order to reliably characterise the peptide population chaperoned by Hsp70 in this 
purification protocol, the peptide identification procedure should be repeated as the 
purification procedure is likely to lead to a wide range of peptides present in very low 
numbers in the preparations, and mass spectrometry uses small sample volumes, reducing 
further the likelihood of getting two strong peptide identifications per protein. Additionally, if 
it were possible to purify Hsp70-peptide complexes fi-om BCG parent strain to sufiBcient
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purity for this analysis, it would be interesting to compare the peptide pools between the 
BCGA/«p/? Hsp70-peptide complexes and those isolated from BCG parent strain to see if the 
peptide populations are affected hspR deletion in BCG.
Hsp70 and GroEL are two well-known antigens of mycobacteria that induce both T-cell and 
B-cell response in humans (Mustafa, 1993; Munk, 1988; Tsoulfa, 1989). Acyl carrier protein 
forms part of the mycolic acid synthesis pathway shuttling intermediate substrates between 
enzyme active domains (Kremer et al., 2001) and there is some evidence that mycobacterial 
acyl carrier protein is a T-cell target (Deenadayalan et al., 2010).
Part of the immunogenicity study looked at the numbers of CD4+ and CD8+ T-cells isolated 
per spleen. As mentioned above, activated T-cells proliferate and a raised number of CD4+ or 
CD8+ T-cells in the vaccinated mice compared to the saline vaccinated mice would suggest 
an expansion of that T-cell population in the vaccinated mice. The CD4+ T-cell population 
per spleen in the BCG parent strain, Hsp70 and Hsp70-peptide complexes vaccinated mice 
showed no difference compared to the saline vaccinated mice. The number of CD8+ T-cells 
per spleen found in the BCG parent strain and Hsp70-peptide complexes vaccinated mice 
showed no difference to the saline vaccinated mice but all three groups had significantly 
greater numbers of CD8+. T-cells compared to the Hsp70 vaccinated mice. Of course, this 
could be an issue of timing, with the number of CD8+ T-cells developing later than 21 days 
in the Hsp70 vaccinated mice. This experiment was limited in that it only investigated one 
time point post vaccination and in the future a time-course investigation of T-ccll populations 
would be useful. Alternatively, the Hsp70 vaccinated mice may have a have a deficiency in 
homing for dendritic cells to the secondary lymphoid organs and thus fail to efficiently prime 
T-cells responses. Activated dendritic cells upregulate CCR7, leading to migration to along a 
chemokine gradient to lymphoid organs. If this homing signal is interrupted, perhaps Hsp70 
stimulation disrupts upregulation of CCR7 on dendritic cells surface, then T-cell responses
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would be comparable to those in naive mice. Future experiments should investigate whether 
Hp70 exposure alter dendritic cell migration.
T-cell responses require T-cell activation before tlie T-cell begins to proliferate or secrete 
cytokines. T-cell activation occurs when the T-cell encounters an antigen-presenting cell that 
presents MHC-T-cell cognate antigen complexes in addition to T-cell costimulatory signals 
from the B7 family. These interact with the T-cell receptor and CD28 on the surface of the T- 
cell leading to activation, proliferation and cytokine production.
The activation of T-cells was assessed by measuring the number of CD4+ and CD8+ T-cells 
that expressed ÇD69 or both CD69 and CD25. Activation of T-cells can be measured through 
the expression of CD69 (Maino et al., 1995). CD69 is also known as the early activation 
antigen and surface expression of CD69 is upregulated shortly after T-cell activation. CD25 
is the IL2 receptor and expression is upregulated on the surface of T-cells after activation but 
sp ears  after CD69 expression. In terms of the background levels of T-cell activation 
observed in the unstimulated splenocyte cultures, Hsp70 vaccination resulted in large 
numbers of CD4+ T-cells that expressed CD69 and CD25 but BCG parent strain and Hsp70- 
peptide vaccination did not result in expression of CD69 or CD25 by CD4+ or CD8+ T-cells 
above the levels observed in saline vaccinated mice
In the PMA and ionomycin stimulated cultures the saline vaccinated mice show the level of 
naive T-cell activation whereas T-cells that have been primed by antigen-presenting cells 
show higher numbers of T-cells that express CD69 and also greater numbers that coexpress 
both CD69 and CD25. The results of the PMA and ionomycin stimulation showed that BCG 
parent strain, Hsp70 and Hsp70-peptide complexes each induced greater levels of CD4+ T- 
cell activation than observed in the saline vaccinated mice However, the majority of the 
activated T-cells in the PMA and ionomycin stimulated splenocyte o f Hsp70 vaccinated mice
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were also present in the unstimulated culture, therefore only BCG parent strain and Hsp70- 
peptide complexes vaccination showed genuine responses above the levels in the 
unstimulated cultures and the PMA stimulated splenocytes from saline vaccinated mice. 
Similarly, BCG parent strain and Hsp70-peptide complexes vaccination resulted in more 
activated CD8+ T-cells than found in saline vaccinated mice, but Hsp70 vaccinated mice had 
no difference in the number of activated CD8+ T-cells compared to saline vaccinated mice.
In mycobacterial vaccine development IFNy is often used to detect an ^propriate immune 
response as IFNy and Type 1 responses are required for clearance of mycobacterial infections 
(Cooper et al., 1993; Cooper et al., 1995b; Flynn et al., 1993). The T-cells in this thesis were 
stained for intracellular accumulation of IFNy and IL4 as these cytokine are typical of Type I 
and Type 2 responses respectively. Both IFNy and IL4 expression was assessed to determine 
if a low IFNy response was due to inhibition due to the induction of Type 2 responses or if it 
was due to a complete absence of a T-cell response. The limitation of this protocol is that 
although IFNy is required for protection it is not a correlate of protection itself, nor are other 
cytokines expressed by T-cells (Kagina et al., 2010). However, this protocol does identify 
whether a vaccine has induced an inappropriate Type 2 biased response and is therefore 
sufficient for preliminary vaccine evaluation as carried out in this thesis.
In terms of the intracellular cytokine staining, BCG parent strain vaccination resulted in 
increased numbers of both CD4+ and CD8+ T-cells that expressed IFNy and IL4 compared to 
the saline vaccinated mice. This was supported by the activation data that showed increased 
activation of T-cells in the BCG parent strain vaccinated mice compared to the saline 
vaccinated mice. Although some of the T-cells fix)m BCG parent strain vaccinated mice 
stained positive for IL4 production, no IL4 was detected in the splenocyte culture 
supernatants. This observation agrees with cytokine production by M  tubercidosis-s^di^c
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T-cell clones that showed increased IL4 mRNA but no detectable secretion of EL4 (Barnes et 
al., 1993).
The Hsp70 vaccination did not result in an increased number of T-cells tliat expressed IFNy 
or IL4 compared to the saline mice but did alter the ratio of IFNy to EL4 leading to a 
significantly more Type I dominated T-cell activity than observed in the saline or BCG 
parent strain vaccinated mice. Again, the T-cell activation results agreed with the intracellular 
cytokine data in that Hsp70 vaccinated mice showed no difference in the size of the T-cell 
response to the saline vaccinated mice.
Vaccination with Hsp70-peptide complexes resulted in an increased number of CD4+ T-cells 
that expressed IFNy compared to the saline group but no difference to the saline group in the 
number of CD8+ T-cells that expressed IFNy or IL4. The intracellular cytokine data concurs 
with the activation data in reporting low T-cell activity in the Hsp70 vaccinated mice.
Consistently throughout this study, there were significant differences between the T-cell 
responses of Hsp70-peptide complex vaccinated mice and the Hsp70 vaccinated mice in the 
numbers of CD4+ or CD8+ T-cells, the number of activated or cytokine producing T-cells 
and the concentrations of secreted cytokine in splenocyte culture supernatants. The Hsp70- 
peptide complex vaccine induce T-cell activation and cytokine production and secretion but 
the Hsp70 vaccine did not differ to the levels observed in saline vaccinated mice.
The differences in response could be due to the peptide in the Hsp70-peptide complexes or 
could be due to the use of ADP in the purification of Hsp70-peptide complexes rather than 
ATP in the purification of Hsp70 fi'om BCGAhspR.
Hsp70 is present and highly conserved in bacteria and mammals, and as such the 
mycobacterial Hsp70 used in this study may be subject to host immune tolerance of
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mammalian Hsp70. In this case, the Hsp70 in both the Hsp70 and Hsp70-peptide complex 
vaccines may not provoke a T-cell response. However, Hsp70-peptide complexes contain 
other non-Hsp70 peptides and T-cell responses to these non-Hsp70 peptides may be 
responsible-for the difference in response between Hsp70 and Hsp70-peptide complexes 
observed in this study. Immune tolerance is partly mediated by T-regulatory cells. These T- 
cells are identified through surface expression of CD4 and CD25 and intracellular expression 
of the transcription factor FoxP3. T-regulatory cells are an important mechanism for avoiding 
autoimmune reactions and produce compounds including interleukin 10 (ILIO), which 
inhibits proinflammatory immune responses. In a proteoglycan-induce arthritis model in 
Balb/c mouse, vaccination with mycobacterial Hsp70 induced Hsp70-specific inhibitory 
responses mediated by ILIO (Wieten et al., 2009). The finding that mycobacterial Hsp70 can 
induce ILIO expression and inhibit proinflammatory responses has been replicated by other 
groups (Detanico et al., 2004; Prakken et al., 2001; Wendling et al., 2000). However, the 
source of the mycobacterial Hsp70 induced ELIO was not been identified. Therefore, 
investigation into T-regulatory cell populations in the Hsp70 and Hsp70-peptide complex 
vaccinated mice is needed to determine if T-regulatory cells are responsible for the difference 
in response between these two vaccines.
Alternatively, the impact of nucleotide presence in the vaccines must also be considered. The 
Hsp70 vaccine was prepared by purification of Hsp70 using ATP-agarose and an elution 
buffer containing ATP (Material and Methods 2.14). The Hsp70-peptide complexes were 
purified using ADP-agarose and an ADP containing elution buffer. Both the Hsp70 and 
Hsp70-peptide complex preparations were dialysed separately overnight with three buffer 
changes of endotoxin-free water to remove non-Hsp70 compounds such as free ATP or ADP; 
however some ATP or ADP may remain in complex with the Hsp70 in these preparations.
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ÀTP has been shown to interact with antigen-presenting cells through purinergic receptors on 
the cell surface leading to maturation of the dendritic cells as assessed by expression of 
maturation markers such as CD83 and CD80/86 (Berchtold et al., 1999), MHC-peptide 
complexes, the secretion of cytokines such as IL12 and T-cell stimulatory capacity (Schnurr 
et al., 2000). However, other studies have shown that the exposure to ATP results in a semi- 
mature phenotype of the dendritic cells characterised by a lack the secretion of 
proinflammatory cytokines or chemokines for monocytes recruitment (Horckmans et al., 
2006). Instead, ATP exposure resulted in secretion of ILIO (Wilkin et al., 2002) and 
inhibitory compounds thrombospondin-1 and idoleamine 2,3-dioxygenase by dendritic cells 
(Marteau et al., 2005). In the data presented in this chuter the Hsp70 vaccinated mice 
demonstrated a Type 1-biased T-cell response but no increased numbers of CD4+ or CD8+ 
T-cells that were activated or expressed IFNy or BL4 compared to the saline vaccinated mice, 
nor did these mice express cytokine when stimulated for 72hr with PMA and ionomycin. This 
suggests that T-cells were not efficiently primed by Hsp70 vaccination and this was possibly 
due to ATP-dendritic cell interactions leading to inhibitory or tolerogenic signals. In 
contrast, the Hsp70-peptide complexes vaccinated mice did demonstrate increased T-cell 
cytokine expression equivalent to the levels observed in the BCG parent strain vaccinated 
mice and above the levels in the saline vaccinated mice. Exposure to ADP is not inhibitory 
and can enhance dendritic cell stimulatory properties through the P2Y12 receptor, resulting in 
greater levels of specific T-cell activation (Ben Addi et al., 2010). Therefore, the difference 
between the Hsp70 and the Hsp70-peptide complexes vaccinated mice may be due partly to 
the presence of peptides and partly due to the presence of ATP bound by the Hsp70.
The intracellular cytokine staining data was supported by the CBA data where 72 hour 
culture Supernatants of splenocytes cultures from BCG parent strain vaccinated mice had the 
highest IFNy concentration after ex vivo culture with PMA and ionomycin. Although 1 -cells
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that expressed IL4 were detected by intracellular cytokine staining neither IL4 nor EL5 were 
detected in the BCG parent strain splenocyte cultures that were unstimulated or stimulated 
with PMA and ionomycin above the experimental assay limit of detection of 20pg/ml as 
given by the manufacturer. However, PMA and ionomycin stimulation induces the 
expression of IFNy more effectively than the expression of IL4 (Baran et al., 2001), so this 
stimulation may have distorted the skew of the immune response as detected in the 
unstimulated T-cells.
Overall the effect of vaccination with Hsp70-peptide complexes appeared to be equivalent to 
BCG parent strain in the secretion of IL-2, TNFa by PMA and ionomycin stimulated 
splenocyte culture. The IFNy concentrations were lower than observed in the BCG cultures 
but showed less variance. Mycobacteria can induce Type 2-biased responses as a mechanism 
to evade IFNy mediated destruction by binding to a C-type lectin receptor, DC-SIGN, on the 
surface of antigen-presenting cells (Gagliardi et al., 2005; Geijtenbeek et al., 2003; Wieland 
et al., 2007).
The intracellular cytokine staining showed that Hsp70-peptide complexes induced CD4+ T- 
cell IFNy but did not produce CD8+ T-cell responses in the mice. However, 72hour 
splenocyte stimulation resulted in cytokine secretion equivalent to that found in BCG parent 
strain vaccinated mice. Therefore, Hsp70-peptide complexes appear to make a suitable 
candidate for further research as an anti-mycobacterial vaccine. For further research, it would 
be interesting to see if Hsp70-peptide complexes induced MyeAg-speeifie T-cell activation 
and cytokine production and also if the T-cell responses can be increased with further booster 
vaccinations rather than the two used in this chapter, or perhaps as a booster for BCG primed 
mice.
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M. tuberculosis challenge model in C57B/6 mice showed no protective effect from Hsp70 
vaccination or from BCG parent strain prime with an Hsp70 boost (unpublished data, J 
Keeble, NIBSC). This agrees with the data presented in this chapter that found splenocyte 
proliferation in BCG parent strain, Hsp70 or Hsp70-peptide complexes vaccinated mice was 
not stimulated by Hsp70, nor did Hsp70 vaccination evoke strong T-cell activity in vivo.
In terms of future work I propose numerous repeats of the Hsp70-peptide purification to more 
fully characterise the peptide repertoire of Hsp70-peptide complexes with the addition of 
Hsp70-peptide complexes isolated from BCG parent strain. In addition, it would be useful to 
stimulate splenocytes from BCG parent strain and Hsp70-peptide complexes vaccinated mice 
with peptides isolated from Hsp70-peptide complexes such as acyl carrier protein as 
identified in this chapter.
Additionally, it would be interesting to determine whether the large population of activated 
T-cells in the Hsp70 vaccinated mice are T-regulatory cells by measuring expression of 
FoxP3. Polyfunctional T-cells have been recently identified as more reliable correlates of  
protection than single expressing IFNy T-cells. Polyfunctional T-cells are identified through 
to coexpression of two or more cytokines. Co-expression of IL2, TNFa and IFNy were found 
to be protective in Leishmania major infection models (Darrah et al., 2007) further 
investigation revealed polyfunctional T-cells at sites of disease in TB patients (El Fenniri et 
al., 2011) and may represent new correlates of protection in M. tuberculosis research. It 
would be interesting to look at polyfunctional T-cclls especially as the IIsp70-peptide 
complexes had similar IL2 levels in the PMA stimulated splenocyte culture supernatants as 
observed in BCG vaccinated mice splenocyte cultures.
Finally, it would be necessary to perform an aerosol challenge experiment with M 
tuberculosis to establish the protective efficacy of vaccination with Hsp70-peptide
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complexes. Another strategy would be to use Hsp70-peptide complexes as a booster for BCG 
vaccinated mice as the majority of people currently receive à BCG vaccination and it would 
be useful to determine whether Hsp70-peptide complexes booster may enhance the T-cells 
responses induced by BCG.
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3.4 Conclusion
It was possible to purify pure preparations of Hsp70 and Hsp70-peptide complexes from 
BCGAhspR using the ATP or ADP agarose affinity chromatography system. The peptides 
separated from Hsp70-peptide complexes comprised primarily of Hsp70 peptide fragments. 
As Hsp70 is the most highly expressed protein in BCGAhspR Hsp70 peptides are likely to 
represent a high proportion of peptides bound by Hsp70, particularly in BCGAhspR, which 
over-expressed Hsp70. Acyl carrier protein is an Hsp70 chaperoned peptide that can be 
separated from Hsp70-peptide complexes.
Hsp70 vaccination did not result in enhanced splenocyte proliferation, T-cell expression of 
IFNy or EL4, or secretion of cytokines by splenocytes compared to the saline vaccinated mice 
for any culture condition tested although the ratio of IFNy to IL4 production by T-cells was 
increased compared to saline and BCG vaccinated mice. The mice did not exhibit Hsp70- 
specific splenocyte proliferation indicating that Hsp70 vaccination did not prime an Hsp70- 
specific response. However, there may be a substantial T-regulatory cell population in the 
Hsp70 vaccinated mice.
Hsp70-peptide complexes vaccination did result in MycAg-specific splenocyte proliferation 
but not Hsp70-specific proliferation. This shows that Hsp70-peptide complexes primed an 
immune response that was not targeted to Hsp70. The number of CD4+ T-cells that expressed 
IFNy in Hsp70-peptide complexes vaccinated mice was equivalent to that induced by BCG 
parent strain but showed a significantly lower number of CD4+ T-cells that expressed IL4. 
Although there was no increased CD8+ T-cells response compared to saline vaccinated mice 
these mice had equivalent secretion of cytokine in 72 hour culture as BCG parent strain 
vaccinated mice.
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Chapter 4: The immunogenicitv of BCG 
Pasteur that over-express heat shock 
proteins
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4.1 Introduction
One research approach in mycobacterial vaccine development is to enhance the protective 
effect that BCG vaccination generates. In the previous chapter we investigated the 
immunogenicity of purified Hsp70 and Hsp70-peptide complexes and their ability to induce 
MycAg-specific T-cell activation and cytokine production. That study found that Hsp70- 
peptide complexes induced MycAg-specific CD4+ T-cells responses but also skewed both 
the CD4+ and CD8+ T-cell responses to a significantly more Type 1-like cytokine profile 
than observed in BCG parent strain vaccinated mice. As Type 1 T-cell responses are required 
for efficient immune responses against mycobacteria (Cooper et al., 1993; Cooper et al., 
1995b; Flynn et al., 1993), over-expression of Hsp70 may enhance the CD4+ T-cell response 
generated by BCG parent strain vaccination and induce a more IFNy dominated T-cell 
response in the vaccinated mice. Hsp70 expression in mycobacteria is regulated by a 
transcriptional repressor protein, HspR, which binds to HAIR sequences upstream of 
regulated genes preventing transcription of the target gene. Over-expression of Hsp70 by 
BCG can be achieved by a deletion of hspR, which resulted in constitutively high expression 
of Hsp70 in the BCGA/wpR mutant (Stewart et al., 2001).
The effect of Hsp70 is reportedly due to the chaperone activity of the Hsp70 delivering bound 
peptides for more efficient processing and presentation by host antigen-processing cells 
(APCs) in addition to the APC stimulating effect of Hsp70 (Retzlafif et al., 1994). Another 
mycobacterial molecular chaperone, GroEL, has also been shown to exhibit similar immune- 
stimulatory activity inducing antigen-presenting cell maturation and proinflammatory 
cytokine expression (Lewthwaite et al., 2001). The chaperone function of GroEL as modelled 
in Escherichia coli involves the enclosure of incorrectly folded peptides in a GroEL cage 
where intermolecular interactions between the peptide and the GroEL cage mediates peptide 
refolding (Weissman et al., 1995; Weissman et al., 1994). Mycobacterial GroEL has been
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shown to stimulate the maturation of APCs and secretion of proinflammatory cytokines 
(Lewthwaite et al., 2001). Maturation of APCs is necessary for efficient T-cell stimulation 
and therefore, over-expression of GroEL by BCG may result in enhanced APC maturation 
and proinflammatory cytokine release with greater subsequent T-cell responses to 
mycobacterial antigens.
Mycobacteria have a a GroE operon comprising of GroEL and GroES but also have a 
duplicate copy of GroEL, called GroEL2, located separately on the chromosome (Qamra et 
al., 2005). Expression of the GroE operon is regulated by HrcA, which binds to repeated 
sequences, controlling inverted repeat of chaperone expression (CIRCE) sequences, upstream 
of GroE operon preventing transcription of GfoEL and GroES (Stewart et al., 2002). GroEL2 
lacks an upstream CIRCE sequence and is therefore unlikely to be controlled through HrcA 
binding.
The hypothesis for this work was that Hsp70 over-expression in BCGAhspR, or GroEL 1 
over-expression in BCGAhrcA, would result in greater levels of MycAg-specific T-cell 
activation and IFNy production in vaccinated mice compared to vaccination with BCG parent 
strain. Furthermore, the over-expression of both Hsp70 and GroEL 1 in BCGAhspRAhrcA 
would induce greater MycAg-specific T-cell activity than BCG parent strain, BCGAhspR or 
BCGAArc/4 in vaccinated mice.
The aim of this chuter was to investigate the immunogenicity of BCG strains that 
overexpress Hsp70 and GroEL. The specific objectives were to:
1. Engineer a BCG that lacks hrcA, BCG AhrcA, which overexpresses GroEL 1
2. Investigate the immunogenicity of BCGA/w/j/2, BCG AhrcA and 
BCG AhspRAhrcA by measuring T-cell activation and cytokine production
■_______ .______________________________   Pa g e I 101
4.2 Results
4.2.1 Deletion of hrcA in BCG wildtype was non-viable
One strategy to increase the immunogenicity of BCG Pasteur and the resulting protection 
from mycobacterial infection was to over-express molecular chaperones. Ch^erones Hsp70 
and GroEL have shown potential to deliver peptides for enhanced peptide-specific T-cell 
responses in addition to inducing Hsp70-specific and GroEL-specific T- and B-cell 
responses.
As mentioned in Chapter 3, Hsp70 expression is regulated by a repressor, HspR. A BCG 
Pasteur strain that has a targeted deletion of hspR constitutively over-expressed Hsp70 
(Stewart et al., 2002) has shown some potential enhancement of BCG immunogenicity and 
protection (Stewart et al., 2001).
To further enhance the immunogenicity of BCGAhspR the hrcA gene was deleted using 
plasmid pSMT163 and replaced with a gene for kanamycin resistance (Stewart et al., 2001) to 
produce BCGtshspRAhrcA. Deletion of both hspR and hrcA resulted in BCGAhspRAhrcA 
over-expressing both Hsp70 and GroEL 1.
In this study several attempts were made using pSMT163 to knock-out the hrcA gene in BCG 
Pasteur wildtype. The plasmid pSMT163 was electroporated into BCG and double crossover 
gene replacement events were selected un a single step by plating onto 7H11 containing 
kanamycin and 2% sucrose. Despite persistent efforts no transformants were obtained.
Mycobacteria contain two copies of GroEL but only GroEL 1 is downstream of a hrcA 
binding site so it is likely that only GroEL 1 expression is upregulated in the BCGAhrcA. The 
GroEL molecules in mycobacteria purify in native conditions as dimers (Qamra and Mande, 
2004). There is some evidence that although the two GroEL chaperones exhibiting high
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sequence similarity (Kong et al., 1993) the chaperones fulfill independent functions in 
mycobacteria (Qamra et al., 2005). This dysregulation of relative GroEL 1 and GroEL2 
expression may lead to interference with the GroEL functions, which include assisting the 
folding of several essential proteins (Houry et al., 1999) and lead therefore to toxicity and cell 
death. In contrast to BCGAhrcA, the BCGAhspRAhrcA mutant may be able to tolerate the 
excess GroEL through the chaperone function of the excess Hsp70.
4.2.2 Immunogenicity Study
In order to assess the immunogenicity of BCGAhspR and BCGAhspRAhrcA groups of five 
C57B/6 female mice aged 6 weeks were vaccinated with saline, or 2 x 10  ^c.f.u BCG parent 
strain, BCGAhspR or BCGAhspRAhrcA. At 21 days post vaccination the splenocytes were 
harvested and cultured ex vivo in Complete medium, PMA and ionomycin or with 
mycobacterial antigen (MycAg).
The splenocytes were stained to identify CD4+ and CD8+ T-cells and to identify T-cells that 
expressed CD69 and CD25, indicating T-cell activation. The splenocytes were also stained to 
identify the T-cells that express IFNy or EL4, cytokine representative of Type 1 and Type 2 
response respectively. Type 1-like T-cell responses are required for efficient clearance of 
mycobacterial infections (Gassier et al., 1998; Langermans et al., 2005; Weir et al., 2008).
The numbers of CD4+ and CD8+ T-cells
The relative numbers of CD4+ and CD8+ T-cells per spleen suggests whether a T-cell subset 
underwent proliferation in vivo as a result of vaccination.
Mice vaccinated with BCG parent strain ot'BCGAhspR l^cA  resulted in larger numbers of 
CD4+ T-cells per spleen than was found in saline vaccinated mice (Figure 21a). Vaccination
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with BCG parent strain, BCGAhspR or BCGAhspRAhrcA resulted in larger numbers of 
CD8+ T-cells present in the spleens (Figure 21b).
This suggests that BCG parent strain and BCGAhspRAhrcA induced expansion of the CD4+ 
T-cell populations whereas all three BCG vaccines induced proliferation of the CD8+ T-cell 
populations compared to the saline vaccinated mice.
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Figure 21: The number of CD4+ and CD8+ T-cells isolated per spleen. Groups of 5 mice were vaccinated as 
described in Materials and Methods 2.21. The splenocytes were harvested at 21 days post-vaccination and 
cultured overnight in Complete medium. Brefeldin A was added at 9 hours. The graphs show the number of 
CD4+T-cells (a) and CD8+ T-cells (b) that were isolated per spleen. Each mouse is represented by a data point 
with the vaccine group mean and S.E.M displayed on the graphs. ANOVA and the Bonferroni correction were 
used for the statistical analysis with comparison to saline (i), to BCG parent strain (ii) and BCGAAjp  ^ (iii) 
shown by the horizontal bars. *, **, *** and **** indicate a significance levels of p<0.05, 0.01, 0.001 and 
0.0001 respectively.
CD4+ and CD8+ T-cell expression of CD69 and CD25
To further characterise the immune response induced by the BCGAhspR or BCGAhspRAhrcA 
vaccination, the activation of CD4+ and CD8+ T-cell subsets after ex vivo culture were 
measured. Surface expression of CD69 and CD25 are used in T-cell research as phenotypic 
markers of T-cell activation.
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Activation o f  CD4+ T-cells
The unstimulated splenocytes of each vaccine group showed low levels of background T-cell 
activation (Figure 22a). However, there were some differences between the vaccine groups 
with BCG parent strain and BCGAhspR vaccination resulting in a higher number of CD69 
expressing CD4+ T-cells than observed in saline or BCGAhspR vaccinated mice (Figure 
22a). There were higher numbers of CD4+ T-cells that co-expressed CD69 and CD25 in 
BCGAhspRAhrcA vaccinated mice than found in both saline, BCG parent strain or 
BCGAhspR vaccinated mice (Figure 22a).
Vaccination with BCG parent strain or BCGAhspRAhrcA resulted in a greater number of 
activated CD4+ T-cells as measured by CD69 and CD25 co-expression after culture with 
PMA and ionomycin compared to the saline vaccinated mice (Figure 22b). Mice vaccinated 
with BCGAhspR had a significantly lower number of CD4+ T-cells that responded to culture 
with PMA and ionomycin by expression of CD69 compared to saline vaccinated mice.
The BCG parent strain vaccinated mice had significantly greater numbers of CD4+ T-cells 
that expressed CD69 or co-expressed CD69 and CD25 after ex vivo culture with MycAg 
compared to all other vaccine groups (Figure 22c). This increased CD4+ T-cell activation is 
MycAg-specific as it is above the background level of CD69 expression or CD69 CD25 co­
expression found in the unstimulated CD4+ T-cells (Appendix 2.1a and b)..
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Figure 22: The number of CD4+ T-cells that expressed CD69 or co-expressed CD69 and CD25 after ex 
vivo culture of the splenocytes. Groups of 5 mice were vaccinated as described in Materials and Methods 2.21. 
The splenocytes were harvested at 21 days post-vaccination and cultured overnight either in medium alone (a), 
with PMA and ionomycin (b) or with MycAg (lOpg/ml) (c). Brefeldin A was added to the culture media at 9 
hours, The graphs show the mem and S.E.M of the number of C D 4t T-cells that expressed CD69 (lower 
section of the bar) or co-expressed both CD69 and CD25 (upper section of each bar) after ex vivo culture of the 
splenocytes. Statistical comparisons were made using one-way ANOVA and the Bonferroni correction with the 
statistical differences displayed on the graphs as horizontal bars with comparison to saline (i), BCG parent strain 
(ii) and BCGAhspR (iii) shown. *, **, *** and **** represent significance levels p<0.05, 0.01, 0.001 and 
0.0001 respectively.
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Vaccination with BCGAhspRAhrcA does not induce any MycAg-specific CD4+ T-cell 
activation (Figure 22c) even though the CD4+ T-cells have clearly been primed by prior 
antigen exposure as demonstrated by their response to PMA and ionomycin (Figure 22b).
Activation o f CD8+ T-cells
The unstimulated splenocytes of each vaccine group have low numbers of CD8+ T-cells that 
express CD69 or co-express CD69 and CD25 (Figure 23a) although the number of CD8+ T- 
cells that were CD69+ CD25+ was greater in BCGAhspRAhrcA than in saline vaccinated 
mice.
The BCG parent strain and BCGAhspRAhrcA vaccinated mice both contained higher 
numbers of activated CD8+ T-cells after ex vivo culture with PMA and ionomycin compared 
to the saline vaccinated mice (Figure 23 b). Vaccination with BCGAhspR resulted in a low 
number of activated CD8+ T-cells that respond to PMA and ionomycin stimulation compared 
to the other two BCG vaccines (Figure 23b).
Activation of MycAg-specific CD8+ T-cells is greatest in mice that were vaccinated with 
BCG parent strain compared to the other vaccine groups as assessed by the surface 
expression of CD69 or co-expression of CD69 and CD25 (Figure 23c, Appendix 2.1c and d). 
BCGAhspR and BCGAhspRAhrcA vaccinated mice, as with the CD4+ T-cells, showed no 
difference fi'om the level of CD8+ T-cells activation observed in saline vaccinated mice when 
stimulated with MycAg (Figure 23c).
Again, the BCGAhspRAhrcA vaccinated mice showed a complete lack of MycAg-specific 
CD8+ T-cell activation (Figure 23, Appendix 2.1c and d) despite having responded strongly 
to PMA and ionomycin stimulation (Figure 23b) indicating efficient priming of the T-cell 
population but a defect in recognition or response to MycAg.
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Figure 23: The number of CD8+ T-cells that expressed CD69 or co-expressed CD69 and CD2S after ex 
vivo culture of the splenocytes. Groups of 5 mice were vaccinated as described in 2.19. The splenocytes were 
harvested at 21 days post-vaccination and cultured overnight either in Complete medium alone (a), with PMA 
and ionomycin (b) or with MycAg (lOpg/ml) (c). Brefeldin A was added to the culture media at 9 hours. The 
graphs show the mean and S.E.M of the number of CD4+ T-cells that expressed CD69 (lower section of the bar) 
or co-expressed both CD69 and CD25 (upper section of each bai) after ex vivo  culture of tire splenocytes. 
Statistical comparisons were made using one-way ANOVA and the Bonferroni correction with the statistical 
differences displayed on the graphs as horizontal bars with comparison to saline (i), BCG parent strain (ii) and 
BCGAhspR (iii) shown. *, **, *** and **** represent significance levels p<0.05, 0.01, 0.001 and 0.0001 
respectively.
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The BCGAhspR vaccinated mice showed no CD8+ T-cell activation above the level observed 
in the saline vaccinated mice for all culture conditions.
The activation data suggest that while BCGAhspRAhrcA vaccination may have efBciently 
primed CD8+ T-cells these were unable to respond to MycAg stimulation. Vaccination with 
BCG parent strain did result in priming of CD8+ T-cells and these were able to successfully 
respond to MycAg-stimulation by activation.
Alternatively, it is possible that the lack of MycAg-specific activation is due to a bystander 
effect where the signals from antigen-presenting cells, and T-cells that are responding, lead to 
priming of surrounding T-cells in a non-antigen specific manner. These bystander cells would 
respond to PMA and ionomycin stimulation but not to MycAg stimulation.
CD4+ and CD8+ T-cell expression of IFNy and EL4
As described earlier, T-cell subsets were investigated for EFNy or IL4 expression after ex vivo 
culture of splenocytes to determine the level of cytokine production and the type of immune 
response.
Expression o f  IFNy and IL4 by CD4+ T-cells
In the unstimulated splenocyte cultures there were no differences in the number of CD4+ T- 
cells that produced IFNy between the vaccine groups (Figure 24a).
The PMA and ionomycin ex vivo stimulation induced significant numbers of CD4+ T-cells to 
produce IFNy compared to the unstimulated controls. This demonstrates that the intracellular 
cytokine staining protocol was working. There were significantly more CD4+ T-cells that
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expressed IFNy in the BCG parent strain vaccinated mice than in the saline control (Figure 
24b).
The culture of splenocytes with MycAg identified MycAg-specific T-cells that are capable of 
responding to antigen-stimulation through the production of either IFNy, indicating a Type 1- 
like response, or IL4, suggesting a Type 2 skew to the immune response. The usual response 
elicited by vaccination with BCG parent strain involves the production of IFNy by T-cells 
(Huygen et al., 1992), which is often used as a correlate of protection in M  tuberculosis 
vaccine studies. The data presented here support this finding as there were greater numbers of 
CD4+ T-cells in BCG parent strain vaccinated mice expressed IFNy than found in the saline 
or BCGAhspRAhrcA vaccinated mice when stimulated with MycAg (Figure 24c). The BCG 
parent strain response is MycAg-specific as the number of CD4+ T-cells that expressed IFNy 
was significantly greater than the levels observed in the unstimulated splenocyte cultures 
(Appendix 2.2a). '
The intracellular IFNy can be measured by the mean fluorescence intensity (MFI) of staining 
per cell. The splenocytes fi"om each vaccine group show no differences in the intracellular 
level of IFNy produced when cultured without antigen (Figure 25a).
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Figure 24: The number of CD4+ T-cells that expressed IFNy after ex vivo culture of the splenocytes.
Groups of 5 mice were vaccinated as described in Materials and Methods 2.21. The splenocytes were harvested 
at 21 days post-vaccination and cultured overnight either in complete medium (a), PMA and ionomycin (b) or 
with MycAg (lOpg/ml) (c). Brefeldin A was added to the culture media at 9 hours in to the incubation. Ihe 
graphs show the mean and S.E.M of the number of CD4+ T-cells that expressed IFNy after ex vivo culture. 
Statistical comparisons were made using one-way ANOVA and the Bonferroni correction with the statistical 
differences displayed on the graphs as horizontal bars with comparison to saline (i), BCG parent strain (ii) and 
BCGAhspR (iii) shown. *, **, *** and **** represent significance levels p<0.05, 0.01, 0.001 and 0.0001 
respectively.
___________________________________________  .___________ P a g e  I 111
The CD4+ T-cells from all vaccine groups show increased intracellular IFNy when stimulated 
with PMA and ionomycin compared to the unstimulated splenocytes, which showed that the 
CD4+ T-cells in these mice were capable of IFNy production (Figure 25b) but there are no 
differences in the IFNy levels between the vaccine groups.
In agreement with the number of CD4+ T-cells that produced EFNy after MycAg stimulation, 
BCG parent strain vaccination resulted in CD4+ T-cells that had significantly higher 
intracellular IFNy when cultured with MycAg compared to saline vaccinated mice (Figure 
25c) and compared to the unstimulated splenocyte cultures (Appendix 2.3a).
Neither BCGAhspR nor BCGAhspRAhrcA vaccination induced greater EFNy expression after 
MycAg stimulation compared to the saline vaccinated mice (Figure 25c). This is consistent 
with the observation that BCGAhspR induced a much greater Type 2 component to the 
immune response. The expression of EL4 is known to be antagonistic to the expression of 
EFNy and is likely here that the higher numbers of CD4+ T-cells that expressed EL4 were 
responsible for the low intracellular IFNy levels in CD4+ T-cells in BCGAhspR vaccinated 
mice.
BCGAhspRAhrcA vaccinated mice showed no MycAg-specific increases in the CD44- T-cell 
intracellular levels of EFNy above the level observed in the saline vaccinated mice or the 
unstimulated controls (Figure 25c, Appendix 2.3a), which agrees with the data above that 
showed a lack of MycAg-specific immune response by BCGAhspRAhrcA vaccinated mice.
The unstimulated splenocytes of mice vaccinated with BCGAhspR contained an increased 
number of IL4 producing CD4+ T-cells compared to saline vaccinated mice (Figure 26a).
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PMA and ionomycin is a less potent stimulator of IL4 secretion than for IFNy (Baran et al., 
2001) and the numbers o f IL4 producing CD4+ T-cells are lower than the numbers of IFNy 
after ex vivo stimulation with PMA and ionomycin. The number of CD4+ T-cells that express
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Figure 25: The IFNy MFI of CD4+ T-cells that express IFNy after ex vivo culture of the splenocytes.
Groups of 5 mice were vaccinated as described in Materials and Methods 2.21. The splenocytes were harvested 
at 21 days post-vaccination and cultured overnight either in medium alone (a), medium supplemented with PMA 
and ionomycin (b) or medium supplemented with MycAg (lOug/ml) (c). Brefeldin A was .added to the culture 
media at 9 hours. The graphs show the mean and S.E.M o f  Àe IFNy MFI level of the CD4+ T-cells that e>q3ress 
IFNy after ex vivo culture. Statistical comparisons were made using one-way ANOVA and the Bonferroni 
correction with the statistical differences displayed on the graphs as horizontal bars with comparison to saline 
(i), BCG parent strain (ii) and BCGA/w/?/? (iii) shown. *, **, *** and **** represent significance levels p<0.05, 
0.01, 0.001 and 0.0001 respectively.
_________________  -_________;___________________ P a g e  I 113
IL4 after stimulation with PMA and ionomycin were greater in BCG parent strain and 
BCGlihspRÊiJTrçA vaccinated mice than in the saline control (Figure 26b).
There were higher numbers of M ycAg-spcciflc CD4+ T-cclls that expressed IL4 in mice 
vaccinated with BCGA/wp/? compared to all the other vaccine groups (Figure 26c). This 
response is MycAg-specific IL4 production as the levels in the MycAg stimulated 
splenocytes is higher than that of the unstimulated splenocytes (Appendix 2.2b).
The CD4+ T-cells fi’om saline vaccinated mice showed higher intracellular IL4 levels than 
the other vaccine groups (Figure 27a).
The BCG parent strain vaccinated mice were the only vaccine group that showed a significant 
increase in CD4+ T-cell intracellular BL4 levels after stimulation with MycAg compared to 
both the saline control (Figure 27c) and the unstimulated splenocytes (Appendix 2.3b). This 
is supported by the literature that mycobacteria can promote a mixed Type lAType 2 immune 
response in the host organisms through DC-SIGN interaction to inhibit host proinflammatory 
responses (van Kooyk et al., 2003; van Kooyk et al., 2004).
The CD4+ T-cells fi'om mice vaccinated with BCGAhspRAhrcA showed increased 
intracellular IL4 levels after stimulation with PMA and ionomycin compared to the 
unstimulated splenocytes. However, when the splenocytes fi'om BCGAhspRAhrcA mice were 
stimulated with MycAg, the CD4+ T-cells had the lowest intracellular IL4 levels (Figure 
27c). This suggest that while some of the CD4+ T-cells were primed by the 
BCGAhspRI^cA  vaccination to produce IL4, these cells are unable to respond to MycAg by 
expressing IL4.
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Figure 26: The number of CD4+ T-cells that expressed IL4 after ex vivo culture of the splenocytes. Groups 
of 5 mice were vaccinated as described in Materials and Methods 2.21. The splenocytes were harvested at 21 
days post-vaccination and cultured overnight either in complete medium alone (a), with PMA and ionomycin (b) 
or with MycAg (lOpg/ml) (c). Brefeldin A was added to the culture media at 9 hours in to the incubation. The 
gr^hs show the mean and S.E.M of the number of CD4+ T-cells that expressed IL4 after ex vivo culture. 
Statistical comparisons were made using one-way ANOVA and the Bonferroni correction with the statistical 
differences displayed on the graphs as horizontal bars with comparison to saline (i), BCG parent strain (ii) and 
BCGAhspR (iii) shown. *, **, *** and **** represent significance levels p<0.05, 0.01, 0.001 and 0.0001 
respectively.
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Figure 27: The IL4 MFI of CD4+ T-cells that expressed IL4 after ex vivo culture of the splenocytes.
Groups of 5 mice were vaccinated as described in Materials and Methods 2.21. The splenocytes were harvested 
at 21 days post-vaccination and cultured overnight either in complete medium alone (a), with PMA and 
ionomycin (b) or with MycAg (lOpg/ml) (c). Brefeldin A was added to the culture media at 9 hours. The graphs 
show the mean and S.E.M of the IL4 MFI levels of the CD4+ T-cells that expressed IL4 after ex vivo culture. 
Statistical comparisons were made using one-way ANOVA and the Bonferroni correction with the statistical 
differences displayed on the graphs as horizontal bars with comparison to saline (i), BCG parent strain (ii) and 
BCGAhspR (iii) shown. *, **, *** and **** represent significance levels p<0.05, 0.01, 0.001 and 0.0001 
respectively.
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In order to measure th complete magnitude of the CD4+ T-cell response the numbers of 
CD4+ T-cells that expressed IFNy or IL4 were added together. The combined numbers of 
MycAg-specific CD4+ T-cells that express IFNy or IL4 in BCG parent strain and BCGAhspR 
-vaccinated mice are significantly greater than the numbers observed in saline vaccinated mice 
(Figure 28a). BCGAhspRAhrcA vaccination did not induce a greater number of CD4+ T-cells 
to express the cytokine IFNy or IL4 compared to the saline vaccinated mice (Figure 28a).
The type of immune response can be assessed by looking at the ratio of IFNy and IL4 
producing T-cells. C57B/6 mice are prone to express IFNy in response to immune 
stimulation. Here the IFNy:IL4 ratio confirms that saline vaccinated C57B/6 mice do have a 
Type 1-type skew to the CD4+ T-cell cytokine production (Figure 28b). The BCG parent 
strain vaccinated mice have a Type 1-type biased CD4+ T-cell response to MycAg 
stimulation, and this response was significantly more IFNy dominated than the comparable 
response in BCGAhspR vaccinated mice (Figure 28b). Vaccination with BCGAhspR induced 
a mixed Type 1/Type 2-like CD4+ T-cell response. It appears that the higher levels of Hsp70 
in BCGAhspR primed a mixed Type-lAType-2 CD4+ T-cell response. The BCGAhspRAhrcA 
vaccination appeared to induce a mixed Type 1/Type 2 cytokine profile in the CD4+ T-cell 
population in response to MycAg stimulation but this is based on few events as the number of 
CD4+ T-cells that express cytokine did not differ to the levels observed in saline vaccinated 
mice.
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Figure 28: The total number of MycAg-specific CD4+ T-cells that expressed EFNy or IL4 and ratio of 
IFNy to IL4 production. The graphs show the total number of CD4+ T-cells per spleen that responded to ex 
vivo stimulation with MycAg by producing IFNy or IL4 (a) and the ratio of the number of CD4+ T-cells that 
expressed IFNy to the number that expressed IL4 (b). Each mouse is represented by a data point with the 
vaccine group mean and S.E.M shown. Statistical comparisons were made using one-way ANOVA and the 
Bonferroni correction with the statistical differences displayed on the gr^hs as horizontal bars with comparison 
to saline (i), BCG parent strain (ii) and BCGAhspR (iii) shown. *, **, *** and **** represent significance levels 
p<0.05, 0.01, 0.001 and 0.0001 respectively.
Expression o f  IFNy or IL4 by CD8+ T-cells
The unstimulated splenocytes of mice vaccinated with BCGAhspR had higher numbers of 
CD8+ T-cells that expressed IFNy compared to saline or BCG parent strain vaccinated mice 
(Figure 29a).
The numbers of CD8+ T-cells that expressed IFNy were increased in all of the vaccine 
groups when the splenocytes were stimulated with PMA and ionomycin compared to the 
unstimulated splenocytes demonstrating that the intracellular staining protocol worked. BCG 
parent strain vaccination resulted in higher numbers of CD8+ T-cells that expressed IFNy 
compared to die saline and the BCGA/w/>J? vaccinated mice (Figure 29b). Vaccination with 
BCGAhspRAhrcA also resulted in a greater number of IFNy producing CD8+ T-cells after
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stimulation with PMA and ionomycin compared to saline and BCGAhspR vaccinated mice 
(Figure 29b).
In comparison, altliougli the CD8+ T-cells from mice vaccinated with BCGAhspRAhrcA 
produced IFNy when stimulated with PMA and ionomycin, indicating that the T-cell had 
been primed by the BCGAhspRAhrcA vaccination (Figure 29b), these CD8+ T-cells did not 
respond to MycAg stimulation by expressing IFNy (Figure 29c, Appendix 2.2c). BCGAhspR 
vaccination also resulted in a low number of MycAg-specific CD8+ T-cells that produced 
IFNy compared to the BCG parent strain vaccinated mice (Figure 29c, Appendix 2.2c).
A previous study found that BCGAhspR induced higher numbers of CD8+ T-cells to express 
IFNy than BCG parent strain (Stewart et al., 2001). Here BCGAhspR did not induce a 
MycAg-specific increase in the number of CD8+ T-cells that expressed IFNy but did result in 
a raised non-antigen induced IFNy production by CD8+ T-cells.
The unstimulated CD8+ T-cells showed low levels of intracellular IFNy, but each BCG based 
vaccine resulted in lower IINy levels compared to the saline vaccinated mice (Figure 30a). 
This appears to be a statistical artefact as a result o f using the geometric mean to the measure 
the mean fluorescence intensity of cytokine staining combined with very few IFNy positive 
cells in the saline vaccinated mice.
The CD8+ T-cells from each vaccine group showed increased intracellular IFNy when 
stimulated with PMA and ionomycin compared to the unstimulated splenocytes (Figure 30b). 
This demonstrated that the intracellular staining protocol was successful at detecting IFNy 
production by the CD8+ T-cells.
The MycAg stimulated CD8+ T-cells fix>m mice vaccinated with BCG parent strain showed 
higher IFNy levels compared to the unstimulated controls (Appendix 2.3c) and also had
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higher IFNy levels than the saline, BCGAhspR and BCGAhspRAhrcA vaccinated mice 
(Figure 30c). '
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Figure 29: The number of CD8+ T-cells that expressed IFNy after ex vivo culture of the splenocytes.
Groups of 5 mice were vaccinated as described in Materials and Methods 2.21. The splenocytes were harvested 
at 21 days post-vaccination and cultured overnight either in medium alone (a), with PMA and ionomycin (b) or 
with MycAg (lOpg/ml) (c). Brefeldin A was added to the culture media at 9 hours. The graphs show the mean 
and S.E.M of the number, of CD8 T-cells that expressed IFNy after ex vivo culture. Each mouse is represented 
by a data point with the vaccine group mean and S.E.M shown. Statistical comparisons were made using one 
way ANOVA and the Bonferroni correction with the statistical differences displayed on the graphs as horizontal 
bars with comparison to saline (i), BCG parent strain (ii) and BCGAhspR (iii) shown. *, **, *** and **** 
represent significance levels p<0.05, 0.01, 0.001 and 0,0001 respectively.
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Figure 30: The IFNy MFI levels of CD8+ T-cells that expressed IFNy after ex vivo culture of the 
splenocytes. Groups of 5 mice were vaccinated as described in Materials and Methods 2.21. The splenocytes 
were harvested at 21 days post-vaccination and cultured overnight either in medium alone (a), with PMA and 
ionomycin (b) or with MycAg (lOpg/ml) (c). Brefeldin A was added to the culture media at 9 hours in to the 
incubation. The graphs show the IFNy MFI levels of the CD8+ T-cells that expressed IFNy after ex vivo culture. 
Each mouse is represented by a data point with the vaccine group mean and S.E.M shown. Statistical 
comparisons were made using one-way ANOVA and the Bonferroni correction with the statistical differences 
displayed on the graphs as horizontal bars with comparison to saline (i), BCG parent strain (ii) and BCGAhspR 
(iii) shown. *, **, *** and **** represent significance levels p<0.05, 0.01, 0.001 and 0.0001 respectively.
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The unstimulated splenocytes from mice vaccinated with BCGA/w/?/? had significantly 
greater numbers of CD8+ T-cells that expressed IL4 than saline vaccinated mice (Figure 
31a).
Ex vivo culture with PMA and ionomycin did not result in increased numbers of CD8+ T- 
cells that expressed IL4 however, PMA and ionomycin are not good stimulators of IL4 
production in T-cells.
Vaccination with BCGA/wp/? resulted in a MycAg-specific increase in the number of IL4 
expressing CD8+ T-cells compared to the unstimulated splenocytes (Appendix 2.2d) and this 
level of EL4 expression was higher than that observed in saline, BCG parent strain or 
BCGA/w/?/?A/ïrc/4 vaccinated mice (Figure 31c).
There were no differences between the vaccine groups in terms of the intracellular IL4 levels 
of the CD8+ T-cells for any of the ex vivo culture conditions.
Vaccination with BCG parent strain induces the greatest number of CD8+ T-cells to express 
either IFNy or BL4 as a MycAg-specific response (Figure 32a). BCGHhspR vaccinated mice 
also showed an increase in the overall number of CD8+ T-cells that expressed IFNy dr IL4 
when challenged ex vivo with MycAg compared to the saline control mice (Figure 32a). The 
BCGàhspRÊ!shrcA vaccinated mice did not show any increase in the MycAgrspecific 
expression of IFNy or EL4 compared to the saline control mice (Figure 32a).
The type of immune response elicited by ex vivo challenge of the splenocytes with MycAg, as 
indicated by the ratio of IFNy to IL4 expressing CD8+ T-cells, remains a IFNy dominated 
CD8+ T-cell response in BCG parent strain vaccinated mice (Figure 32b). BCGA/wpi? 
vaccination induced a MycAg-specific response that is essentially non-polarised; with a ratio 
of IFNy to IL4 of 1.08 ± 0.41 (Figure 32b). BCGAhspRAhrcA vaccination also resulted in a
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less IFNy dominated CD8+ T-cell response than that induced by BCG parent strain (Figure 
33b) although the ratio was more Type I-like than the CD8+ T-cell IFNy to EL4 ratio from 
vaccination with BCGA/*5/?i?.
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Figure 31: The number of Cl)8+ T-cells per spleen that expressed IL4 after ex vivo culture of the 
splenocytes, Groups of 5 mice were vaccinated as described in 2.19. The splenocytes were harvested at 21 days 
post-vaccination and cultured overnight either in medium alone (a), with PMA and ionomycin (b) or with 
MycAg (10|ig/ml) (c). Brefeldin A was added to the culture media at 9. The graphs show the numbers of CD8+ 
T-cells per spleen that expressed IL4 after ex vivo culture. Statistical comparisons were made using one-way 
ANOVA and the Bonferroni correction with the statistical differences displayed on the graphs as horizontal bars 
with comparison to saline (i), BCG parent strain (ii) and BCGAhspR (iii) shown. *, **, *** and **** represent 
significance levels p<0.05, 0.01, 0.001 and 0.0001 respectively.
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Figure 32: The total number of MycAg-specific CD8+ T-cells per spleen that expressed IFNy or IL4 and 
ratio of IFNy to IL4 production. The graphs show the total number of CD8+ T-cells per spleen that responded 
to ex vivo stimulation with MycAg by producing IFNy or IL4 (a) and the ratio of the number of CD4+ T-cells 
that expressed IFNy to the number that expressed IL4 (b). Each mouse is represented by a data point with the 
vaccine group mean and S.E.M shown. Statistical comparisons were made using one-way ANOVA and the 
Bonferroni correction with the statistical differences displayed on the gr^hs as horizontal bars with comparison 
to saline (i), BCG parent strain (ii) and BCG^hspR (iii) shown. *, **, *** and **** represent significance levels 
p<0.05, 0.01, 0.001 and 0.0001 respectively.
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4.3 Discussion
The question investigated in this chapter was whether MycAg-specific T-cell activation and 
cytokine production in BCG vaccinated mice was increased by the over-expression of 
molecular ch^erones by BCG and whether this T-cell response was more strongly Type 1- 
like than in BCG parent strain vaccinated mice.
The increased expression of Hsp70 by BCG parent strain was achieved through knocking out 
the heat shock protein repressor QispR) gene creating the strain BCGA/w/?/? (Stewart et al., 
2001). hrcA is the heat-inducible repressor of transcription of GroEL and further mutagenesis 
o i BCGàhspR with pSMT163 replaced the hrcA gene with a kanamycin resistance gene, to 
form BCGtàispRAhrcÂ (Stewart et al., 2002).
Several attempts in this study were made to produce a single hrcA knockout in BCG parent 
strain but no successful clones were obtained. No other group has published a successful 
attempt at engineering BCGAArc/4. It is possible that the dysregulation of GroEL expression 
is toxic to the cell and that the double knockout, BCGdihspRAhrcA was produced due to the 
chaperone function of Hsp70 preventing the toxicity of the over-expression of GroEL,
The T-cell responses induced by vaccination with BCGhhspR and BCG^hspRAhrcA were 
analysed to determine whether over-expression of molecular chaperones increased the 
MycAg-specific T-cell activity compared to the levels o f response generated by vaccination 
with BCG parent strain. Hsp70 is known to chaperone peptides and increase the processing 
and presentation of these peptides by antigen-presenting cells, resulting in a greater induction 
of T-cell responses. Hsp70 has also been implicated in enhanced maturation of antigen- 
presenting cells, a feature that may explain the increased peptide presentation.
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Rather than purify the Hsp70 or Hsp70-peptide complexes, a$ described in Materials and 
Methods 2.14 and 2.15 and utilised in vaccination experiments in Chapter 3, it was 
hypothesised that over-expressing the Hsp70 within the BCG Pasteur may be sufficient itself 
for increasing peptide presentation. Initial evidence in support of this is the finding that 
BCGlshspR vaccination can induce increased CD8+ T-cell IFNy production compared to 
BCG vaccination (Stewart et al., 2001). This study was structured very differently, using a 
different route of vaccination, different time-point of T-cell evaluation . and different 
techniques for stimulating the T-cells and measuring the responses. In particular, it has been 
demonstrated that stimulation with different antigens can provoke different responses by T- 
cells (Dockrell, 2011). Therefore, using MycAg, which may contain lipids and DNA in 
addition to protein antigens, rather than PPD may have elicited a different response from the 
T-cells in culture.
It was anticipated that using BCGA/w/?R as a vaccine would maintain the MycAg-specific T- 
cell response found in BCG parent strain vaccinated mice, as the majority of BCG antigens 
would not be dramatically affected by the high intracellular Hsp70 levels. Additionally, the 
excess Hsp70 would enhance this immune response either by promoting the maturation of 
antigen-presenting cells or by improving the presentation of mycobacterial peptides to the 
immune cells. Finally, the use of whole BCG Pasteur would act as an adjuvant, attracting 
other immune cells to the vaccination site due to engagement of pathogen recognition 
receptors on antigen-presenting cells resulting in secretion of chemokines more efficiently 
than protein-only vaccines. The over-expression of Hsp70 by BCGtahspR may have swamped 
the immune response, reducing the general MycAg response. The previous chuter suggested 
that mycobacterial Hsp70 may have had an inhibitory effect on T-cell responses in this 
experimental protocol, and other research has indicated that mycobacterial Hsp70 is capable 
of inducing Type 2 T-cell responses (Wendling et al., 2000). Therefore, the higher levels of
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Hsp70 in BCGAhspR may be responsible for skewing the T-cell response to a mixed Type 
1/Type 2 response.
GroEL, also known as heat shock protein 65 or chaperonin, has been shown in E. coli to 
ch^erone antigen as part of a tetradecameric barrel structure but also, in mycobacteria, to 
chaperone antigen in a dimeric or monomeric formation (Qamra et al., 2005). In addition, 
GroEL has been implicated in enhancing the activation of antigen-presenting cells through 
CD 144 and CD 14 independent mechanisms (Lewthwaite et al., 2001). The BCGdihspRAhrcA 
is hypothesised to be more immunogenic than either BCG parent strain or BCGA/w/?/^ 
through both the enhanced peptide presentation as a result of the chaperone activity of Hsp65 
and through the increased APC activation via a non-chq>erone function of Hsp65.
Mice vaccinated with BCG parent strain showed raised background levels of the expression 
of activation markers CD69 and CD25 by the CD4+ and CD8+ T-cells and also increased 
background expression of IFNy but not 1L4 by the T-cells compared to the saline vaccinated 
mice. These mice showed the greatest number of MycAg-specific activated CD4+ and CD8+ 
T-cells when the splenocytes were challenged ex vivo with MycAg compared to the other 
vaccine groups. The T-cells from BCG parent strain vaccinated mice also showed MycAg- 
specific expression of IFNy but not of 1L4. This agrees with the established immune response 
induced by BCG parent strain in C57B/6 mice (Huygen et al., 1992).
In comparison to BCG parent strain, BCGAhspR vaccinated mice induced an antigen-specific 
cytokine response of the same magnitude as that induced by BCG parent strain. However, the 
cytokine response is significantly polarised towards a Type 2-like phenotype with the highest 
level of 1L4 expression. The CD4+ and CD8+ T-cells show lower levels of MycAg-specific 
activation marker expression than found in BCG parent strain and lower cytokine mean 
fluorescence intensity per cell. This was different to the observation that BCGAhspR induced
_________________________________._________________ P a g e  I 127
stronger CD8+ T-cells responses in vaccinated mice (Stewart et al., 2001). However, this 
study used MycAg for ejc vivo stimulation compared to the PPD used in Stewart, 2001, in 
addition to a different route of vaccination and time-point for the determination of immune 
responses, each of which could lead to different outcomes.
It has been observed that some mycobacteria can induce a more Type 2-like response through 
interactions with DC-SIGN (Gagliardi et al., 2005; Geijtenbeek et al., 2003); this is thought 
to promote the survival of mycobacteria by reducing the microbicidal activity stimulated by 
IFNy. It is possible that overexpression of Hsp70 in the BCGAAspR strain has altered the 
surface phenotype of BCGtJispR making it more efficient at stimulating a type-2 T-cell 
response.
A BCG strain that expresses a fusion of Hsp70 and MMP-11, an immunodominant antigen 
from M. leprae, evokes IFNy production by both the CD4+ and CD8+ T-cells (Mukai et al., 
2009, 2010). However, the paper mentions that the immunogenicity of the BCG 70M strain is 
dependent on the secretion of the Hsp70-MMP-ll fusion construct. In the BCGAhspR it is 
unlikely that the Hsp70 is secreted at high levels by the BCG and this may explain why 
unlike BCG 70M the BCGAhspR showed equivalent cytokine production to BCG parent 
strain, not higher cytokine production.
Vaccination with BCGAhspRAhrcA resulted in the same level of antigen-specific activation 
and cytokine production as saline vaccinated mice. The lack o f response is not due to a lack 
of initial priming of the T-cells as the PMA and ionomycin stimulated cells show high levels 
of activation and cytokine expression compared to the saline vaccinated mice.
T-cell anergy is described as a hyporesponsive state whereby the T-cells remain living but are 
unable to respond to the T-cells cognate antigen either by clonal expansion, termed clonal 
anergy, or through achieving full effector status characterised by cytokine production and the
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expression of activation markers. T-cell anergy can be induced by inqjpropriate 
costimulatory molecules on the surfece of the antigen-presenting cell. While antigen may be 
presented correctly by MHC I and/or n, without the costimulatory molecules the engaged T- 
cell would not fully “activate and would be incapable of responding to antigen. T-cell anergy 
induced by weak activation signals from the APC can be overcome by culturing the cells in 
the presence of PMA and ionomycin (Downward et al., 1990). Therefore, a response 
indicating T-cell anergy here would involve a strong response to PMA and ionomycin culture 
with a lack of MycAg-specific reactivity. This is exactly what was observed in the 
BCGl^hspRAhrcA vaccinated mice; a high response to PMA and ionomycin culture and a 
lack of response to MycAg culture.
The lack of MycAg specific T-cell response may be due to the spreading of the GroEL 
induced tolerance through APC’s. A peptide from mycobacterial GroEL induced tolerised T- 
cells in Lewis rats, which in the presence of antigen spread the tolerant phenotype to other 
non-GroEL-specific T-cells. This tolerance spreading was mediated through cell to cell 
contact with APC’s (Paul et al., 2000a) (Paul et al., 2000b) (van Eden et al., 2000).
Of course, the absence of MycAg-specific T-cell responses in BCGAhspRAhrcA vaccinated 
mice could also indicate bystander activation of local T-cells; as a result of one potent 
antigen, hypothesised in this instance to be GroEL, stimulating an antigen-presenting cell the 
activation signals are received by non-MycAg-specific T-cells, which would activate in the 
presence of PMA and ionomycin but not with MycAg stimulation.
Of course, this study was limited in that it looked specifically at one time-point post 
vaccination, and one time-point after ex yivo stimulation, and investigated only the splenic T- 
cells. The BïCGAhspR and BCGAhspRAhrcA were used in a preliminary challenge study in 
collaboration with NIB SC, Neither BCGAhspR or BCG AhspRAhrcA demonstrated better
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protection in terms of reduced c.f.u. loads in the lungs than BCG parent strain when the 
vaccinated mice were challenged via aerosol infection with M  tuberculosis (personal 
communication, J. Keeble, NIBSC, 2011).
Due to the development of a Type 2-like T-cell response following BCGAhspR 
immunisation, or the induction of T-cell anergy after BCGAhspRAhrcA immunisation, and 
the lack of enhanced protection to M. tuberculosis challenge, neither of these two vaccines 
would make promising candidates for future anti-mycobacterial vaccines.
A key feature of BCG is the vaccine persistence in vivo. Several groups have identified the 
persistence of BCG as the reason for the induction of memory T-cell populations. If the 
overexpression of heat shock protein in BCG results in strains that are more immunogenic, 
these BCG strains may be cleared from the host more quickly. This may explain the lack of 
persistence of the BCGAhspR in chronic phase of infection in a mouse model than BCG 
parent strain (Stewart et al, 2001). A deficiency in persistence in vivo could reduce the ability 
of the recombinant BCG strains to induce strong T-cell responses and may be why the 
BCGAhspR vaccinated mice in this study showed fewer numbers of MycAg-specific CD8+ 
T-c-ells that expressed IFNy than BCG parent strain vaccinated mice. This could be 
investigated through some in vitro culture work using antigen-presenting cells and measuring 
survival of the recombinant BCG strains or survival in vivo could be assayed looking at the 
number of BCG recovered fi’om the spleen or lymph nodes over time.
For future work it would be interesting to look at the maturation of antigen-presenting cells in 
mice that were vaccinated with BCG that over-expressed heat shock proteins compared to 
BCG parent strain vaccinated mice to investigate how the over-expression of heat shock 
proteins influences the initiation and programming of the T-cell response. The BCGAhspR 
vaccinated mice showed a mixed type-1 and type-2 T-cell response to MycAg stimulation
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whereas in Chapters Hsp70 and Hsp70-peptide complexes vaccination resulted in a type-1 
biased T-cell profile. It could be signals received from antigen-presenting cells that induced 
this difference in cytokine profile between the live BCG and the purified Hsp70 vaccinations.
In addition, it would be useful to determine bacterial load over a time course to determine the 
in vivo persistence of the BCG strains that over express Hsp70 or both Hsp70 and GroEL as a 
reduction in persistence may have resulted in the reduced MycAg-specific T-cell responses in 
BCGAAspR and BCGAhspRAhrcA.
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4.4 Conclusion
It was not possible to knock out hrcA in BCG Pasteur wildtype to generate a BCG that over­
expressed GroEL 1. Expression of the two mycobacterial groEL genes is highly regulated and 
overexpressioh of GroEL 1 only may interrupt the functions of GroEL2 resulting in toxicity 
and death for the hrcA deletion in BCG parent strain. Overexpression of GroEL 1 is tolerated 
in the BCGAhspRAhrcA strain potentially due to the chaperone activity of the excess Hsp70.
Over-expression of Hsp70 in BCG Pasteur, BCGAhspR, did not increase the immunogenicity 
of the BCG strain compared to BCG Pasteur wild type. The number of cytokine producing T- 
cells was equivalent to the BCG parent strain vaccinated mice. However, the type of response 
was substantially altered with equal percentages of antigen-specific IFNy and IL4 expressing 
T-cells representing à mixed type-1 and type-2 T-cell response rather than the typical type-1 
bias response typical of mycobacterial vaccination.
A BCGAhspRAhrcA strain over-expresses both Hsp70 and GroEL 1 did not enhance MycAg- 
specific T-cell response compared to BCG Pasteur Wt. The MycAg-specific T-cell response 
was suppressed despite PMA and ionomycin culture showing that the T-cells were initially 
primed to respond. GroEL has been shovm to be a tolerising antigen and may be the agent of 
tolerisation in this study. The MycAg-specific response showed signs of a more Type 2 skew 
than found in BCG parent strain or saline vaccinated mice.
Neither the BCGAhspR nor the BCGAhspR AhrcA appear to be suitable for further 
development as a vaccine against mycobacterial infection.
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Chapter 5: The immunogenicity of 
recomhinant Mycobacterium vaccae 
expressing Heat Shock Proteins
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5.1 Introduction
Mycobacterium vaccae has been investigated as a potential adjunct to the standard M. 
tuberculosis chemotherapy in a number of trials (Cooper et al., 1995a; Khader et al., 2006; 
Khader“et al.; 2005f Mwinga ef al., 2002; Stanford et al., 1990). As a member of the 
Mycobacterial family, M. vaccae shares antigens with M  tuberculosis and vaccination with 
M. vaccae resulted in increased lymphocyte proliferation to challenge with M  tuberculosis 
antigens (Stanford et al., 1990).
In addition to inducing M. tuberculosis reactive T-cells, M. vaccae is less pathogenic than 
BCG, the current standard vaccination against mycobacterial infection, and is therefore an 
attractive alternative to the BCG for use as a vaccine or prophylaxis in immunocompromised 
people.
The M. vaccae immunother^y trials demonstrated varying levels of efficacy from weight- 
gain and increased mycobacterial antigen antibody and T-cell proliferative responses 
(Stanford et al., 1990), and increased sputum conversion and improved chest X-rays (Khader 
et al., 2005) to a complete lack of improvement (Mwinga et al., 2002). Comparisons between 
different trials are complicated by the different endpoints used to assess efficacy and the 
different backgrounds of the cohorts. A meta-analysis of the studies found no benefit to M  
vaccae chemother^y (de and Gamer, 2001)
M  vaccae has been shown to tolerate the presence of plasmids and is also able to stably 
express foreign antigens in the presence of selective agents (Garbe et al., 1994). For that 
reason, M. vaccae represents an attractive method of delivering M. tuberculosis antigens to 
the host immune system without the risk of pathology in immunocompromised individuals.
Alpha-crystallin 2 (Acr2) is a small heat shock protein of approximately 19kDa, which is 
found in M tuberculosis and M. bovis. Acr2 is thought to be involved in translation initiation
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at high temperatures and also contains a putative dimer interface that may be involved in 
chaperone activity of Acr2. Expression of Acr2 by M. tuberculosis is highly upregulated 
upon M. tuberculosis infection of a macrophage and this expression is maintained throughout 
the infection (Wilkinson et al., 2005). This characteristic makes Acr2 an attractive target in 
vaccine research as Acr2-specific T-cells would be able to target a M. tuberculosis infection 
at any stage of infection.
Similarly to the other ch^erones discussed in this thesis, exposure to M  tuberculosis results 
in expansion of Acr2-specific T-cell populations in the host (Stewart et al., 2005), which 
demonstrates the ability of Acr2 to prime T-cell responses.
Various groups have demonstrated that peptides either chaperoned by mycobacterial Hsp70 
or covalently fused to mycobacterial Hsp70 result in significantly enhanced peptide-specific 
T-cell responses. In Chapter 3 Hsp70-peptide complexes were shown to induce MycAg- 
specific CD4+ T-cell responses of a similar magnitude to those generated by BCG parent 
strain vaccination. The CD4+ and CD8+ T-cell responses in both the Hsp70 and the Hsp70- 
peptide complexes vaccinated mice were significantly more Type 1 based than observed in 
BCG parent strain vaccinated mice.
The hypothesis of this chuter was that M. vaccae expressing the M. tuberculosis Acr2 would 
generate a T-cell response to mycobacterial Acr2 in addition to maintaining a general 
MycAg-specific T-cell response. In addition, the fusion of Hsp70 to Acr2 in an M  vaccae 
strain overexpressing Hsp70-Acr2 would induce an enhanced Acr2-specific T-cell response 
as well as maintaining the general MycAg-specific T-cell response.
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The objectives in this study were:
1. To engineer the recombinant M  vaccae strains that overexpressed Acr2 or an 
Hsp70-Acr2 fusion protein, named M  vaccae Aer2 and M. vaccae Hsp70- 
Acr2 respectively.
2. To investigate the immunogenicity of the recombinant M  vaccae strains by 
measuring MycAg-specific and Acr2-specific T-cell activation and cytokine 
production
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5.2 Results
5.2.1 The production of Af. vaccae Acr2 and M, vaccae Hsp70-Acr2
In order to produce the recombinant M  vaccae strains that expressed Acr2 or Hsp70-Acr2 
wild type M. vaccae NCIMB 9937 needed to be transformed with expression plasmids for 
Acr2 and Hsp70-Acr2.
An Acr2 expression plasmid, pSMT3-Acr2 was already available in the lab. It consists of a 
Æco/z-mycobacterial pSMT3 shuttle vector (Garbe et al., 1994) carrying the M. tuberculosis 
acr2 gene downstream of an Hsp60 promotor.
To generate the Hsp70-Acr2 expression plasmid, pSMT3-Hp70-Acr2, the hsp70 gene was 
amplified by PCR from genomic DNA of M. tuberculosis H37Rv, a standard lab strain of M  
tuberculosis. The successful amplification was confirmed by the 2500 base pair size of 
resulting amplified DNA product on a 1% agarose gel stained with GelRed (Figure 33).
The hsp70 DNA sequence was subcloned into a TOPO TA vector and propagated in E. coli 
DH5a. The hsp70 DNA sequence was then digested frx)m the TOPO TA vector with Bam//7 
and ligated with the Bam/f/ digested pSMT3-Acr2 resulting in insertion of the hsp70 gene 
downstream of the Hsp60 promoter and in frame with the acrl gene (Figure 34). The ligation 
product was transformed into E. coli and grown overnight with hygromycin antibiotic 
selection.
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Figure 33: The PCR product of hsp70 PCR amplification. The hsp70 gene from M. tuberculosis H37Rv was amplified by 
PCR following the protocol in Materials and Methods. The PCR product was run on a 1% agarose TAB gel. The band visible 
corresponds to a size of2500bp. The size was determined by the Promega Ikb DNA ladder (Promega, UK).
Transformant colonies were picked and grown overnight for plasmid preparation. The 
purified plasmid, putatively pSMT3-Hsp70-Acr2, was digested with Kpnl to confirm the 
existence and correct orientation of hsplO insertion The pSMT3-Hsp70-Acr plasmid with 
correctly inserted hsp70 was used to transform M  vaccae Wt to create the M. vaccae Hsp70- 
Acr2 strain. M. vaccae Wt was also transformed with pSMT3-Acr2 to create the M  vaccae 
Acr2 strain.
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Hsp70
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Figure 34: The plasmid map of the pSMT3 Hsp70-Acr2 expression plasmid engineered. The map shows 
the Hsp60 promoter upstream of the inserted hsp70 that was ligated into the BamHI site between the Hsp60 
promoter and in frame with the acr2 gene. Also indicated are the hygromycin resistance gene (hyg), the 
mycobacterial origin of replication (Mori) and the positions of restriction enzyme cut sites for BamHI, 
EcoRV, HindlU, Bgill andXbal
The transformed M  vaccae strains were grown as described in Materials and Methods 2.1 
and 2.10 and several clones were picked to confirm the expression of either M. tuberculosis 
Acr2 or the fusion construct Hsp70-Àcr2 by Western blot analysis with an anti-Acr2 antibody 
(Figure 35). The rabbit Acr2 polyclonal antibody cross reacted with a number of M. vaccae 
proteins but a band o f  ^ proximately 90kDa, consistent with the expected size of the Hsp70- 
Acr2 fusion protein was uniquely present in the M  vaccae Hsp70-Acr2 (Figure 35 lane c). 
Also, a band of approximately 15-20kDa was present in increased intensity in the M. vaccae 
Acr2 strain (Figure 35 lane d). A band of this size was present in all lanes and this may 
represent reactivity o f the M. tuberculosis Acr2 antibody to the native M.vaccae alpha 
Giystallin protein.
P a g e  I 139
IBOkDa 250kPa
lOOkDa
70kDa
SSkDa
35kDa
ISkDa
Hsp70-Acr2
Acr2
b
Figure 35: Western blot of M. vaccae Wt, M. vaccae Acr2 and M. vaccae Hsp70-Acr2 probed with rabbit 
Acr2 antibody. 5ml cultures of M. vaccae Wt, M. vaccae Hsp70-Acr2 and M. vaccae Acr2 were lysed by 
mechanical shaking and centrifuged at lOOg. The supernatants of the lysed cultures were run on a 4-12% 
gradient SDS-PAGE gel (Invitrogen, UK) and blotted onto PVDF membrane for 20 minutes at 200mV. The 
membrane was blocked and incubated as described in Materials and Methods 2.17 and 2.18 with anti-Acr2 
antibody as the prim ^ antibody. The Western blot shows the expression of Hsp70-Acr2 in M. vaccae Hsp70- 
Acr2 (lane c), the expression of Acr2 in M. vaccae Acr2 (lane d) and the lack of expression of M. tuberculosis 
H37Rv Acr2 in M. vaccae Wt (lane b). Lane a) shows the artifact of the PageRuler Plus Prestained Protein 
Ladder used for band sizing (Fermentas, UK).
5.2.2 Immunogenicity study
Groups of five C57B/6 female mice aged 6 weeks were vaccinated with saline, live BCG 
Pasteur Wt (2x10^ c.f.u.), or heat-killed M. vaccae Wt (7.5 xlO* c.f.u), M. vaccae Acr2 (7.5 
X 10^  c.f.u) or M. vaccae Hsp70-Acr2 (7.5 x 10  ^c.f.u). The splenocytes were stimulated ex 
vivo as described in Materials and Methods 2.23 and were then stained for flow cytometric 
analysis to identify CD4+ and CD8+ T-cells and to investigate T-cell activation and 
intracellular cytokine production. A representative sample of the flow cytometric analysis of 
M. vaccae Wt vaccinated mouse T-cell activation and production of IFNy and IL4 is shown 
in Appendices 1.5,1.6 and 1.7.
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The number of CD4+ and CD8+ T-cells per spleen
To assess whether a particular T-cell subset had proliferated as a result of vaccination the 
number of CD4+ and ÇD8+ T-cells per spleen were analysed. No vaccine groups 
demonstrated a difference in the number of CD4+ T-cells compared to the saline or BCG 
parent strain vaccinated mice (Figure 36ai and ii). M. vaccae Wt vaccinated mice had a 
greater number of CD4+ T-cells than found in the M  vaccae Hsp70-Acr2 vaccinated mice 
(Figure 36aiii). There were no differences in the number of CD8+ T-cells per spleen between 
any of the vaccine groups (Figure 36b).
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Figure 36: The number of CD4+ and CDD8+ T-eells per spleen. Groups of 5 female C57B/6 mice aged 6 
weeks were vaccinated as described in Materials and Methods 2.21. At 21 days post-initial vaccination the 
splenocytes were harvested and cultured for overnight in Complete Medium. Brefeldin A was added to the cell 
culture at 3 hours. The cells were harvested and stained as described in Materials and Methods. The graphs 
show the numbers of CD4+ T-cells (a) and the number of CD8+ T-cells (b) that were isolated per spleen. Each 
mouse is represented by a data point and the vaccine group mean and S.E.M are shown on each gr^h. 
Statistical comparisons were made using one-way ANOVA and the Bonferroni correction. Statistical 
comparisons were made using one-way A N O v a  and the Bonferroni correction. Significant differences are 
indicated by the horizontal bars above the graphs, * equals a significance level of p<0.05 for comparisons to 
saline (i), BCG parent strain (ii), M. vaccae Wt (iii) or M. vaccae Acr2 (iv).
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CD4+ and CD8+ T-cell expression of CD69 and CD25
The vaccines BCG parent strain, M. vaccae Wt or M  vaccæ  Acr2 all induced a greater 
number of unstimulated CD4+ T-cells to express CD69 compared to vaccination with saline 
(Figure 37a). The number of unstimulated CD4+ T-cells that expressed both CD69 and CD25 
was higher in mice vaccinated with BCG parent strain or M  vaccae Acr2 compared to mice 
vaccinated with M. vaccae Hsp70-Acr2 (Figure 37a) but the numbers remain low.
Each vaccine group showed increased numbers of CD4+ T-cells that expressed CD69 after ex 
vivo stimulation with PMA and ionomycin compared to the unstimulated splenocytes. This 
demonstrated that the CD4+ T-cells in the mice were capable of responding to stimulation 
and that the staining protocol for CD69 and CD25 surface antigens worked correctly (Figure 
37b).
After MycAg stimulation the mice vaccinated with BCG parent strain and M  vaccae Wt both 
showed increased numbers of CD4+ T-cells that expressed CD69 and that co-expressed 
CD69 and CD25 compared to the saline vaccinated mice (Figure 37c), This was a MycAg- 
specific increase in CD69 expression and both CD69 and CD25 by BCG parent strain and M. 
vaccae Wt vaccinated mice as these numbers were above the levels in the unstimulated 
splenocytes (Appendix 3.1).
Mice that, were vaccinated with BCG parent strain, M. vaccae Wt or M. vaccae Acr2 showed 
higher numbers of CD4+ T-cells that expressed CD69 than the saline vaccinated mice after ex 
vivo culture with Acr2 protein (Figure 37d). However, none of these results differ 
significantly fi’om the unstimulated splenocyte controls (Figure 37a, Appendix 3.1), so this 
CD69 expression was not Acr2-specific. M. vaccae A ct!  vaccinated mice did show an Acr2- 
specific increase in the number of CD4+ T-cells that co-expressed CD69 CD25 compared to 
the saline control (Figure 37d, Appendix 3.1).
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Figure 37: The number of CD4+ T-cells that expressed CD69 or both CD69 and CD25 after ex vivo 
culture of the splenocytes. Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods 2.21. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
overnight in medium (a), PMA and ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell 
culture at 3 hours. The cells were harvested and stained as described in Materials and Methods 2.22 and 2.23. 
The graphs show the numbers of CD4+ T-cells that expressed CD69 (lower section of the bars) or co-expressed 
CD69 and CD25 (upper section of the bars). The graphs show the mean and S.E.M (error bars) for each vaccine 
group. The statistical comparisons displayed refer to the differences in the total number of CD4+ T-cells that 
expressed CD69 (the height of each column). Statistical comparisons were made using one-way ANOVA and 
the Bonferroni correction. Significant differences are indicated by the horizontal bars, * equals a significance 
level of p<0.05, ** equals a significance level of p<0.01 and *** equals a significance level of p^.OOl. 
Comparisons to saline (i), comparisons to BCG parent strain (ii) and comparisons to Hsp70 (iii) are shown for 
the total number of CD69+ CD4+ T-cells (*) and for the number of CD4+ T-cells that are CD69 and CD25 (•).
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Compared to the saline vaccinated mice, the unstimulated splenocytes from mice vaccinated 
with BCG parent strain and M. vaccae Acr2 had higher numbers of CD8+ T-cells that 
expressed CD69 and higher numbers that co-expressed CD69 and CD25 (Figure 38a).
The PMA and ionomycin stimulated splenocytes showed increased numbers of activated 
CD8+ T-cells compared to the unstimulated controls (Figure 38b) which showed that the 
CD8+ T-cells are capable of responding to stimulation and that the staining protocol is 
capable of detecting CD8+ T-cell activation.
There were increased numbers of CD8+ T-cells that expressed CD69 or co-expressed CD69 
and CD25 in the BCG parent strain and M  vaccæ  Wt vaccinated mice compared to the 
saline vaccinated mice (Figure 38c). These increases were MycAg-specific as the levels were 
above those observed in the unstimulated splenocytes for these mice (Appendix 3.2).
Similarly to the results of the CD4+ T-cells, there were differences in the number of activated 
CD8+ T-cells in the vaccine groups after ex vivo stimulation with Acr2 with raised numbers 
of CD8+ T-cells that expressed CD69 found in the BCG parent strain, M. vaccae Wt and M. 
vaccae Acr2 vaccinated mice compared to the saline group (Figure 38d) and M  vaccae Acr2 
mice also had higher levels of CD8+ T-cells that co-expressed CD69 and CD25 compared to 
the saline vaccinated mice (Figure 38d). However, none of the vaccines differed from the 
unstimulated controls in the number of CD8+ T-cells that expressed CD69 or CD69 CD25 
(Appendix 3.2) so these differences were not Acr2-specific.
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Figure 38: The numbers of CD8+ T-cells that expressed CD69 or both CD69 and CD25 after ex vivo 
culture of the splenocytes. Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods 2.21. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
overnight in medium (a), PMA and ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell 
culture at 9 hours. The cells were harvested and stained as described in Materials and Methods 2.22 and 2.23. 
The graphs show the numbers of CD8+ T-cells that expressed CD69 (lower section of the bars) or co-expressed 
CD69 and CD25 (upper section of the bars). The graphs show the mean and S.E.M (error bars) for each vaccine 
group. The statistical comparisons displayed refer to the differences in the total numbers of CD8+ T-cells that 
express CD69. Statistical comparisons were made using one-way ANOVA and the Bonferroni correction. 
Significant differences are indicated by the horizontal bars, * equals a significance level of p<0.05, ** equals a 
Significance level of p<0.01 and *** equals a significance level of p<0.001. Comparisons to saline (i), 
comparisons to BCG parent strain (ii) and comparisons to Hsp70 (iii) are shown for the total number of CD69+ 
CD8+ T-cells (*) and for the number of CD8+ T-cells that are CD69 and CD25 (•) .
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CD4+ and CD8+ T-cell expression of IFNy and IL4
As described earlier, groups of five C57B/6 -female mice aged 6 weeks were vaccinated with 
saline, BCG Pasteur Wt, M. vaccae Wt, M. vaccae Acr2 or M. vaccae Hsp70-Acr2. The 
splenocytes were harvested at 21 days post vaccination and stimulated ex vivo to investigate 
the level of MycAg-specific and Acr2-specific T-cell response as characterized by T-cell 
production of the cytokines IFNy and IL4.
Expression o f  IFNy and IL4 by. CD4+ T-cells
All the vaccine groups showed low numbers of CD4+ T-cells that expressed IFNy when 
unstimulated (Figure 39a). PMA and ionomycin stimulation resulted in an increase in the 
number of IFNy producing CD4+ T-cells in each vaccine group compared to the unstimulated 
controls (Figure 39b), which demonstrated that the intracellular staining protocol was capable 
of detecting the production of cytokines and that the CD4+ T-cells were capable of 
responding to stimulation.
Mice that were vaccinated with M.. vaccae Hsp70-Acr2 showed the only MycAg-specific 
increase in the number of CD4+ T-cells that expressed IFNy compared to the unstimulated 
control (Appendix 4.3) and compared to the saline vaccinated mice (Figure 39c).
The M. vaccae Acr2 vaccinated mice showed increased numbers of CD4+ T-cells that 
expressed IFNy in response to stimulation with Acr2 compared to the saline and BCG parent 
strain vaccinated mice (Figure 39d) and this increase was Acr2-specific (Appendix 3.3).
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Figure 39: The number of IFNy producing CD4+ T-cells after ex vivo culture of the splenocytes. Groups of 
5 female C57B/6 mice aged 6 weeks were vaccinated as described in Materials and Methods 2.21. At 21 days 
post-initial vaccination the splenocytes were harvested and cultured for overnight in medium (a), PMA and 
ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell culture at 9 hours. The cells were 
harvested and stained as described in Materials and Methods 2.22 and 2.23. The graphs show the number of 
CD4+ r-cells that stained positive for iPNy. Individual data points are shown as well as the mean and S.B.M  
(bars) for each vaccine group. Statistical comparisons were made using one-way ANOVA and the Bonferroni 
correction. Significant differences are indicated by the horizontal bars, * equals a significance level of p<0.05, 
** equals a significance level of p<0.01, *** equals a significance level of p<0.001 and **** equals a 
significance level of pXO.OOOl.
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The unstimulated ÇD4+ T-cells showed no variation between the vaccine groups in terms of 
the intracellular IFNy level.(Figure 40a). Compared to the unstimulated control all vaccine 
groups demonstrated an increase in the IFNy MFI levels of CD4+ T-cells after stimulation 
-with PMA and ionomycin (Figure 40b, Appendix 3.4).
BCG parent strain and M. vaccae Wt vaccinated mice had increased intracellular IFNy levels 
in the CD4+ T-cells that expressed IFNy compared to saline vaccinated mice after ex vivo 
stimulation with MycAg compared to the saline vaccinated mice (Figure 40c). This was a 
MycAg-specific response as the IFNy MFI is greater than in unstimulated CD4+ T-cells for 
these mice (Appendix 3.4).
No bacterial vaccine group demonstrated an increase in the CD4+ T-cell intracellular IFNy 
levels above the levels seen in saline vaccinated CD4+ T-cells in response to ex vivo culture 
with Acr2 (Figure 40d, Appendix 3.4).
Although M  vaccae Hsp70-Acr2 vaccinated mice showed a MycAg-specific increase in the 
number CD4+ T-cells that expressed IFNy these cells showed no MycAg-specific increase in 
intracellular IFNy levels (Appendix 3.4). The M  vaccae Acr2 vaccinated mice showed an
Acr2-speccific increase in the number of CD4+ T-cells that expressed IFNy but no definitive
/ ,
increase in intracellular IFNy levels.
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Figure 40: The EFNy MFI level o f IFNy producing CD4+ T-cells after ex vivo culture of the splenocytes.
Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in Materials and Methods 2.21. At 
21 days post-initial vaccination the splenocytes were harvested and cultured for overnight in medium (a), PMA 
and ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell culture at 9 hours. The cells were 
harvested and stained as described in Materials and Methods 2.22 and 2.23. The graphs show the IFNy MFI 
levels of CD4+ T-cells that stained positive for IFNy. Individual data points are shown as well as the mean and 
S.E.M (bars) for each vaccine group. Statistical comparisons were made using one-way ANOVA and the 
Bonferroni correction. Significant differences are indicated by the horizontal bars, * equals a significance level 
of p<0.05, ** equals a significance level of p<0.01, *** equals a significance level of pO.OOl and **** equals 
a significance level of p<0.0001.
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The unstimulated splenocytes of mice vaccinated with M  .vaccae Hsp70-Acr2 had a higher 
number of CD4+ T-cells that expressed IT^ than mice vaccinate with saline or BCG parent 
strain (Figure 41a).
PMA and ionomycin are not potent stimulators of IL4 expression (Baran et al., 2001) and as 
such the number of CD4+ T-cells that expressed IL4 after PMA and ionomycin treatment do 
not show increased numbers compared to the unstimulated CD4+ T-cells. However, as 
observed in the unstimulated splenocyte cultures, the M. vaccae Hsp70-Acr2 vaccinated mice 
showed higher numbers o f CD4+ T-cells that expressed EL4 compared to all other vaccine 
groups (Figure 41b).
The mice vaccinated with M. vaccae Hsp70-Acr2 showed a MycAg-specific increase in the 
number of CD4+ T-cells that expressed IL4 compared to the unstimulated controls 
(Appendix 3.5) and compared to all the other vaccine groups (Figure 41c).
Although M  vaccae Hsp70-Acr2 vaccinated mice have raised numbers of CD4+ T-cell that 
make IL4 after ex vivo stimulation with Acr2 (Figure 4 Id) this response was not significantly 
different to the levels observed in the unstimulated controls for this vaccine group (Appendix 
3.5).
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Figure 41: The number of EL4 producing CD4+ T-cells after ex vivo culture of the splenocytes. Groups of 5 
femde C57B/6 mice aged 6 weeks were vaccinated as described in Materials and Methods 2.21. At 21 days 
post-initial vaccination the splenocytes were harvested and cultured for overnight in medium (a), PMA and 
ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell culture at 9 hours. The cells were 
harvested and stained as described in Materials and Methods 2.22 and 2.23. The graphs show the number of 
CD4+ T-cells that stained positive for IL4. Individual data jyoints are shown as well as the mean and S.E.M 
(bars) for each vaccine ^oup. Statistical comparisons were made using one-way ANOVA and the Bonferroni 
correction. Significant differences are indicated by the horizontal bars, * equals a significance level of p<0.05, 
** equals a significance level of p<0.01, *** equals a significance level of p<0.001 and **** equals a 
significance level of p<0.0001.
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The unstimulated CD4+ T-cells from mice vaccinated with M. vaccae Hsp70-Acr2 have 
lower IL4 expression per cell compared to the saline, BCG parent strain and M  vaccae Wt 
vaccinated mice, as indicated by the IL4 mean fluorescence intensity (MFI) of the IL4 
-producing CD4+ T-cells (Figure 42a).
The PMA and ionomycin stimulated CD4+ T-cells from BCG parent strain vaccinated mice 
showed reduced intracellular IL4 levels compared to the unstimulated splenocytes (Figure 
42b). It is likely that this was due to the increased expression of IFNy by these cells (Figure 
40b), of which PMA and ionomycin is a strong inducer, and which is an antagonist of IL4 
expression.
No vaccine group demonstrated a MycAg-specific increase in the intracellular IL4 levels of 
CD4+ T-cells above the levels observed in the unstimulated controls (Appendix 3.6). Nor did 
any vaccine group show an Acr2-speciflc increase in intracellular BL4 levels compared to the 
unstimulated controls (Appendix 3.6).
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Figure 42: The IL4 MFI level of IL4 producing CD4+ T-cells after ex vivo culture of the splenocytes.
Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in Materials and Methods 2.21. At 
21 days post-initial vaccination the splenocytes were harvested and cultured for overnight in Complete medium 
(a) or PMA and ionomycin (b). Brefeldin A was added to the cell culture at 9 hours. The cells were harvested 
and stained as described in Materials and Methods 2.22 and 2.23. The graphs show the EL4 MFI levels of CD4+ 
T-cells that stained positive for IL4 in the unstimulated splenocyte cultures. Individual data points are shown as 
well as the mean and S.E.M (bars) for each vaccine group. Statistical comparisons were made using one-way 
ANOVA and the Bonferroni correction. Significant differences are indicated by the horizontal bars, * equals a 
significance level of p<0.05, ** equals a significance level of p<0.01, *** equals a significance level o f p<0.001 
and **** equals a significance level of p<0.0001.
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As in previous chapters, to determine the overall size of the CD4+ T-cell response the 
numbers of CD4+ T-cells that expressed IFNy or IL4 were combined for further analysis.
The mice that were vaccinated with M. vaccae Hsp70-Acr2 had significantly greater numbers 
of CD4+ T-cells that expressed EFNy or IL4 after ex vivo stimulation of the splenocytes with 
MycAg compared to the other vaccine groups (Figure 43 a). There were no differences in the 
ratio of the number of CD4+ T-cells that expressed IFNy compared to IL4 after MycAg 
stimulation (Figure 43b).
The number of Acr2-specific CD4+ T-cells that expressed either EFNy or EL4 was increased 
in M. vaccae Acr2 vaccinated mice compared to saline or BCG parent strain vaccinated mice 
(Figure 43 c). The CD4+T-cell response was significantly more EFNy dominated in M  vaccae 
Acr2 vaccinated mice than in mice vaccinated with M. vaccae Wt or M  vaccae Hsp70-Acr2 
(Figure 43d).
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Figure 43: The total number of CD4+ T-cells that expressed IFNy or 1L4 per spleen and the ratio of the 
number of CD4+ T-cells that expressed IFNy to IL4 after ex vivo stimulation with MycAg or Acr2. The
graphs show the combined number of CD4+ T-cells that expressed IFNy or IL4 after ex vivo stimulation with 
MycAg (a) or Acr2 (c). The bars indicate the mean for each vaccine group with S.E.M bars. The statistical 
comparisons displayed are for the combined total of IFNy+ and EL4+ CD4+ T-cells and were produced through 
ANOVA and the Bonferroni correction. The ratio of the number of CD4+ T-cells that expressed IFNy or IL4 
after ex v/vo. stimulation with MycAg (b) or with Acr2 (d) with each data point representing a mouse and the 
bars showing the mean and S.E.M for the vaccine groups. The horizontal lines show the significance level for 
each vaccine group compared to mice vaccinated with saline (i), BCG parent strain (ii), to M. vaccae Wt (iii) 
and to M. vaccae Acr2 (iv) with *, **, *** or *** representing significance levels of p<0.05, 0.01, 0.001 or 
0.0001 respectively.
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E xpression o f IFNy and IL4 by CD8+ T-cells
To examine the immune response elicited by vaccination and ex v/vo stimulation the CD8+ 
T-cells were assessed in their ability to produce IFNy, a cytokine typical of a Type 1 
response, of"IL4, aT cytokine indicative of a Type 2 response, and the relative levels of 
cytokine expression.
The number of IFNy producing CD8+ T-cells in unstimulated cultures showed no variation 
between the vaccine groups (Figure 44a).
Ex vivo stimulation with PMA and ionomycin resulted in an increase in the number of CD81 
T-cells that expressed IFNy compared to the unstimulated CD8+ T-cells for each vaccine 
group (Figure 44b). This confirmed that the ex vivo stimulation and staining protocol was 
successful in detecting IFNy production by the CD8+ T-cells.
Mice that were vaccinated with M. vaccae Wt or M. vaccae Hsp70-Acr2 showed significantly 
greater numbers of CD8+ T-cells that expressed IFNy in response to stimulation with MycAg 
compared to saline vaccination (Figure 44c) and these increases were MycAg-specific 
(Appendix 3.7). M. vaccae Acr2 vaccinated mice showed no difference to saline vaccinated 
mice in the number of MycAg-stimulated CD8+ T-cells that expressed IFNy (Figure 44c).
The number of CD8+ T-cells that expressed IFNy was higher in mice vaccinated with M. 
vaccae Acr2 compared to saline, BCG parent strain or M  v(wcae Wt vaccinated mice (Figure 
44d). This response by M  vaccae Acr2 vaccinated mice was Acr2-specific induction of IFNy 
(Appendix 3.7).
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Figure 44: The number of CD8+ T-ceUs per mouse that expressed IFNy after ex vivo culture of the 
splenocytes Groups of 5 female Ci7R/6 mice aged 6 weeks were vaccinated as described in Materials and 
Methods 2.21. At 21 days post-initial vaccination the splenocytes were harvested and cultured for overnight in 
medium (a), PMA and ionomycin (h), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell culture at 9 
hours. The cells were harvested and stained as described in Materials and Methods 2.22 and 2.23. The graphs 
show the number of CD8+ T-cells that expressed IFNy after ex vivo culture of the splenocytes. Individual data 
points are shown as well as the mean and S.E.M (bars) for each vaccine group. Statistical comparisons were 
made using one-way ANOVA and the Bonferroni correction. The horizontal lines show the significance level 
. for each vaccine group compared to mice vaccinated with saline (i), BCG parent strain (ii), to M. vaccae Wt (iii) 
and to M. vaccae Acr2 (iv) with *, **, *** or *** representing significance levels of p<0.05, 0.01, 0.001 or 
0.0001 respectively.
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The unstimulated CD8+ T-cells of mice vaccinated with M: vaccae Wt and M. vaccae Acr2 
have higher intracellular IFNy levels as demonstrated by the MFI value, than mice vaccinated 
with saline or with BCG parent strain (Figure 45a).
Each"vaccine group demonstrated an increase in intracellular IFNy levels in the CD8+ T-cells 
after stimulation with PMA and ionomycin compared to the unstimulated CD8+ T-cells 
(Figure 45a and b) but M  vaccae Hsp70-Acr2 vaccinated mice showed a lower level of IFNy 
expression than the other vaccine groups (Figure 45b).
MycAg-specific increases in intracellular IFNy levels of CD8+ T-cells were observed in mice 
that were vaccinated with BCG parent strain and M. vaccae Wt above the levels found in 
saline, M. vaccae Acr2 or M  vaccae Hsp70-Acr2 vaccinated mice (Figure 45c) and above the 
levels in the unstimulated splenocytes (Appendix 3.8).
Although M. vaccae Wt vaccinated mice had higher intracellular IFNy levels compared to the 
saline and BCG parent strain vaccinated mice (Figure 45d), these levels were not 
significantly different to the background IFNy levels found in the unstimulated controls for 
M. vaccae Wt vaccinated mice (Appendix 3.8) and therefore do not represent an Acr2- 
specific induction of IFNy.
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Figure 45; The IFNy MFI level of IFNy producing CD8+ T-cells after €x yivç culture of the splenocytes. 
Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in Materials and Methods 2.21. At 
21 days post-initial vaccination the splenocytes were harvested and cultured for overnight in medium (a), PMA 
and ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell culture at 9 hours. The cells were 
harvested and stained as described in Materials and Methods 2.22 and 2.23. The graphs show the IFNy MFI 
levels of CD8+ T-cells that stained positive for IFNy. Individual data points are shown as well as thé mean and 
S.E.M (bars) for each vaccine group. Statistical comparisons were made using one-way ANOVA and the 
Bonferroni correction. I'he horizontal lines show the significance level for each vaccine group compared to mice 
vaccinated with saline (i), BCG parent strain (ii), to M. vaccae Wt (iii) and to M. vaccae Acr2 (iv) with *, **, 
*** or *** representing significance levels of p<0.05, 0.01, 0.001 or 0.0001 respectively.
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The iinstimulated splenocytes from mice vaccinated with M  vaccae Hsp70-Acr2 had higher 
numbers of CD8+ T-cells that produced EL4 compared to the saline, BCG parent strain and 
M vaccae Acr2 vaccinated mice (Figure 46a).
-The "mice that were vaccinated with M. vaccae Hsp70-Acr2 showed a higher number of 
CD8+ T-cells that expressed IL4 than all other vaccine groups after stimulation with PMA 
and ionomycin (Figiire 46b).
The M. vaccae Hsp70-Acr2 vaccinated mice demonstrated a MycAg-specific increase in the 
number of CD8+ T-cells that expressied IL4 compared to the unstimulated control (Appendix 
3.9) and compared to all the other vaccine groups (Figure 46c).
Although M. vaccae Hsp70-Acr2 vaccinated mice have raised numbers of IL4 producing 
CD8-I- T-cells compared to the other vaccine groups (Figure 46d) this is not an Acr2-specific 
induction o f IL4 as it does not differ from the levels observed in the unstimulated control 
(Appendix 3.9).
The unstimulated CD8+ T-cells from mice that were vaccinated with BCG parent strain had 
higher intracellular IL4 levels compared to the saline vaccinated mice (Figure 47a). The BCG 
parent strain and M. vaccae Wt vaccinated mice had higher IL4 levels than the M. vaccae 
Acr2 and M  vaccae Hsp70-Acr2 vaccinated mice in the unstimulated splenocytes cultures.
The CD8+ T-cells did not show an increase in intracellular IL4 in response to stimulation 
with PMA and ionomycin (Figure 47b), which agrees with tlie evidence that PMA and 
ionomycin is not as potent a stimulator of IL4 expression as of IFNy (Baran et al., 2001).
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Figure 46: The number of CD8+ T-ceUs per mouse that expressed IL4 after ex vtvo culture of the 
splenocytes. Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in Materials and 
Methods 2.21. At 21 days post-initial vaccination the splenocytes were harvested and cultured for overnight in 
medium (a), PMA and ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell culture at 9 
hours. The cells.were harvested and stained as described in Materials and Methods 2.22 and 2.23. The graphs 
show the number of CD8+ T-cells that expressed IL4 after ex vivo culture of the splenocytes. Individual data 
points are shown as well as the mean and S.E.M (bars) for each vaccine group. Statistical comparisons were 
made using one-way ANOVA and the Bonferroni correction. The horizontal lines show the significance level 
for each vaccine group compared to mice vaccinated with saline (i), BCG parent strain (ii), to M. vaccae Wt (iii)
and to M. vaccae Acr2 (iv) with *, 
0.0001 respectively.
or *** representing significance levels of p<0.05, 0.01, 0.001 or
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Figure 47: The IL4 MFI level of CD8+ T-cells that expressed ÏL4 after ex. vivo culture of the splenocytes. 
Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in Materials and Methods 2.21. At 
21 days post-initial vaccination the splenocytes were harvested and cultured for overnight in medium (a), PMA 
and ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell culture at 9 hours. The cells were 
harvested and stained as described in Materials and Methods 2.22 and 2.23. The graphs show the IL4 MFI levels 
of CD8+ T-cells that stained positive for IL4. Individual data points are shown as well as the mean and S.E.M 
(bars) for each vaccine group. Statistical comparisons were made using one-way ANOVA and the Bonferroni 
correction. The horizontal lines show the significance level for each vaccine group compared to mice vaccinated 
with saline (i), BCG parent strain (ii), to M. vaccae Wt (iii) and to M. vaccae Acr2 (iv) with *, **, *** or *** 
representing significance levels of p<0.05, O.OI, 0.001 or 0.0001 respectively.
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Although the mice vaccinated with BCG parent strain had higher intracellular IL4 levels in 
the MycAg stimulated splenocyte cultures (Figure 47c) and in the Acr2 stimulated cultures 
(Figure 47d) compared to the saline, M. vaccae Acr2 and M. vaccae Hsp70-Acr2 vaccine 
groups, the levels ^bservW were not different to the levels in the unstimulated controls 
(Appendix 3.10) and therefore the EL4 was not induced in a MycAg- or Acr2-specific 
manner.
Mice that were vaccinated with M. vaccae Wt or M. vaccae Hsp70-Acr2 had significantly 
greater numbers of CD8+ T-cells that expressed either IFNy or IL4 after ex vivo stimulation 
of the splenocytes with MycAg compared to the saline, BCG parent strain or M  vaccae Acr2 
vaccinated mice (Figure 48a).
The CD8+ T-cell response to MycAg was IFNy dominated in the BCG parent strain and M  
vaccae Wt vaccinated mice but was essentially non-polarized, with equal parts Type 1/Type 
2, in the mice vaccinated with M. vaccae Acr2 or M. vaccae Hsp70-Acr2 (Figure 48b).
Compared to the saline vaccinated mice, the mice vaccinated with M  vaccae Acr2 had raised 
numbers of CD8+ T-cells that responded to stimulation with Acr2 by expressing IFNy or DL4. 
The M  vaccae Hsp70-Acr2 vaccinated mice also had raised numbers of CD8+ T-cells that 
expressed IFNy or BL4 compared to the saline and BCG parent strain vaccinated mice after 
stimulation with Acr2. Neither the BCG parent strain nor M. vaccae Wt mice responded to 
Acr2 stimulation through the expression of IFNy or IL4 by the CD8+ T-cells.
While the M. vaccae Acr2 vaccinated mice had IFNy dominated CD8+ T-cell responses to 
Acr2 stimulation, the CD8+ T-cells fi'om M. vaccae Hsp70-Acr2 vaccinated mice had a 
mixed Type 1/Type 2 profile (Figure 48c âild d).
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Figure 48: The total number of CD8+ T-cells that expressed IFNy or IL4 per spleen and the ratio of the 
number of CD8+ T-cells that expressed IFNy to EL4 after ex vivo stimulation with MycAg or Acr2. The
graphs show the combined number of CD8+ T-cells that expressed IFNy or IL4 after ex vivo stimulation with 
MycAg (a) or Acr2 (c). The bars indicate the mean for each vaccine group with S.E.M bars. The statistical 
comparisons displayed are for the combined total o f IFNy+ and IL4+ CD8+ T-cells and were produced through 
ANOVA and the Bonferroni correction. The horizontal bars show the significance level for each vaccine group 
compared to mice vaccinated with saline (i), BCG parent strain (ii), to M. vaccae Wt (iii) and to M. vaccae Acr2 
(iv).The ratio of the number of CD8+ T-cells that expressed IFNy or IL4 after ex vivo stimulation with MycAg 
(b) or with Acr2 (d) with each data point representing a mouse and the bars showing the mean and S.E.M for the 
vaccine groups. Statistical comparisons were made using ANOVA and the Bonferroni correction. The horizontal 
lines show the significance level for each vaccine group compared to mice vaccinated with saline (i), BCG 
parent strain (ii), to M. vaccae Wt (iii) and to M. vaccae Acr2 (iv) with *, **, *** or *** representing 
significance levels o f p<0.05, O.OI, 0.001 or 0.0001 respectively.
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5.3 Discussion
The data presented in this chapter demonstrates that the plasmids pSMT3Acr2 and 
pSMT3Hsp70-Acr2 can be transformed into M. vaccae Wt and that the proteins Acr2 and 
Hsp70-Acr2 were expressed by the M. vaccae and were readily detectable using Western blot 
analysis. The Acr2 and Hsp70-Acr2 were detectable at approximately equal levels in the 
recombinant M  vaccae strains.
In this research the T-cell subsets were identified by the surface expression of CD3 with 
either CD4+ or CD8+, as both CD4+ and CD8+ T-cell are known to be involved in a 
successful immune response towards mycobacteria (Orme, 1987). In addition, the surface 
antigens CD69 and CD25 were chosen for analysis as representing activated T-cells and the 
cytokine IFNy and IL4 were chosen to indicate Type 1-like and Type 2-like responses 
respectively. Both cytokines were examined as a low IFNy response may be due to a Type 2 
polarised response or no response at all.
The numbers of CD4+ and CD8+ T-cells isolated per spleen were displayed to demonstrate 
whether proliferation of a particular T-cell subset has occurred in vivo. The data presented 
here suggested that M. vaccae Hsp70-Acr2 was not as effective as M. vaccae Wt in inducing 
CD4+ T-cell proliferation but there were no differences in the numbers of CD8+ T-cells 
between the vaccine groups.
T-cell activation was investigated as in order to respond to antigen challenge T-cells must be 
activated. Both BCG parent strain and M. vaccae Wt vaccinated mice demonstrated MycAg- 
specific increases in the numbers of activated T-cells showing that the MycAg stimulation 
was effective. Neither the M. vaccae Acr2 nor the M  vaccae Hsp70-Acr2 vaccinated mice 
showed any MycAg-specific or Acr2-specific activation of CD4+ or CD8+ T-cells. M. 
vaccae can spontaneously switch colony phenotype fi'om a rough surface to a smooth surface
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when cultured at 30°C and the smooth surface phenotype has reduced ability to induce a 
Type 1 T-cell response compared to rough surfaced M. vaccae (Rodriguez-Guell et al., 2006). 
Work in Mycobacterium smegmatis suggests that the smooth surface phenotype reduces 
-uptake-of M. smegmatis by macrophages (Kocincova et al., 2009) and that the switching of 
phenotype is due to mobile genetic elements (MGE) (Kocincova et al., 2008). Cellular stress 
can activate MGEs, so it is possible that stress from the transformation procedure activated 
MGEs in the M. vaccae that disrupted the synthesis of glycopetidolipids resulting in a smooth 
surface phenotype and therefore recombinant M  vaccae strains that were less immunogenic 
than M  vaccae Wt.
The effect of vaccination with M. vaccae Wt on the splenic T-cells of C57B/6 mice was to 
induce a strong CD8+ T-cell response characterised by MycAg-specific activation and ffNy 
expression. The MycAg-specific CD4+ T-cells also produced IFNy but to a lesser extent than 
the CD8+ T-cells. This is supported by other studies in the literature which found strong 
CD8+ T-cell responses in M. vaccae vaccinated mice (Skinner et al., 1997) and that M. 
vaccae can act as a Type 1 inducing adjuvant for non-mycobacterial proteins administered 
with M. vaccae (Skinner et al., 2001).
Vaccination with M. vaccae Acr2 resulted in no MycAg-specific activation or cytokine 
production. Both the CD4+ and CD8+ T-cells expressed IFNy when cultured with Acr2. In 
other recombinant M. vaccae systems T-cell reactivity to the foreign antigen is observed in a 
typically Type 1 dominant reaction (Abou-Zeid et al., 1997). Usually the response to MyeAg 
is maintained in addition to the response targeted to the foreign antigen (Hetzel et al., 1998). 
In this research, although the T-cells responded to the Acr2 expressed by the M. vaccae Acr2 
the T-cells appeared to have lost responsiveness to MycAg.
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The expectation for the M. vaccae Hsp70-Acr2 strain was that the T-cells of vaccinated mice 
would react to MycAg and to Acr2 but the magnitude of the T-cell reactivity to Acr2 would 
be greater than in M. vaccae Acr2 vaccinated mice. The MycAg-specific CD8+ T-cell 
response was the same magnitude as found in M  vaccae wt vaccinated mice but it was a 
mixed Type 1 and Type 2 with equal proportions of IFNy and IL4 producing CD8+ T-cells. 
The CD4+ T-cell response to MycAg stimulation was much greater in M  vaccae Hsp70- 
Acr2 mice than found in the M  vaccae Wt mice and, as with the CD8+ T-cells, the response 
was equal parts IFNy and IL4.
In contrast to the increased number of T-cells that expressed IFNy or IL4 after MycAg or 
Acr2 stimulation, the M. vaccae Hsp70-Acr2 and M. vaccae Acr2 vaccinated mice showed 
low levels of intracellular IFNy and IL4 in this study. This again, could reflect phenotypic 
changes in the recombinant M. vaccae as a consequence of the transformation procedure, as 
mentioned above with regard to the reduced activation levels.
The M. vaccae Hsp70-Acr2 vaccination appears to have induced a generalised increase in the 
level o f T-cell response as shown by the raised number of cytokine producing T-cells in the 
unstimulated splenocyte cultures in addition to the MycAg-specific increase in cytokine 
producing T-cells. This heightened immune response may be the result of Hsp70 induced 
maturation of antigen-presenting cells and resulting cytokine production and enhancement of 
antigen-presentation (Kuppner et al., 2001; Retzlaff et al., 1994).
Studies into proteoglycan-induced arthritis in BALB/c mice found that vaccination with 
Hsp70 induces an IFNy production and also results in ELIO secretion fi'om CD4+ CD25+ T- 
cells (Wieten et al., 2009). ELIO is known to be a strongly inhibitory cytokine that can 
suppress cytokine production by other T-cells. The T-cells fi'om M. vaccae Hsp70-Acr2 mice 
show a lack of activation marker expression and demonstrated low intracellular cytokine
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levels compared to the M. vaccae Wt mice when stimulated with MycAg. It is possible that 
the excess M  tuberculosis Hsp70 in the M. vaccae Hsp70-Acr2 bacteria induced a Type 2 
and inhibitory immune response in the C57B/6 mice.
Further, vaccination with M. vaccae Hsp70-Acr2 did not induce a stronger Acr2-specific T- 
cell response than observed in M. vaccae Acr2 vaccinated mice. Other studies have used 
fusion constructs of mycobacterial Hsp70 to other antigens have been used in other studies to 
enhance immune response towards a target antigen (Tobian et al., 2004a; Tobian et al., 
2004b). The plasmid used to create the Hsp70-Acr2 fusion construct in this study was 
expressed from an Hsp60 promoter on the plasmid pSMT3. As expression from the Hsp60 
promoter can be unstable in mycobacteria (Al-Zarouni and Dale, 2002; Carroll et al., 2010) 
the plasmid was engineered to transcribe the first 10 amino acids of Hsp60 as part of a 
translational fusion to the target gene to ensure more stable expression of the acr2 and hsp70- 
acr2 sequences. It is possible that the addition of the Hsp60 residues interrupted the ability of 
the Hsp70 to enhance antigen processing and presentation of the fused Acr2.
Hsp70 relies on interactions with co-chaperones to deliver peptides to the proteasome for 
degradation, a major pathway for presentation of antigen by MHC class 1. Fusing the Hsp70 
to Acr2 should result in increased efficiency of presentation of Acr2 to CD8+ T-cells 
(Harmala et al., 2002). B-cell lymphoma 2 associated athanogene (BAG) 1 and BAG-3 are 
co-chaperones involved in proteasomal degradation of peptides chaperoned by Hsp70 in 
eukaryotic cells (Kcttcm ct al., 2011) and they bind to the Hsp70 as part of their function. 
The GroEL residues at the N-terminus of the Hsp70-Acr2 construct may interrupt these 
interactions with BAG-1 and BAG-3, reducing the efficiency of transfer of Hsp70-Acr2 to 
the proteasome for degradation and presentation of Acr2. This potential lack of targeting to 
the proteasome may explain the absence of enhanced Acr2-specific T-cell activity observed
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in the M  vaccae Hsp70-Acr2 vaccinated mice compared to the M. vaccae Acr2 mice 
observed in the work presented here,
Of the recombinant M. vaccae strains investigated here, it would seem that M  vaccae Acr2 is 
the more likely candidate vaccine to take forward for further testing and development. 
Although the overall response by M  vaccae Hsp70-Acr2 vaccinated mice exceeds that of the 
other M  vaccae strains, it is mixed Type 1 and Type 2 and may involve inhibitory cytokines. 
Therefore, as M. vaccae Acr2 did successfully induce an Acr2-specific IFNy response by 
both CD4+ and CD8+ T-cells, this strain shows the greater potential of the two recombinant 
strains for further development. However, caution is required as the cytokine levels induced 
by Acr2 stimulation in M. vaccae Acr2 vaccinated mice remained relatively low and these 
mice also lacked a MycAg-specific T-cell response. Of course, it could be that the Acr2- 
specific T-cell response peaked at a different time-point to the 21 day response examined in 
this study and it would be useful to look at other time-points for Acr2 responsiveness. In 
preliminary challenge experiments neither M  vaccae Wt nor M  vaccae Acr2 vaccination 
demonstrated any protective potential in terms of reduction in the numbers of M. tuberculosis 
in the lungs of aerosol challenged mice (personal communication, J Keeble, NIB SC). The 
lack of protection from vaccination with heat-killed M. vaccae Wt is supported by other 
studies that showed in vitro induction of IFNy by splenocyte stimulation with mycobacterial 
antigens but no overall protection from challenge (Abou-Zeid et al., 1997) and no 
improvement in M. tuberculosis patients treated with M. vaccae in addition to the standard 
chemotherapy (de Bruyn and Gamer, 2003)
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5.4 Conclusion
We found that vaccination of C57B/6 mice with M  vaccœ  Wt induced a strong antigen- 
specific CD8+ T-cell response characterized by EFNy expression with a reduced Type 1-like 
CD4+ T-cell response. In contrast, vaccination with M. vaccae Acr2 resulted in a Type 1- 
biased CD4+ and CD8+ T-cell response that was directed exclusively towards Acr2 epitopes. 
However, the T-cell response to MycAg induced by vaccination with M  vaccae Wt was 
absent in the M. vaccae Acr2 mice. The fusion of Hsp70 and Acr2 was expected to enhance 
the response directed towards Acr2 epitopes compared to that found in M. vaccae Acr2 
vaccinated mice. The M. vaccae Hsp70-Acr2 mice exhibited strong MycAg-specific CD4+ 
and CD8+ T-cell responses but only a low level Acr2-specific cytokine production by CD8+ 
T-cells, much lower than that of M  vaccae Àcr2 mice. Further, rather than a Type 1 
dominated response the cytokine profile was mixed equally between Type land Type 2 
cytokines. EFNy, and a Type 1 immune response, have long been identified as correlates of 
protection against mycobacterial infection. For tliis reason, M. vaccae Acr2 and not M. 
vaccae Hsp70-Acr2 appears to be the better anti-mycobacterial candidate but neither M. 
vaccae Wt or M. vaccae Acr2 showed protection in aerosol challenge experiments.
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Chapter 6: General discussion
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This thesis investigated the T ^ l l  responses generated by vaccination with mycobacterial 
Hsp70 or Hsp70-peptide complexes, with BCG strains that over-expressed heat shock 
proteins or with M. vaccae strains that expressed M  tuberculosis Acr2 or a fusion of Hsp70 
^ d  Acr2. Tjoell activity was investigated as efficient Type 1-like T-cell responses are 
required for the clearance of mycobacterial infections (Cooper et al., 1993; Cooper et al., 
1995b; Dofifinger et al., 2002). The splenic T-cell populations were assessed for activation 
and expression of IFNy and IL4 after ex vivo stimulation to determine whether the vaccines 
induced CD4+ or CD8+ T-cell responses and if these were Type 1 or Type 2 biased.
The conclusions from Chapter 3 were that Hsp70-peptide complexes contain a variety of 
mycobacterial peptides including Hsp70, GroEL and acyl carrier protein peptides. GroEL 
may co-purify with Hsp70 through binding the ATP- or ADP-agarose or through binding to 
the binding cleft in Hsp70. Other studies have shown that Hsp70 should carry a much more 
diverse set of peptides. A larger scale analysis o f the mycobacterial ADP-purified Hsp70 is 
required to identify a more comprehensive list of Hsp70 peptide partners. Mice vaccinated 
with Hsp70-peptide complexes displayed a Type 1-biased CD4+T-cell response to a similar 
magnitude as BCG parent strain but lacked an increase, in CD8+ T-cell responses, and also 
demonstrated MycAg-specific but not Hsp70-specific proliferation of splenocytes. 
Vaccination with Hsp70 did not result in T-cell production of IFNy or IL4 above the numbers 
observed in saline vaccinated mice nor did it result in Hsp70-specific or MycAg-specific 
increased proliferation of splenocytes. However, it did skew the T-cell responses towards a 
more Type 1 profile than found in the saline or BCG parent strain vaccinated mice. In 
addition, Hsp70 vaccination resulted in a significant increase in the number of CD4+ T-cells 
that expressed CD25 compared to all other vaccine groups.
The study undertaken in Chapter 4 showed that vaccination with BCGA/wpR induced 
MycAg-specific splenocyte proliferation. In addition, BCGA/upR resulted in MycAg-specific
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CD4+ and CD8+ T-cell cytokine production but with a mixed Type 1/Type 2 profile 
compared to the Type 1 dominated response in BCG parent strain.
liCGlshspRAhrcA vaccination resulted in CD4+ and CD8+ T-cells that showed high rates of 
“activation arid cytokine production in response to PMA and ionomycin stimulation but lacked 
response to stimulation with MycAg. It is possible that this response represents a form of T- 
cell anergy where the T-cells maintain proliferative potential but fail to achieve full effector 
functions including activation and cytokine production.
The M. vaccae Wt strain tolerated the presence of plasmids and expressed the Acr2 and 
Hsp70-Acr2. The T-cells in M. vaccae Acr2 vaccinated mice lacked MycAg-specific 
activation or cytokine production but did induce Acr2-specific IFNy expression by both 
CD4+ and CD8+ T-cell, although the level per cell o f IFNy was low compared to the saline 
or M  vaccae Wt vaccinated mice.
The M. vaccae Hsp70-Acr2 vaccinated mice showed higher numbers of CD4+ and CD8+ T- 
cells that expressed IFNy or IL4 compared to the other vaccine groups in the unstimulated 
splenocyte cultures. The T-cells in M. vaccae Hsp70-Acr2 vaccinated mice also showed 
greater MycAg-specific CD4+ T-cell IFNy production than the other vaccine groups and 
equivalent numbers of CD8+ T-cells that expressed IFNy as observed in the M  vaccae Wt 
vaccinated mice. There was some Acr2-specific induction of the cytokines by T-cells after 
vaccination with M  vaccae Hsp70-Acr2 but fusion of Hsp70 and Acr2 did not result in 
enhanced Acr2-specific T-cells responses compared to the M. vaccae Acr2 vaccinated mice. 
The cytokine profile by both CD4+ and CD8+ T-cells was equal parts Type 1 and Type 2 
with low levels of cytokine per cell compared to the M. vaccae Wt vaccinated mice so 
appeared to be a weak and non-polarised MycAg-specific recall response.
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Vaccination of C57B/6 female mice with Hsp70 and Hsp70-peptide complexes purified fiom 
BCGAhspR induced Type 1-biased T-cell responses whereas exposure to Hsp70 as part of 
either a live whole cell vaccine, BCGAhspR, or a heat killed whole cell vaccine, M. vaccae 
Hsp70-Acr2^resulted in mixed Type 1 and Type 2 responses. Considering the importance of 
dendritic cells in initiating and programming the T-cell responses and the differences in 
response generated by the vaccines investigated in this thesis, the effect of vaccination on 
dendritic cells activity appears to be essential to understand why these alternative T-cell 
responses were observed.
T-cell responses are partly driven by the peptides presented by antigen-presenting cells and 
partly influenced by other antigen-presenting cell factors such as costimulatory signals, 
chemokines and cytokines. The magnitude and type of response demonstrated by T-cell s can 
be programmed by antigen-presenting cells. The differences in the T-cell responses found 
between the vaccine groups may be due to differences in antigen-presenting cell activity as a 
result of the vaccinations.
Dendritic cells are specialised antigen-presenting cells found in all locations in the body. 
These cells constantly ingest antigen for processing. When microbial signals lead to dendritic 
cell activation the cells migrate to secondary lymphoid organs, increase their antigen 
presentation and also express T-cell costimulatory signals and stimulatory cytokines such as 
EL 12. The dendritic cells are essential in stimulating and programming the T-cell response, 
whether Type 1 or Type 2 biased (Reis e Sousa et al., 1999) and are also important in the 
maintenance of memory T-cell populations. The activity of dendritic cells in generating the 
T-cell response is particularly important in mycobacterial protection as a lack of IL2 
secretion by dendritic cells is associated with disease progression (Cooper et al., 1995b).
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Mycobacterial Hsp70 is an attractive molecule in anti-mycobacterial research as it has been 
shown to interact with dendritic cells and macrophages through cell surface receptors (Asea 
et al., 2000b; Basu et al., 2001; Becker et al., 2002; Delneste et al., 2002; Tobian et al., 
2004a; Wangjet al.,^00 l)^ h e re  engagement with these receptors leads to internalisation of 
Hsp70. The idea is that Hsp70 can be used as a carrier molecule for other peptides targeting 
their delivery to host immune cells (Suzue et al., 1997; Tobian et al., 2004b; Udono and 
Srivastava, 1993). In addition, mycobacterial Hsp70 has been shown to act as an adjuvant by 
inducing the maturation of antigen-presenting cells (Harmala et al., 2002; MacAry et al., 
2004) thereby enhancing the presentation of antigens and the strength of the costimulatory 
signals.
It is likely that the mechanism of antigen-presenting cell interaction with Hsp70 differed 
between the protein subunit vaccines and the whole cell vaccines. Mammalian Hsp70 
interaction is thought to be mediated by CD40 (Becker et al., 2002; Wang et al., 2001), CD91 
(Basu et al., 2001), LOXl (Delneste et al., 2002), CD14 (Asea et al., 2000b), and human 
CCR5 mediates mycobacterial Hsp70 stimulation of antigen-presenting cells CCR5 (Floto et 
al., 2006). Diese Hsp70 receptors may interact with the free Hsp70 and Hsp70-peptide 
complexes but may not interact with the Hsp70 expressed by BCG and M. vaccae if it 
remains intracellular.
BCG and M. vaccae as whole bacteria would be engulfed by antigen-presenting cells via 
phagocytosis. The phagosome fuses with a lysosome to digest the engulfed bacteria. This 
process may result in the excess Hsp70 in the BCGAhspR, BCG AhspR AhrcA and M  vaccae 
Hsp70-Acr2 vaccines not interacting with the putative Hsp70 receptors if they are not present 
on the phagosomal membrane. For example, CD91 is downregulated on the phagosomal 
membrane of activated macrophages (Tena et al., 2003) so Hsp70 released through 
phagosomal lysis of the BCG or M. vaccae may not be taken into the cell via CD91. Further
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research is required to investigate whether any other receptors for Hsp70 are located on a 
phagosomal membrane and if these are a mechanism for interaction between Hsp70 and the 
antigen-presenting cell.
In order to investigate whether the mechanism of interaction between the Hsp70 and the 
dendritic cells affects the induction and programming of the immune response, dendritic cells 
could be cultured with soluble Hsp70, with Hsp70 bound to agarose beads or with Hsp70 
contained within a liposome. If the difference in the T-cell responses between the Hsp70 and 
the whole bacterium vaccines that expressed Hsp70 were due to the response by dendritic 
cells to Hsp70 engagement via surface receptors or via phagocytosed particles, or due to 
release of hidden Hsp70 through lysis of the BCG, represented by the liposome package of 
Hsp70, within the phagolysosome then one would expect to see alternative phenotypes in the 
dendritic cells. The expression of maturation markers including CD80/CD86 members of the 
B7 family, alterations in surface expression of adhesion molecules and MHC molecules in 
addition to detecting IL12 or ILIO secretion could be investigated. This would show whether 
the route of interaction between Hsp70 and the antigen-presenting cell can result in altered 
antigen-presenting cell phenotypes and therefore differences in the antigen-presenting cells’ 
ability to prime Type 1-like T-cell responses. Confirmation of receptor-mediated endocytosis 
or phagocytosis would require blocking of that process through receptor-specific antibodies 
or through culture with cytocholasin D to block phagocytosis.
Vaccination with BCGAhspR or M. vaccae Hsp70-Acr2 induced a mixed Type- 1/Type 2 
cytokine profile in response to MycAg stimulation, compared to the Type 1 biased T-cell 
response in BCG parent strain vaccinated mice. This Type 1/Type 2 response may be the 
result of T-cell stimulation
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Macrophages form a heterogeneous cell population. Macrophages can be divided into two 
populations depending on their activation pathway and subsequent activity; classically and 
alternatively activated macrophages. Macrophages require two signals to achieve classical 
activ^on; IFNy (Nathan et al., 1983) and TNFa, or TNFa inducers such as TLR 4 ligand, 
LPS (Tracey and Cerami, 1994). Classically activated macrophages produce nitric oxide 
(Denis, 1991; Hibbs, 2002; Hibbs et al., 1987) and secretes IFNy, TNFa and IL12, 
stimulating Type 1 T-cells responses and activation of surrounding macrophages (Gordon, 
2003; Mantovani et al., 2005).
Alternatively activated macrophages also require two signals for activation, namely ligation 
of Fc gamma receptors (FcyR) (Anderson and Mosser, 2002b) and stimulation by ligation of 
TLRs, CD40 or CD44 (Mosser, 2003). Alternatively activated macrophages secrete ILIO but 
do not produce IL12, ELI or IL18 (Verreck et al., 2004; Verreck et al., 2006), and this 
population o f macrophages can induce EL4 production by T-cells (Anderson and Mosser, 
2002a). Therefore, alternatively activated macrophages may be responsible for the mixed 
Type 1/ Type 2 T-cell cytokine profile in the mice vaccinated with Hsp70-overexpressing 
bacterial vaccines. In addition to skewing the T-cell response away from a Type 1 response, 
EL-10 producing alternatively activated macrophages are more permissive of mycobacterial 
growth than classically activated macrophages (Verreck et al., 2004) and hence their 
induction would be of a concern in the development of mycobacterial vaccines. Future 
investigations should look at whether EL-10 production by macrophages is induced by 
vaccination.
As mentioned before, EL-10 has been detected by some studies after mycobacterial Hsp70 
vaccination (Prakken et al., 2001; Wieten et al., 2009). In order to determine whether 
stimulation by mycobacterial Hsp70 induces alternative activation of macrophages, which 
may be the cause of the mixed Type 1/Type-2 T-cell responses in BCG A/up/? or M  vaccae
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Hsp70-Acr2 vaccinated mice, ILIO expression by macrophages could be measured in vitro 
co-culture of macrophages and mycobacterial Hsp70 or BCGAhspR or M. vaccae Hsp70- 
Acr2 should be carried out.
"Another characteri^ic of alternatively activated macrophages is the production of 
indoleamine 2,3-dioxygenase (Grohmann et al., 2003b), which is an enzyme involved in 
tryptophan catabolism. Secretion of indoleamine 2,3-dioxygenase results in tryptophan 
depletion in surrounding cells and inhibition of proliferation of surrounding cells (Frumento 
et al., 2002). This indoleamine 2,3-dioxygenase induced inhibition is observable even in 
mitogen-stimulated T-cell cultures. Indoleamine 2i3-dioxygenase production was discussed 
in Chapter 3 with reference to its production by dendritic cells in a semi-mature or 
alternatively activated state, caused by potential exposure to ATP contained in the Hsp70 
vaccine. Indoleamine 2,3-dioxygenase production by dendritic cells and macrophages is 
involved in the generation of T-regulatory cell populations and maintenance of T-cell anergy. 
T-regulatory cells can express ILIO and may be the source of mycobacterial Hsp70 induced 
ILIO (Wendling et al., 2000). Another in vitro coculture experiment of macrophages, T-cells 
and Hsp70 could investigate the whether macrophages cultured with mycobacterial Hsp70 
express indoleamine 2,3-dioxygenase, and if they can induce the T-regulatory cell population.
Of course it is possible that the hygromycin resistance gene used to construct the BCGAhspR, 
BCGAhspRAhrcA and the M. vaccae Hsp70-Acr2 strains influenced the T-cell responses 
resulting in the mixed Type 1/Type 2 profile. However, the M  vaccae Acr2 strains also 
contained the hygromycin-resistance gene and mice vaccinated with this strain induced Type 
1-biased T-cell responses. A more suitable control would be to produce an M. vaccae strain 
that contained the empty pSMT3 plasmid or engineer a BCG with the hygromycin resistance 
gene inserted between genes as these would express the resistance gene without alterations in 
Hsp70 or Acr2 expression. Nevertheless, comparing the M  vaccae Hsp70-Acr2 and the M.
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vaccae Acr2 strain, the data suggests that it is the overexpression of Hsp70 that was 
responsible for the mixed cytokine profile of the T-cells in the mice that were vaccinated with 
BCGAhspR, BCGAhspRAhrcA and the M  vaccae Hsp70-Acr2.
~M tuberculosis can interact with dendritic cells via DC-SIGN (Tailleux et al., 2003), a c-type 
lectin involved in the uptake of bacterial cells. DC-SIGN engagement results in ILIO 
production by the dendritic cells (C^arros et al., 2006) and this Type 2 induction appears to 
be mediated by M. tuberculosis surface lipoarabinmannan-DC-SIGN ligation(Geijtenbeek et 
al., 2003; Maeda et al., 2003). Some splenic T-cells in BCG parent strain vaccinated mice did 
express IL4, indicating a level of Type 2 induction but the numbers of T-cells that expressed 
IL4 were significantly greater in mice vaccinated with BCGAhspR, BCGAhspRAhrcA or M  
vaccae Hsp70Acr2. It is possible that the greater induction of Type 2 T-cell responses in the 
BCGAhspR, BCGAhspRAhrcA and the M  vaccae Hsp70Acr2 vaccinated mice was due to a 
synergistic effect of DC-SIGN ligation and stimulation via Hsp70 that may be on the surface 
of the recombinant mycobacteria. Alternatively, the overexpression of Hsp70 may altered the 
phenotype of the recombinant BCG and M  vaccae strains such that they are more able to 
induce ILIO expression by dendritic cells compared to wildtype BCG and M  vaccae.
One further potential explanation for the induction of mixed Type 1/Type 2 T-cell responses 
in the mice that received BCGtJispR, BC G /^pRA hrcA  or M  vaccae Hsp70Acr2 compared 
to the Type 1 only response found in the Hsp70 and Hsp70-peptide complexes vaccinated 
mice is the difference in antigen dosage. A study that investigated the effect of antigen85B 
(Ag85B) dose in recombinant BCG on T-cell responses found that a low dose of antigen 
resulted in Type 1 T-cell responses whereas a higher expression of Ag85B in the BCG 
induced mixed Type 1/Type 2 T-cell responses (Dhar et al., 2003). Expression of 19kDa 
antigen, 38kDa antigen or ESAT-6 TB antigens in BCG generated three different antigen- 
specific T-cell cytokine profiles: Type 1, Type 2 and Type 1/Type 2 respectively (Rao et al..
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2003). Each of the antigens were expressed from a Trm promoter, which gives strong 
expression of downstream antigens in mycobacteria. The 19kDa and 38kDa antigens were 
secreted by the recombinant BCG strains but ESAT-6 was not detected in the extracellular 
media. JFollowing this model, is likely to be the level of Hsp70 dosage that has determined the 
cytokine profile of the immune response because, as mentioned before, the M. vaccae Acr2 
vaccinated mice had Type 1-biased T-cell activity.
Clearly, these two studies show how important it is not only to choose an antigen but to 
consider other factors that may affect the induction of T-cell responses and demonstrates the 
need for better understanding of how BCG vaccination generates responses to foreign, 
antigens.
Of course, as heat shock proteins have been shown to enhance the immune response either 
through delivery of peptides or induction of maturation o f antigen-presenting cells, there is 
the possibility that overexpression of heat shock proteins results in a bacterial strain that is 
“too” immunogenic. Induction of such a rapid and strong primary response could result in 
clearance of the vaccine before adequate memory T-cell populations are established. 
Vaccination with BCG exploits the natural persistence of the bacterium to result in long-term 
antigen exposure in the host, a condition that more successfully initiates the formation of 
memory T-cells than single doses of protein-based vaccines. Enhanced immune responses 
may destroy the persistence capacity of the recombinant BCG, reducing the overall antigen- 
exposure and a lack of memory T-cells. Overexpression of Hsp70 in M  tuberculosis resulted 
in more rapid growth during acute phase of infection in C57B/6 mice but lower bacterial 
numbers than found in BCG parent strain during chronic infection (Stewart et al., 2001). 
These mice exhibited Hsp70-specific IFNy expression and a more Type 1 biased T-cell 
response than BCG parent strain mice. However, this paper used intravenous injection of 
BCG rather than subcutaneous injection, which has been shown to alter the immune response
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generated (Khalil et al., 1975) and also a longer time between infection and sacrifice (35 days 
compared to the 21 days used in this thesis).
Another factor discussed in Chapter 3 is the presence of ATP in the Hsp70 vaccine and the 
impact this has on programming the antigen-presenting cells and resulting T-cells responses. 
As a review, while some groups have found ATP exposure to be stimulatory of dendritic cell 
maturation and to induce the secretion of proinflammatory cytokines, other groups have 
shown ATP to have an alternative effect characterised by expression, not of proinflammatory 
cytokines or monocytes recruiting chemokines, but of ELIO and inhibitory molecules 
thrombospondin- 1 and idoleamine 2,3-dioxygenase (Marteau et al., 2005). Murine dendritic 
cells lack the same P2Y receptors studied on the human dendritic cells but murine dendritic 
cells still exhibited the same inhibitory or tolerogenic phenotype (Ben Addi et al., 2008). The 
BCGAhspR, BCGAhspRAhrcA and M. vaccae Hsp70-Acr2 vaccinated mice each displayed a 
mixed Type 1/Type 2 T-cell cytokine profile. This Type 2 induction may be the result not 
only of excess Hsp70 but maybe of increased ATP exposure by the dendritic cells in the 
vaccinated mice. Hsp70 may deliver ATP to the dendritic cells in a similar maimer that 
peptides can be delivered to the dendritic cell by Hsp70. The number of T-cells that 
expressed IFNy or EL4 was larger in the BCGA/w/?/? and M. vaccae Hsp70-Acr2 vaccinated 
mice than that observed in Hsp70 only vaccinated mice in Chapter 3 and this may be due to a 
synergy of ATP-Hsp70 signalling and the stimulation of other mycobacterial-specific 
receptors such as the mannose receptor, DC-SIGN. Of course, the ATP-delivery by Hsp70 
hypothesis requires the construct to be stable although adenosine fi’om degraded ATP has 
been shown to induce a similar Type 2 or tolerogenic phenotype in murine dendritic cells. 
(Ben Addi et al., 2008).
One way to test this Hsp70-ATP delivery hypothesis would be to generate a BCG strain that 
overexpressed an Hsp70 with a disrupted nucleotide binding site or engineer an M. vaccae
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strain that overexpressed Hsp70-Acr2 fusion also with a disrupted Hsp70 nucleotide binding 
site. It would then be possible to assess the effect on dendritic and T-cell activity in 
vaccinated mice and determine whether the excess Hsp70 or the delivered ATP or ADP were 
responsible for skewing the T-cell responses towards a mixed cytokine profile.
It appears likely that the overexpression of Hsp70 by BCG or M  vaccae mediated the mixed 
Type 1/Type 2 T-cell profile as this response was observed in two separate experiments using 
different species of mycobacteria, live recombinant BCG and heat-killed recombinant M. 
vaccae. It would be interesting to create plasmids encoding Hsp70 with varying promoter 
strengths to see if the mixed Type 1/Type 2 T-cell responses were due only to the high 
expression levels of Hsp70 or Hsp70-Acr2 as suggested by one study (Dhar et al., 2003) or if 
variation in the expression levels of Hsp70 would still induce the same mixed Type 1/Type 2 
response. Another direction would be to disrupt the ATP-binding domain, as described 
above, to determine whether the excess Hsp70 or Hsp70-Acr2 delivered excess ATP to the 
antigen-presenting cells in the mice that received BCGAhspR, BCGAhspRAhrcA and M  
vaccae Hsp70-Acr2.
Of course, one major limitation of the work presented here is that B-cell responses were not 
examined. B-cells secrete antibodies that bind to pathogens and target them for destruction by 
macrophage and dendritic cells. Due to this mechanism B-cells and the humoral response are 
thought to be important for extracellular infections, with intracellular pathogens most 
effectively targeted by cellular mediated immunity. Although antibody responses to 
mycobacterial antigens have been recorded there was no evidence that B-cells were involved 
in a successful immune response to mycobacterial infection as mouse (Johnson et al., 1997) 
and human studies on B-cell deficiencies (Doffinger et al., 2005) showed no differences in 
response between healthy and B-cell deficient subjects. However, B-cell responses have been 
shown to be important in control of mycobacterial infection (Maglione et al., 2007;
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Vordermeier et al., 1996). More recently, mycobacterial-specific IgA has been shown to 
provide protection when administered with human cytokines (Balu et al., 2011; Tjamlund et 
al., 2006). It would be worthwhile investigating whether the vaccines studied in this thesis 
induce IgA secretion by B-cells in the lungs, and also to look at T-cell responses in the lungs, 
to measure the mucosal immunity generated by vaccination with Hsp70-peptide complexes or 
the recombinant BCG strains and M. vaccae strains.
The data presented in this thesis suggests that Hsp70-peptide complexes show potential as 
anti-mycobacterial vaccine candidates. However, as EFNy production doesn’t necessarily 
correlate with protective efficacy. Correlates of protection are biomarkers that occur in 
immune individuals but not in susceptible individuals, although they may not cause 
protection themselves. IFNy production is required for protection to mycobacterial diseases, 
as shown by high fi'equency of non-pathogenic mycobacterial infections in mouse models 
people with IFNy pathway deficiencies (Cooper et al., 1993; Cooper et al., 2002; Cooper et 
al., 1997; Cooper et al., 1995b; Levin et al., 1995; Newport, 2003). However, people with M. 
tuberculosis infections are still enable of producing IFNy in response to stimulation and 
several studies have highlighted the lack of correlation between mycobacterial antigen 
induced IFNy production and protection (Agger and Andersen, 2001; Weir et al., 2006) and 
that the numbers of CD4+ T-cells that express IFNy (Mittrucker et al., 2007) do not correlate 
with protection. Therefore, although IFNy is required for protection, other factors in addition 
to IFNy determine the level of protection.
There is significant research ongoing into identifying human correlates of mycobacterial 
protection. One avenue under investigation as a new and more reliable correlate of protection 
is the level of T-cells that express more than one cytokine, referred to as multi-functional T- 
cells. Multi-functional T-cells coexpress two or more cytokines with IFNy, TNFa and IL2 
expression identified in polyfunctional T-cells that protect against mycobacterial infection . A
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lack of multi-functional T-cells that express IFNy, TNFa and IL-2 may explain the absence of 
protection observed in M. vaccae Acr2 vaccinated mice despite the induction of IFNy 
expressing Acr2-specific T-cells. Furthermore, if multi-functional T-cellS are required for 
protection then Hsp70-peptide complexes should be compared to BCG for the ability to 
generate this population of T-cells. There is some evidence that antigen-load can influence 
the induction of multi-functional T-cell populations (Aagaard et al., 2009; Day et al., 2008) 
and that lung multi-functional T-cells are important for protection (Forbes et al., 2008). 
Therefore, the detection of multi-functional T-cells, dosage response experiments and 
analysis of lung immunology are new direction for the progression of the research presented 
in this thesis. However, some recent research has failed to validate the link between 
protection and the occurrence of multi-functional T-cells in human neonates (Kagina et al., 
2010).
In vivo challenge experiments are more effective at evaluating vaccine efficacy than in vitro 
experiments and are an obvious avenue for future work. In collaboration with NIB SC, 
BCGAhspR and BCGùJispRAhrcA were compared to BCG parent strain in a mouse aerosol 
infection model for protection assessed by reductions in lung c.f.u. Neither BCG strain that 
overexpressed heat shock proteins induced enhanced protection from M. tuberculosis 
compared to BCG parent strain vaccination. In addition, neither M  vaccae Wt nor M. vaccae 
Acr2 protected mice from aerosol infection with M. tuberculosis H37Rv despite inducing 
IFNy expression by T-cells in the study in Chapter 5. Of course, there are limitations in the 
use of animal models and it may be insightful to evaluate the protective efficacy of these 
vaccines in a guinea pig model as well.
Additionally, in vitro modelling of Hsp70 and dendritic cell interactions would be desirable 
to determine the impact of ATP and ADP exposure as part of the Hsp70 complex on dendritic 
cell activity. One advantage of BCG over protein subunit vaccines is the natural persistence
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of BCG in the host, leading to longer antigen exposures. To account for this a prime and 
boost schedule was used for the Hsp70 and Hsp70-peptide complexes vaccination in this 
thesis. It would be interesting to investigate how the T-cell responses change with further 
Hsp7Q=peptide complexes booster vaccinations and determine the optimal number of doses 
for increased T-cell responses and protection from aerosol challenge with M  tuberculosis. 
Alternatively, BCG parent strain could be used as a prime and Hsp70-peptide complexes as a 
boost vaccination. As a final point, further repeats of the Hsp70-peptide separation protocol 
are required to widen the number of peptides confirmed as Hsp70-associated and also a 
comparison between the peptide pool of BCGAhspR described in this thesis and the peptide 
pool from Hsp70-peptide complexes purified from BCG parent strain.
From the data presented in this thesis a new vaccine consisting of BCG that overexpresses 
Acr2 from an expression plasmid may represent a future heat-shock based live bacterial 
vaccine. The M  vaccae experiment showed that recombinantly expressed M. tuberculosis 
Acr2 induced Acr2-specific CD4+ and CD8+ T-cells that expressed IFNy when stimulated ex 
vivo with Acr2. Overexpressing Acr2 in BCG would potentially allow the induction of an 
Acr2-specific population of T-cells without the confounding factor of the surface phenotype 
in M. vaccae that can alter the induction of Type 1 T-cell responses (Rodriguez-Guell et al., 
2006). The mycobacterial Hsp60 promoter was chosen to engineer the Acr2 and Hsp70-Acr2 
expression plasmids as it provides high levels of expression of downstream genes 
(Dellagostin et al., 1995). However, other groups have found that the mycobacterial Hsp60 
promoter is not tolerated on a plasmid by BCG and that transformed BCG frequently have 
deletions in the Hsp60 promoter region of the plasmids (Al-Zarouni and Dale, 2002; Carroll 
et al., 2010). In expression experiments deletion of Hsp60 promoter regions in mycobacterial 
expression plasmids with the Hsp60 promoter were detected in BCG transformants (data not 
shown). Therefore, it would be advisable to incorporate a non-Hsp60 promoter, such as the
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rpsA promoter, into a mycobacterial shuttle plasmid to stably express M. tuberculosis A crl in 
BCG DanishSI.
One major limitation in the work presented in this thesis was that only one time point post­
vaccination was investigated and that the splenocyte responses to ex vivo culture were 
analysed at 24 hours for intracellular cytokine analysis, or at 72 hours for cytokine secretion. 
Optimal time-points for cytokine detection vary according to the cytokine under investigation 
so using a single time-point in the studies in this thesis may distort the representation of the 
actual T-cell responses. Further, only one time point post vaccination was investigated so the 
data presented here is lacking in information about how the T-cell response develops over 
time. Future work should incorporate multiple time points to characterise the full 
development of the T-cell immune response.
As mentioned throughout this thesis, vaccination with Hsp70 or BCGAhspR, 
BCGAhspRAhrcA or M. vaccae Hsp70-Acr2 resulted in lack of T-cell responses that may be 
the due to a failure o f the vaccine to prime T-cells or the induction o f inhibitory or anergic 
pathways. It would also be valuable to look for the presence of T-regulatory cells by CD25 
and FoxP3 staining, or to investigate ELIO or idolamine production by antigen-presenting 
cells to determine whether the T-cell responses observed in mice that were vaccinated with 
Hsp70 or BCGAhspR, BCGùJvspRAhrcA or M. vaccae Hsp70-Acr2 were due to inhibitory 
compounds secreted by T-regulatory cells or from signals from antigen-presenting cells.
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Conclusion
Mycobacterial Hsp70 does show evidence of immunogenicity but as a delivery vector for 
other mycobacterial or model peptides rather than as a target of the immune response. 
Overexpression of Hsp70 in bacteria is useful for Hsp70 and Hsp70-peptide complexes 
purification but not for the production of a whole cell bacterial vaccine. The response to 
Hsp70 may be complicated by host immune tolerance for eukaryotic Hsp70 and also for 
bacterial Hsp70 molecules as it is likely that the host is exposed to Hsp70 frequently from 
environmental bacteria on mucosal surfaces. Equally, issues of host tolerance may also exist 
for vaccination with GroEL over-expressing bacteria, or DNA vaccines encoding hsp70 or 
groEL as targets of the immune response. The heat shock protein Acr2 showed higher 
numbers of Acr2-specific CD4+ and CD8+ T-cells that expressed IFNy and therefore appears 
to be a more promising heat shock protein than either Hsp70 or GroEL for future vaccine 
development. Although M  vaccae is a suitable expression vector for Acr2 it was not a 
suitable delivery vector and BCG would be a better choice for an M  tuberculosis Acr2 
expressing whole cell bacterial vaccine.
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Appendices 
Appendix 1
1.1: Representative example of flow cytometric analysis for the activation of CD4+ and CD8+ T-cells, 
measured by the surface expression of CD69 and CD25, from saline vaccinated mice. The splenocytes were 
collected and displayed according to forward scatter and side scatter with the lymphocyte population gated (ai). 
The lymphocyte population was displayed according to forward scatter and CD3-PerCp-Cy5 fluorescence and 
the CD3+ population were gated (aii). TheCD3+ lymphocytes were displayed according to CD4-APC 
fluorescence and CD8-FITC fluorescence with the CD3+ CD4+ population and the CD3+ CD8+ population 
gated (aiii). The CD4+ T-cells and CD8+ T-cells were displayed according to CD69-Pe-Cy7 and CD25-Pe 
fluorescence for the unstimulated splenocytes (hi an bii respectively), the PMA and ionomycin stimulated 
splenocytes (ci and cii respectively) and the MycAg stimulated splenocytes (di and dii). The appropriate isotype 
controls are displayed in density plots iii and iv.
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1.2: Representative example of flow cytometric analysis for the activation of CD4+ and CD8+ T-cells, 
measured by the surface expression of CD69 and CD25, from BCG Wt vaccinated mice. The splenocytes 
were collected and displayed according to forward scatter and side scatter with the lymphocyte population gated 
(ai). I he lymphocyte population was displayed according to forward scatter and CU3-FerCp-(JyS fluorescence 
and the CD3+ population were gated (aii). TheCD3+ lymphocytes were displayed according to CD4-APC 
fluorescence and CD8-FITC fluorescence with the CD3+ CD4+ population and the CD3+ CD8+ population 
gated (aiii). The CD8+ T-cells and CD4+ T-cells were displayed according to CD69-Pe-Cy7 and CD25-Pe 
fluorescence for the unstimulated splenocytes (hi an bii respectively), the PMA and ionomycin stimulated 
splenocytes (ci and cii respectively) and the MycAg stimulated splenocytes (di and dii). The appropriate isotype 
controls are displayed in density plots iii and iv.
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U :  Representative example of flow cytometric analysis for the expression of IFNy and IL4 by CD4+ and 
CD8+ T-cells, measured by the intracellular cytokine staining, from saline vaccinated mice. The
splenocytes were collected and displayed according to forward scatter and side scatter with the lymphocyte 
population gated (ai). The lymphocyte population was displayed according to forward scatter and CD3-PerCp- 
Cy5 fluorescence and the CD3+ population were gated (aii). The CD3+ lymphocytes were displayed according 
to C D 4-A F C  fluorescence and CD 8-hTi C fluorescence with the C D 3+ C D 4+  population and the C D 3+ C D 8+  
population gated (aiii). The CD4+ T-cells and CD8+ T-cells were displayed according to IFNy-Pe fluorescence 
•for the unstimUlated spleTiocytes (hi an bii respectively), the PMA and ionomycin stimulated splenocytes (ci and 
cii respectively),the MycAg stimulated splenocytes (di and dii respectively). Also displayed are the histograms 
of IL4 fluorescence of CD4+ T-cells and CD8+ T-cells fi’om unstimulated splenocytes (ei and eii), PMA and 
ionomycin stimulated splenocytes (fl and fli) and the MycAg stimulated splenocytes (gi and gii). Appropriate 
isotype controls for IFNy and IL4 staining are shown in histograms iii and iv for each culture condition.
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1.4 Representative example of flow cytometric analysis for the expression of IFNy by CD4+ and CD8+ T- 
cells, measured by the intracellular staining for IFNy, from BCG parent strain vaccinated mice. The
splenocytes were collected and-displayed according to forward scatter and side scatter with the lymphocyte 
population gated (ai). The lymphocyte population was displayed according to forward scatter and CD3-PerCp- 
Cy5 fluorescence and the CD3+ population were gated (aii). The CD3+ lymphocytes were displayed according 
to CD4-APC fluorescence and CD8-F1TC fluorescence with the CD3+ CD4+ population and the CD3+ CD8+ 
population gated (aiii). The CD4+ T-cells and CD8+ T-cells were displayed according to IFNy-Pe fluorescence 
for the unstimulated splenocytes (hi an bii respectively), the PMA and ionomycin stimulated splenocytes (ci and 
cii respectively), and the MycAg stimulated splenocytes (di and dii respectively). Also displayed are the 
histograms of IL4 fluorescence of CD4+ T-cells and CD8+ T-cells from unstimulated splenocytes (ei and eii), 
PMA and ionomycin stimulated splenocytes (fi and fli) and the MycAg stimulated splenocytes (gi and gii). 
Appropriate isotype controls for IFNy and IL4 staining are shown in histograms iii and iv for each culture 
condition.
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1.5: Representative example of flow cytometric analysis for the activation of CD4+ and CD8+ T-cells, 
measured by the surface expression of CD69 and CD25, from M. vaccae Wt vaccinated mice. The
splenocytes were collected and displayed according to forward scatter and side scatter with the lymphocyte 
population gated (ai). The lymphocyte population was displayed according to forward scatter and CD3-PerCp- 
Cy5 fluorescence and the CD3+ population were gated (aii). TheCD3+ lymphocytes were displayed according 
to CÜ4-APC fluorescence and Cd 8-FITC fluorescence with the CD3+ CD4+ population and the CD3+ CD8+ 
population gated (aiii). The CD8+ T-cells and CD4+ T-cells were displayed according to CD69-Pe-Cy7 and 
CD25-Pe fluorescence for the unstimulated splenocytes (hi an bii respectively), the PMA and ionomycin 
stimulated splenocytes (ci and cii respectively), the MycAg stimulated splenocytes (di and dii) and the Acr2 
stimulated splenocyte (ei and ii respectively). The appropriate isotype controls are displayed in density plots iii 
and iv.
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1.6: Representative example of flow cytometric analysis for the expression of IFNy by CD4+ and CD8+ T- 
cells, measured by the intracellular cytokine staining, from M. vaccae Wt vaccinated mice. The splenocytes 
were collected and displayed according to forward scatter and side scatter with the lymphocyte population gated 
(ai). The lymphocyte population was displayed according to forward scatter and CD3-PerCp-Cy5 fluorescence 
and the CD3+ population were gated (aii). The CD3+ lymphocytes were displayed according to CD4-APÇ 
fluorescence and CD8-F1TC fluorescence with the CD3+ CD4+ population and the CD3+ CD8+ population 
gated (aiii). The CD4+ T-cells and CD8+ T-cells were displayed according to IFNy-Pe fluorescence for the 
-unstimulated splenocytes“(bi an'bii respectively), the PMA and ionomycin stimulated splenocytes (ci and cii 
respectively), the MycAg stimulated splenocytes (di and dii respectively) and the Acr2 stimulated splenocytes 
(ei and eii respectively). Appropriate isotype controls for IFNy and IL4 staining are shown in histograms iii and 
iv for each culture condition.
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1.7: Representative example of flow cytometric analysis for the expression of EL4 hy CD4+ and CD8+ T- 
cells, measured hy the intracellular cytokine staining, from M. vaccae Wt vaccinated mice. The CD4+ and 
CD8+ T-cell populations were identified as described in Appendix 1.6. The CD4+ T-cells and CD8+ T-cells 
were displayed according to IL4-Pe-Cy7 fluorescence for the unstimulated splenocytes (ai an aii respectively), 
the PMA and ionomycin stimulated splenocytes (hi and bii respectively),the MycAg stimulated splenocytes (ci 
and cii respectively) and the Acr2 stimulated splenocytes (di and dii respectively). Appropriate isotype controls 
for IFNy and IL4 staining are shown in histograms iii and iv for each culture condition.
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Appendix 2
2.1: A comparison of the numbers of CD4+ and CD8+ T-cells that expressed CD69 or both CD69 and 
CD25 between the unstimulated and the MycAg stimulated splenocyte cultures. Mice were vaccinated as 
described in Materials and Methods 2.21. The splenocytes were h^ested at 21 days post-vaccination and were 
stimulated overnight as described in Material and Methods 2.22 and 2.23. Shown here are the Student’s T-test 
results for the comparisons between the unstimulated and the MycAg-stimulated splenocyte cultures for the 
number of CD4+ T-cells per spleen that expressed CD69 (a), the number of CD4+ T-cells per spleen that 
expressed both CD69 and CD25 (b), the number of CD8+ T-cells per spleen that expressed CD69 (c) and the 
number of CD8+ T-cells per spleen that expressed both CD69 and CD25 (d).
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U nstim ula ted  
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v.s. MycAg
BCGWt ^
BCG ùhspRÊJtrcA
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2.2: A comparison of the numbers of CD4+ and CD8+ T-cells that expressed IFNy or IL4 between the 
unstimulated and the MycAg stimulated splenocyte cultures. Mice were vaccinated as described in 
Materials and Methods 2.21. The splenocytes were harvested at 21 days post-vaccination and were stimulated 
overnight as described in Material and Methods 2.22 and 2.23. Shown here are the Student’s T-test results for 
the comparisons between the unstimulated and the MycAg-stimulated splenocyte cultures for the number of 
CD4+ T-cells per spleen that expressed IFNy (à), the number of CD4+ T-cells per spleen that expressed IL4 (b), 
the number of CD8+ T-cells per spleen that expressed IFNy (c) and the number of CD8+ T-cells per spleen that 
expressed IL4 (d).
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2.3: A comparison of the mean fluorescence intensity of CD4+ and CD8+ T-cells that expressed IFNy or 
EL4 between the unstimulated and the MycAg stiulated splenocyte cultures. Mice were vaccinated as 
described in Materials and Methods 2.21. The splenocytes were harvested at 21 days post-vaccination and were 
stimulated overnight as described in Material and Methods 2.22 and 2.23. Shown here are the Student’s T-test 
results for the comparisons between the unstimulated and the MycAg-stimulated splenocyte cultures for the 
number of CD4+ T-cells per spleen that expressed IFNy (a), the number of CD4+ T-cells per spleen that 
expressed IL4 (b), the number of CD8+ T-cells per spleen that expressed IFNy (c) and the number of CD8+ T- 
-cells per spleen that expressed IL4 (d).
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Appendix 3
3.1: The number of CD4+ T-cells that expressed CD69 or co-expressed CD69 and CD2S after ex vivo 
culture. Mice were vaccinated as described in Materials and Methods 2.21. The splenocytes were harvested at 
21 days post-vaccination and were stimulated overnight as described in Material and Methods 2.22 and 2.23. 
Shown here arc the repeated measures ANOVA outcomes for the intra-vaccine comparisons of the number of 
CD4+ T-cells that expressed CD69 (a) and the Bonferroni post hoc test level of significance (b). Also shown are 
Jhe repeMed mesures ANOVA outcomes for the intra-vaccine comparisons of the number of CD4+ T-cells that 
expressed both CD69 and CD25 (c) and the Bonferroni post hoc test level of significance (d). PMA and 
ionomycin results were excluded for this analysis.
Vaccine ANOVA '
b)
c)
d)
0001
VQÇcùé
Vaccine Unstimulated Unstimulated | MycAg
MycAg Acr2 j Acr2
vaccae
Vaccine
0001
M. Vaccae Acr2
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3.2: The number of CD8+ T-cells that expressed CD69 or co-expressed CD69 and CD2S after ex vivo 
culture. Mice were vaccinated as described in Materials and Methods 2.21. The splenocytes were harvested at 
21 days post-vaccination and were stimulated overnight as described in Material and Methods 2.22 and 2.23. 
Shown here are the repeated measures ANOVA outcomes for the intra-vaccine comparisons of the number of 
CD8+ T-cells that expressed CD69 (a) and the Bonferroni post hoc test level of significance (b). Also shown are 
the repeated measures ANOVA outcomes for the intra-vaccine comparisons of the number of CD8+ T-cells that 
expressed both CD69 and CD25 (c) and the Bonferroni post hoc test level of significance (d). PMA and 
ionomycin results were excluded for this analysis.
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3.3: The difference in the numbers of CD4+ T-cells that expressed IFNy due to the ex vivo culture 
conditions of the splenocytes Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods 2.21. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
overnight in medium (a), PMA and ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell 
culture at 3 hours. The cells were harvested and stained as described in Materials and Methods 2.22 and 2.23. 
The tables show the repeated measures analysis of variance (ANOVA) outcome for intra-vaccine comparisons 
(a) that show the differences in the numbers of CD4+ T-cells that expressed TFNy between the ex vivo culture 
conditions. The Bonferroni post hoc test results (b) show the significance level of the test statistic for the two 
conditions compared, or ns for non-significant results. PMA and ionomycin results were excluded for this 
analysis.
a) Vaccine ANOVA
Saline m w s
A m .
Qf03r7i
b) Vaccine U n stim u la ted
MycAg
U n st im u la ted
AcrZ
MycAg
AcrZ
P a g e  I 200
3.4: The difference in the IFNy MFI levels of CD4+ T-cells that expressed IFNy due to the ex vivo culture 
conditions of the splenocytes Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
overnight in medium (a), PMA and ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell 
culture at 3 hours. The cells were harvested and stained as described in Materials and Methods. The tables show 
the repeated measures analysis of variance (ANOVA) outcome for intra-vaccine comparisons (a) that show the 
differences in thê'IFNy MFI levels of CD4+ T-cells that expressed fFNy between the ex vivo culture conditions. 
The Bonferroni post hoc test results (b) show the significance level of the test statistic for the two conditions 
compared, or ns for non-significant results. PMA and ionomycin results were excluded for this analysis.
a ) Vaccine ANOVA
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3.5: The difference in the numbers of CD4+ T-cells that expressed IL4 due to the ex vivo culture 
conditions of the splenocytes Groups of 5 female CS7B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
overnight in medium (a), PMA and ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell 
culture at 3 hours. The cells were harvested and stained as described in Materials and Methods. The tables show 
the repeated measures analysis of variance (ANOVA) outcome for intra-vaccine comparisons (red box) that 
show the differences in the numbers of CD4+ T-cells that expressed IL4 between the ex vivo culture conditions. 
The Bonferroni post hoc test results (blue boxes) show the significance level of the test statistic for the two 
conditions compared, or ns for non-significant results. PMA and ionomycin results were excluded for this 
analysis.
a) Vaccine ANOVA
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3.6: The difference in the IL4 MFI levels of CD4+ T-cells that expressed IL4 due to the ex vivo culture 
conditions of the splenocytes Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
overnight in medium (a), PMA and ionomycin (b), MycAg (c), or Acr2 (d) Brefeldin A was added to the cell 
culture at 3 hours. The cells were harvested and stained as described in Materials and Methods. The tables show 
the repeated measures analysis of variance (ANOVA) outcome for intra-vaccine comparisons (a) that show the 
"differences in the IL4 MFI levels of CD4+ T-cells that expressed IL4 between the ex vivo culture conditions. 
The Bonferroni post hoc test results (b) show the significance level of the test statistic for the two conditions 
compared, or ns for non-significant results. PMA and ionomycin results were excluded for this analysis.
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3.7: The difference in the number of CD8+ T-cells that expressed IFNy due to the ex vivo culture 
conditions of the splenocytes Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
overnight in medium (a), PMA and ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell 
culture at 3 hours. The cells were harvested and stained as described in Materials and Methods. The tables show 
the repeated measures analysis of variance (ANOVA) outcome for intra-vaccine comparisons (a) that show the 
differences in the number of CD8+ T-cells that expressed IFNy between the ex vivo culture conditions. The 
Bonferroni post hoc test results (b) show the significance level of the test statistic for the two conditions 
compared, or ns for non-significant results. PMA and ionomycin results were excluded for this analysis.
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3.8: The difference in the IFNy MFI leveb of CD8+ T-cells that expressed IFNy due to the ex vivo culture 
conditions of the splenocytes Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
overnight in medium (a), PMA and ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell 
culture at 3 hours. The cells were harvested and stained as described in Materials and Methods. The tables show 
the repeated measures analysis of variance (ANOVA) outcome for intra-vaccine comparisons (a) that show the 
differermes in the IFNy MFI levels of CD8+ T-cells that expressed IFNy between the ex vivo culture conditions. 
The Bonferroni post hoc test results (b) show the significance level of the test statistic for the two conditions 
compared, or ns for non-significant results. PMA and ionomycin results were excluded for this analysis.
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3.9: The difference in number of CD8+ T-cells that expressed EL4 due to the ex vivo culture conditions of 
the splenocytes Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in Materials and 
Methods. At 21 days post-initial vaccination the splenocytes were harvested and cultured for overnight in 
medium (a), PMA and ionomycin (b), MycAg (c), or Acr2 (d). Brefeldin A was added to the cell culture at 3 
hours. The cells were harvested and stained as described in Materials and Methods. The tables show the 
repeated measures analysis of variance (ANOVA) outcome for intra-vaccine comparisons (a) that show the 
differences in the number of CD8+ T-cells that expressed IL4 between the ex vivo culture conditions. The 
Bonferroni post hoc test results (b) show the significance level of the test statistic for the two conditions 
compared, or ns for non-significant results. PMA and ionomycin results were excluded for this analysis.
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3.10: The difference in IL4 MFI levels of CD8+ T-cells that expressed IL4 due to the ex vivo culture 
conditions of the splenocytes Groups of 5 female C57B/6 mice aged 6 weeks were vaccinated as described in 
Materials and Methods 2.21. At 21 days post-initial vaccination the splenocytes were harvested and cultured for 
overnight in medium (a), PMA and ionomycin (b), MycAg (c), or Acr2 (dÿ Brefeldin A was added to the cell 
culture at 3 hours. The cells were harvested and stained as described in Materials and Methods 2.22 and 2.23. 
The tables showjhe repeated measures analysis of variance (ANOVA) outcome for intra-vaccine comparisons 
(a) that show the differences in the IL4 MFI levels of CD8+ T-cells that expressed IL4 between the ex vivo 
culture conditions. The Bonferroni post hoc test results (b) show the significance level of the test statistic for the 
two conditions compared, or ns for non-significant results. PMA and ionomycin results were excluded for this 
analysis. •
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